CURABLE RESIN COMPOSITION, CURED FILM, LAMINATE, METHOD FOR PRODUCING CURED FILM, AND SEMICONDUCTOR DEVICE

The use of specific resin precursors and metallocene compounds in curable resin compositions enhances resolution and chemical resistance in semiconductor device manufacturing, addressing the challenge of high-resolution pattern formation.

JP7595062B2Active Publication Date: 2024-12-05FUJIFILM CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2022503684
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-02-28
Filing Date
2021-02-25
Publication Date
2024-12-05
Estimated Expiration
2041-02-25

AI Technical Summary

Technical Problem

Existing curable resin compositions used in semiconductor devices face challenges in achieving high resolution during pattern formation.

Method used

A curable resin composition comprising polyimide, polybenzoxazole, and polyamide-imide precursors with specific cyclic structures and organometallic complexes, particularly metallocene compounds, is used to enhance resolution through uniform dispersion of the organometallic complexes, enabling improved pattern formation.

Benefits of technology

The composition achieves excellent resolution and chemical resistance in pattern formation, reducing development residues and pattern breakage, thereby improving manufacturing efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007595062000001
    Figure 0007595062000001
  • Figure 0007595062000002
    Figure 0007595062000002
  • Figure 0007595062000003
    Figure 0007595062000003
Patent Text Reader

Abstract

This curable resin composition contains an organometallic complex and at least one type of resin selected from the group consisting of a polyimide precursor containing a cyclic imide structure and / or a cyclic isoimide structure, a polybenzoxazole precursor containing a benzoxazole structure, and a polyamide-imide precursor containing a cyclic imide structure and / or a cyclic isoimide structure, wherein the molar content of the cyclic imide structures, the cyclic isoimide structures or the benzoxazole structures is a specific amount; this cured film is obtained by curing the curable resin composition; the laminate includes the cured film; the production method produces the cured film; and the semiconductor device contains the cured film or the laminate.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a curable resin composition, a cured film, a laminate, a method for producing a cured film, and a semiconductor device. [Background technology]

[0002] Resins such as polyimide, polybenzoxazole, and polyamideimide are used in various applications due to their excellent heat resistance and insulating properties. The applications are not particularly limited, but for example, in the case of semiconductor devices for mounting, they can be used as insulating films, sealing materials, or protective films. They are also used as base films and coverlays for flexible substrates.

[0003] For example, in the above-mentioned applications, resins such as polyimide, polybenzoxazole, and polyamideimide are used in the form of a curable resin composition containing at least one resin selected from the group consisting of polyimide precursors, polybenzoxazole precursors, and polyamideimide precursors. Such a curable resin composition is applied to a substrate by, for example, coating to form a photosensitive film, and then, if necessary, exposure, development, heating, etc. are performed to form a cured product on the substrate. The polyimide precursor, polybenzoxazole precursor, and polyamideimide precursor are cyclized, for example, by heating, and become polyimide, polybenzoxazole, and polyamideimide, respectively, in the cured product. Since the curable resin composition can be applied by a known coating method, etc., it can be said to have excellent adaptability in manufacturing, for example, high degree of freedom in designing the shape, size, application position, etc., of the applied curable resin composition. In addition to the high performance of polyimide, polybenzoxazole, polyamideimide, etc., from the viewpoint of such excellent adaptability in manufacturing, the industrial application development of the above-mentioned curable resin composition is expected to continue.

[0004] For example, Patent Document 1 describes a negative photosensitive resin composition containing 100 parts by mass of a polyimide precursor having a specific structure, 1 to 20 parts by mass of a photopolymerization initiator, and 0.01 to 10 parts by mass of a monocarboxylic acid compound having 2 to 30 carbon atoms and having one or more functional groups selected from the group consisting of a hydroxyl group, an ether group, and an ester group. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] JP 2011-191749 A Summary of the Invention [Problem to be solved by the invention]

[0006] In forming a pattern from a curable resin composition, there is a demand for improved resolution.

[0007] An object of the present invention is to provide a curable resin composition having excellent resolution during pattern formation, a cured film obtained by curing the curable resin composition, a laminate including the cured film, a method for producing the cured film, and a semiconductor device including the cured film or the laminate. [Means for solving the problem]

[0008] Examples of typical embodiments of the present invention are given below. <1> At least one resin selected from the group consisting of a polyimide precursor having at least one of a cyclic imide structure and a cyclic isoimide structure, a polybenzoxazole precursor having a benzoxazole structure, and a polyamideimide precursor having at least one of a cyclic imide structure and a cyclic isoimide structure, and Contains organometallic complexes, the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyimide precursor is 0.08 to 1.68 mmol / g; the molar amount of the benzoxazole structure contained in 1 g of the polybenzoxazole precursor is 0.22 to 3.97 mmol / g; the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyamideimide precursor is 0.062 to 1.186 mmol / g; Curable resin composition. <2> Further comprising a photoinitiator; <1> The curable resin composition according to claim 1. <3> The photopolymerization initiator is an oxime compound. <1> or <2> The curable resin composition according to claim 1. <4> Further comprising a crosslinking agent, <1> ~ <3> 13. The curable resin composition according to claim 12, <5> The organometallic complex is a metallocene compound. <1> ~ <4> 13. The curable resin composition according to claim 12, <6> The metal contained in the organometallic complex is at least one metal selected from the group consisting of titanium, zirconium, and hafnium. <1> ~ <5> 13. The curable resin composition according to claim 12, <7> The organometallic complex has a photoradical polymerization initiation ability. <1> ~ <6> 13. The curable resin composition according to claim 12, <8> Used to form a photosensitive film for negative development, <1> ~ <7> 13. The curable resin composition according to claim 12, <9> Used to form an interlayer insulating film for a redistribution layer, <1> ~ <8> 13. The curable resin composition according to claim 12, <10> <1> ~ <9> 2. A cured film obtained by curing the curable resin composition according to claim 1. <11> <10> 2. A laminate comprising two or more layers of the cured film according to claim 1, and a metal layer between any two adjacent cured films. <12> <1> ~ <9> 13. A method for producing a cured film, comprising: a film formation step of applying the curable resin composition according to any one of the above to a substrate to form a film. <13> The method includes an exposure step of exposing the film to light and a development step of developing the film. <12> A method for producing the cured film according to claim 1. <14> The exposure light used in the exposure contains light having a wavelength of 405 nm. <13> A method for producing the cured film according to claim 1. <15> The exposure is by a laser direct imaging method. <13> or <14> A method for producing the cured film according to claim 1. <16> The film is heated at 50 to 450 ° C. <12> ~ <15> 13. A method for producing the cured film according to any one of the above items. <17> <10> or a cured film according to <11> A semiconductor device comprising the stack according to claim 1. Effect of the Invention

[0009] According to the present invention, there are provided a curable resin composition having excellent resolution during pattern formation, a cured film obtained by curing the curable resin composition, a laminate including the cured film, a method for producing the cured film, and a semiconductor device including the cured film or the laminate. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The main embodiments of the present invention will be described below, however, the present invention is not limited to the embodiments explicitly described. In this specification, a numerical range expressed using the symbol "to" means a range that includes the numerical values ​​before and after "to" as the lower limit and upper limit, respectively. In this specification, the term "process" includes not only an independent process but also a process that cannot be clearly distinguished from other processes, so long as the process can achieve its intended effect. In the description of groups (atomic groups) in this specification, when there is no indication of whether they are substituted or unsubstituted, the term encompasses both groups (atomic groups) that have no substituents and groups (atomic groups) that have a substituent. For example, the term "alkyl group" encompasses not only alkyl groups that have no substituents (unsubstituted alkyl groups) but also alkyl groups that have a substituent (substituted alkyl groups). In this specification, unless otherwise specified, the term "exposure" includes not only exposure using light but also exposure using particle beams such as electron beams and ion beams. Examples of light used for exposure include the bright line spectrum of a mercury lamp, far ultraviolet light represented by an excimer laser, extreme ultraviolet light (EUV light), X-rays, electron beams, and other actinic rays or radiation. In this specification, "(meth)acrylate" means both or either of "acrylate" and "methacrylate", "(meth)acrylic" means both or either of "acrylic" and "methacrylic", and "(meth)acryloyl" means both or either of "acryloyl" and "methacryloyl". In this specification, Me in the structural formulae represents a methyl group, Et represents an ethyl group, Bu represents a butyl group, and Ph represents a phenyl group. In this specification, the total solid content refers to the total mass of all components of the composition excluding the solvent, and in this specification, the solid content concentration refers to the mass percentage of the other components excluding the solvent with respect to the total mass of the composition. In this specification, the weight average molecular weight (Mw) and the number average molecular weight (Mn) are defined as polystyrene equivalent values ​​according to gel permeation chromatography (GPC measurement) unless otherwise specified. In this specification, the weight average molecular weight (Mw) and the number average molecular weight (Mn) can be determined, for example, by using HLC-8220GPC (manufactured by Tosoh Corporation) and guard columns HZ-L, TSKgel Super HZM-M, TSKgel Super HZ4000, TSKgel Super HZ3000, and TSKgel Super HZ2000 (manufactured by Tosoh Corporation). Unless otherwise specified, these molecular weights are measured using THF (tetrahydrofuran) as an eluent. In addition, detection in GPC measurement is performed using a UV ray (ultraviolet ray) detector at a wavelength of 254 nm unless otherwise specified. In this specification, when the positional relationship of each layer constituting the laminate is described as "upper" or "lower", it is sufficient that there is another layer above or below the reference layer among the multiple layers being noted. In other words, a third layer or element may be interposed between the reference layer and the other layer, and the reference layer does not need to be in contact with the other layer. In addition, unless otherwise specified, the direction in which the layers are stacked on the substrate is referred to as "upper", or, in the case of a photosensitive film, the direction from the substrate to the photosensitive film is referred to as "upper", and the opposite direction is referred to as "lower". Note that such a vertical direction is set for the convenience of this specification, and in actual embodiments, the "upper" direction in this specification may be different from the vertical upward direction. In this specification, unless otherwise specified, the composition may contain, as each component contained in the composition, two or more compounds corresponding to that component. Furthermore, unless otherwise specified, the content of each component in the composition means the total content of all compounds corresponding to that component. In this specification, unless otherwise specified, the temperature is 23° C., the atmospheric pressure is 101,325 Pa (1 atm), and the relative humidity is 50% RH. As used herein, combinations of preferred aspects are more preferred aspects.

[0011] (Curable resin composition) The curable resin composition of the present invention comprises at least one resin (hereinafter also referred to as "specific resin") selected from the group consisting of a polyimide precursor containing at least one of a cyclic imide structure and a cyclic isoimide structure, a polybenzoxazole precursor containing a benzoxazole structure, and a polyamideimide precursor containing at least one of a cyclic imide structure and a cyclic isoimide structure, and an organometallic complex, wherein the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyimide precursor is 0.08 to 1.68 mmol / g, the molar content of the benzoxazole structure contained in 1 g of the polybenzoxazole precursor is 0.22 to 3.97 mmol / g, and the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyamideimide precursor is 0.062 to 1.186 mmol / g.

[0012] The curable resin composition of the present invention is preferably used for forming a photosensitive film to be exposed to light and developed, and is preferably used for forming a film to be exposed to light and developed using a developer containing an organic solvent. The curable resin composition of the present invention is preferably used for forming a photosensitive film to be subjected to negative development. In the present invention, negative development refers to a development in which the non-exposed areas are removed by development during exposure and development, and positive development refers to a development in which the exposed areas are removed by development. As the exposure method, the developer, and the development method, for example, the exposure method described in the exposure step and the developer and development method described in the development step in the description of the method for producing a cured film described later can be used.

[0013] The curable resin composition of the present invention is excellent in exposure sensitivity and in chemical resistance of the obtained pattern. The mechanism by which the above effects are obtained is unclear, but is speculated to be as follows.

[0014] For example, as described in Patent Document 1, an organic titanium compound or the like is added to a curable resin composition in order to improve chemical resistance. However, when a composition containing an organometallic complex is used for patterning, the organometallic complex may aggregate within the film, resulting in a decrease in resolution. In the present invention, a resin containing a specific amount of a cyclic imide structure, a cyclic isoimide structure, or a benzoxazole structure is used as the resin in the resin composition. It is believed that the strong interaction between these structures and the organometallic complex causes the organometallic complex contained in the composition to be dispersed in a nearly uniform state within the film. As a result, it is presumed that the resin composition of the present invention has excellent resolution.

[0015] The components contained in the curable resin composition of the present invention will be described in detail below.

[0016] <Specific resin> The curable resin composition of the present invention contains at least one resin (specific resin) selected from the group consisting of a polyimide precursor containing at least one of a cyclic imide structure and a cyclic isoimide structure, a polybenzoxazole precursor containing a benzoxazole structure, and a polyamideimide precursor containing at least one of a cyclic imide structure and a cyclic isoimide structure. The curable resin composition of the present invention preferably contains, as the specific resin, a polyimide precursor containing at least one of a cyclic imide structure and a cyclic isoimide structure. In addition, the specific resin preferably has a radical polymerizable group. When the specific resin has a radical polymerizable group, the curable resin composition preferably contains a photoradical polymerization initiator described later as a photosensitizer, more preferably contains a photoradical polymerization initiator described later as a photosensitizer and a radical crosslinking agent described later, and further preferably contains a photoradical polymerization initiator described later as a photosensitizer, a radical crosslinking agent described later, and a sensitizer described later. For example, a negative photosensitive film is formed from such a curable resin composition. The specific resin may also have a polarity conversion group such as an acid-decomposable group. When the specific resin has an acid decomposable group, the curable resin composition preferably contains a photoacid generator as described below as a photosensitizer. From such a curable resin composition, for example, a chemically amplified positive-type photosensitive film or negative-type photosensitive film is formed.

[0017] When the resin composition contains a polyimide precursor as the specific resin, from the viewpoint of resolution, the total molar content of the cyclic imide structure and the cyclic isoimide structure in 1 g of the polyimide precursor is 0.08 to 1.68 mmol / g, preferably 0.10 to 1.00 mmol / g, more preferably 0.12 to 0.80 mmol / g, and even more preferably 0.15 to 0.60 mmol / g. The polyimide precursor preferably contains at least a cyclic imide structure. The polyimide precursor may have at least one of a cyclic imide structure and a cyclic isoimide structure in a side chain, but preferably has it in the main chain. In this specification, the main chain of a resin refers to the relatively longest molecular chain in the molecule. When the resin composition contains a polybenzoxazole precursor as the specific resin, from the viewpoint of resolution, the molar amount of the benzoxazole structure in 1 g of the polybenzoxazole precursor is 0.22 to 3.97 mmol / g, preferably 0.25 to 3.00 mmol / g, more preferably 0.28 to 2.50 mmol / g, and even more preferably 0.30 to 2.00 mmol / g. The polybenzoxazole precursor may have a benzoxazole structure in a side chain, but preferably has it in the main chain. When the resin composition contains a polyamideimide precursor as the specific resin, from the viewpoint of resolution, the total molar content of the cyclic imide structure and the cyclic isoimide structure in 1 g of the polyamideimide precursor is 0.062 to 1.186 mmol / g, preferably 0.070 to 1.000 mmol / g, more preferably 0.080 to 0.800 mmol / g, and even more preferably 0.090 to 0.700 mmol / g. In addition, the polyamide-imide precursor preferably contains at least a cyclic imide structure. The polyamideimide precursor may have at least one of a cyclic imide structure and a cyclic isoimide structure in a side chain, but preferably has it in the main chain.

[0018] [Polyimide precursor] The polyimide precursor used in the present invention is not particularly limited in terms of its type, but it preferably contains a repeating unit represented by the following formula (2). [ka] In formula (2), A 1 and A 2 each independently represents an oxygen atom or NH; R 111 represents a divalent organic group, R 115 represents a tetravalent organic group, R 113 and R 114 each independently represents a hydrogen atom or a monovalent organic group.

[0019] A in Equation (2) 1 and A 2 each independently represents an oxygen atom or NH, and an oxygen atom is preferred. R in Equation (2) 111 represents a divalent organic group. Examples of the divalent organic group include a linear or branched aliphatic group, a cyclic aliphatic group, and a group containing an aromatic group. A linear or branched aliphatic group having 2 to 20 carbon atoms, a cyclic aliphatic group having 6 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group consisting of a combination thereof is preferred, and a group containing an aromatic group having 6 to 20 carbon atoms is more preferred. A particularly preferred embodiment of the present invention is a group represented by -Ar-L-Ar-. Here, each Ar is independently an aromatic group, and L is an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -CO-, -S-, -SO2-, or NHCO-, or a group consisting of a combination of two or more of the above. The preferred ranges of these are as described above.

[0020] R 111 is preferably derived from a diamine. Examples of diamines used in the production of the polyimide precursor include linear or branched aliphatic, cyclic aliphatic or aromatic diamines. Only one type of diamine may be used, or two or more types may be used. Specifically, it is preferable that the diamine contains a linear or branched aliphatic group having 2 to 20 carbon atoms, a cyclic aliphatic group having 6 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group consisting of a combination thereof, and it is more preferable that the diamine contains a group consisting of an aromatic group having 6 to 20 carbon atoms. Examples of the aromatic group include the following.

[0021] [ka] In the formula, A is preferably a single bond, an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, -SO2-, NHCO-, or a group selected from these combinations, more preferably a single bond, an alkylene group having 1 to 3 carbon atoms which may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, or -SO2-, and even more preferably -CH2-, -O-, -S-, -SO2-, -C(CF3)2-, or -C(CH3)2-. In the formula, * represents a bonding site with another structure.

[0022] Specific examples of diamines include 1,2-diaminoethane, 1,2-diaminopropane, 1,3-diaminopropane, 1,4-diaminobutane, and 1,6-diaminohexane; 1,2- or 1,3-diaminocyclopentane, 1,2-, 1,3-, or 1,4-diaminocyclohexane, 1,2-, 1,3-, or 1,4-bis(aminomethyl)cyclohexane, bis-(4-aminocyclohexyl)methane, bis-(3-aminocyclohexyl)methane, 4,4'-diamino-3,3'-dimethylcyclohexylmethane, and isophoronediamine; m- or p-phenylenediamine, diaminotoluene, 4,4'- or 3,3'-diaminobiphenyl, 4,4'-diaminodiphenyl ether, 3,3-diaminodiphenyl ether, 4,4'- and 3,3'-diaminodiphenylmethane, 4,4'- and 3,3'-diaminodiphenyl sulfone, 4,4'- and 3,3'-diaminodiphenyl sulfide, 4,4'- or 3,3'-diaminobenzophenone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'- Diaminobiphenyl, 2,2-bis(4-aminophenyl)propane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis(3-hydroxy-4-aminophenyl)propane, 2,2-bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, bis(3-amino-4-hydroxyphenyl)sulfone, bis(4-amino-3-hydroxyphenyl)sulfone, 4 ,4'-Diaminoparaterphenyl, 4,4'-bis(4-aminophenoxy)biphenyl, bis[4-(4-aminophenoxy)phenyl]sulfone, bis[4-(3-aminophenoxy)phenyl]sulfone, bis[4-(2-aminophenoxy)phenyl]sulfone, 1,4-bis(4-aminophenoxy)benzene, 9,10-bis(4-aminophenyl)anthracene, 3,3'-dimethyl-4,4'-diaminodiphenylsulfone, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 1,3-Bis(4-aminophenyl)benzene, 3,3'-diethyl-4,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenylmethane, 4,4'-diaminooctafluorobiphenyl, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 3,3',4,4'-tetraaminobiphenyl, 3,3',4,4'-tetraaminodiphenyl ether, 1 ,4-diaminoanthraquinone, 1,5-diaminoanthraquinone, 3,3-dihydroxy-4,4'-diaminobiphenyl, 9,9'-bis(4-aminophenyl)fluorene, 4,4'-dimethyl-3,3'-diaminodiphenyl sulfone, 3,3',5,5'-tetramethyl-4,4'-diaminodiphenylmethane, 2,4- and 2,5-diaminocumene, 2,5-dimethyl-p-phenylenediamine, acetoguanamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,4,6-trimethyl-m-phenylenediamine, bis( 3-aminopropyl)tetramethyldisiloxane, 2,7-diaminofluorene, 2,5-diaminopyridine, 1,2-bis(4-aminophenyl)ethane, diaminobenzanilide, esters of diaminobenzoic acid, 1,5-diaminonaphthalene, diaminobenzotrifluoride, 1,3-bis(4-aminophenyl)hexafluoropropane, 1,4-bis(4-aminophenyl)octafluorobutane, 1,5-bis(4-aminophenyl)decafluoropentane, 1,7-bis(4-aminophenyl)tetradecafluoroheptane, 2,2- Bis[4-(3-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(2-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-dimethylphenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-bis(trifluoromethyl)phenyl]hexafluoropropane, p-bis(4-amino-2-trifluoromethylphenoxy)benzene, 4,4'-bis(4-amino-2-trifluoromethylphenoxy)biphenyl, 4,At least one diamine selected from 4'-bis(4-amino-3-trifluoromethylphenoxy)biphenyl, 4,4'-bis(4-amino-2-trifluoromethylphenoxy)diphenyl sulfone, 4,4'-bis(3-amino-5-trifluoromethylphenoxy)diphenyl sulfone, 2,2-bis[4-(4-amino-3-trifluoromethylphenoxy)phenyl]hexafluoropropane, 3,3',5,5'-tetramethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,2',5,5',6,6'-hexafluorotolidine, and 4,4'-diaminoquaterphenyl can be mentioned.

[0023] Also preferred are the diamines (DA-1) to (DA-18) described in paragraphs 0030 to 0031 of WO 2017 / 038598.

[0024] In addition, diamines having two or more alkylene glycol units in the main chain described in paragraphs 0032 to 0034 of WO 2017 / 038598 are also preferably used.

[0025] R 111 is preferably represented by -Ar-L-Ar- from the viewpoint of flexibility of the obtained organic film. Here, each Ar is independently an aromatic group, and L is an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -CO-, -S-, -SO2- or NHCO-, or a group consisting of a combination of two or more of the above. Ar is preferably a phenylene group, and L is preferably an aliphatic hydrocarbon group having 1 or 2 carbon atoms which may be substituted with a fluorine atom, -O-, -CO-, -S- or SO2-. The aliphatic hydrocarbon group here is preferably an alkylene group.

[0026] Also, R 111 From the viewpoint of i-line transmittance, it is preferable that the divalent organic group represented by the following formula (51) or formula (61) is used. In particular, from the viewpoints of i-line transmittance and ease of availability, it is more preferable that the divalent organic group represented by the formula (61) is used. Formula (51) [ka] In formula (51), R 50 ~R 57 are each independently a hydrogen atom, a fluorine atom, or a monovalent organic group; R 50 ~R 57 At least one of is a fluorine atom, a methyl group, or a trifluoromethyl group. R 50 ~R 57 Examples of the monovalent organic group include an unsubstituted alkyl group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms) and a fluorinated alkyl group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms). [ka] In formula (61), R 58 and R 59 are each independently a fluorine atom or a trifluoromethyl group. Examples of the diamine compound giving the structure of formula (51) or (61) include 2,2'-dimethylbenzidine, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(fluoro)-4,4'-diaminobiphenyl, 4,4'-diaminooctafluorobiphenyl, etc. These may be used alone or in combination of two or more.

[0027] In addition, the following diamines can also be suitably used. [ka]

[0028] R in Equation (2) 115 represents a tetravalent organic group. As the tetravalent organic group, a tetravalent organic group containing an aromatic ring is preferable, and a group represented by the following formula (5) or formula (6) is more preferable. In formula (5) or formula (6), each * independently represents a bonding site to another structure. [ka] In formula (5), R 112 is preferably a single bond, an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -CO-, -S-, -SO2-, NHCO-, or a group selected from these combinations, more preferably a single bond, an alkylene group having 1 to 3 carbon atoms which may be substituted with a fluorine atom, -O-, -CO-, -S-, and SO2-, and further preferably a divalent group selected from the group consisting of -CH2-, -C(CF3)2-, -C(CH3)2-, -O-, -CO-, -S-, and SO2-.

[0029] R 115 Specifically, the tetracarboxylic acid residue remaining after removal of the anhydride group from the tetracarboxylic acid dianhydride can be mentioned. Only one type of tetracarboxylic acid dianhydride may be used, or two or more types of tetracarboxylic acid dianhydrides may be used. The tetracarboxylic dianhydride is preferably represented by the following formula (O). [ka] In formula (O), R 115 R represents a tetravalent organic group. 115 The preferred range of R in formula (2) is 115 The same definition and preferred range are also the same.

[0030] Specific examples of tetracarboxylic dianhydrides include pyromellitic dianhydride (PMDA), 3,3',4,4'-biphenyltetracarboxylic dianhydride, 3,3',4,4'-diphenylsulfide tetracarboxylic dianhydride, 3,3',4,4'-diphenylsulfone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-diphenylmethane tetracarboxylic dianhydride, 2,2 ',3,3'-Diphenylmethanetetracarboxylic dianhydride, 2,3,3',4'-Biphenyltetracarboxylic dianhydride, 2,3,3',4'-Benzophenonetetracarboxylic dianhydride, 4,4'-oxydiphthalic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,4,5,7-naphthalenetetracarboxylic dianhydride, 2,2-bis(3,4-dicarboxyphenyl)propane dianhydride, 2,2-bis(2, 1,3-diphenylhexafluoropropane-3,3,4,4-tetracarboxylic dianhydride, 1,4,5,6-naphthalenetetracarboxylic dianhydride, 2,2',3,3'-diphenyltetracarboxylic dianhydride, 3,4,9,10-perylenetetracarboxylic dianhydride, 1,2,4,5-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 1,8,9,10-phenanthrenetetracarboxylic dianhydride, 1,1-bis(2,3-dicarboxyphenyl)ethane dianhydride, 1,1-bis(3,4-dicarboxyphenyl)ethane dianhydride, 1,2,3,4-benzenetetracarboxylic dianhydride, and their alkyl and alkoxy derivatives having 1 to 6 carbon atoms.

[0031] Further, preferred examples include the tetracarboxylic dianhydrides (DAA-1) to (DAA-5) described in paragraph 0038 of WO 2017 / 038598.

[0032] R 111 and R 115 It is also preferable that at least one of R111 Examples of the residue include residues of bisaminophenol derivatives.

[0033] R 113 and R 114 each independently represents a hydrogen atom or a monovalent organic group; R 113 and R 114 It is preferable that at least one of the above contains a polymerizable group, and it is more preferable that both of the above contain a polymerizable group. The polymerizable group is a group capable of undergoing a crosslinking reaction by the action of heat, radicals, etc., and is preferably a radically polymerizable group. Specific examples of the polymerizable group include a group having an ethylenically unsaturated bond, an alkoxymethyl group, a hydroxymethyl group, an acyloxymethyl group, an epoxy group, an oxetanyl group, a benzoxazolyl group, a blocked isocyanate group, a methylol group, and an amino group. As the radically polymerizable group possessed by the polyimide precursor or the like, a group having an ethylenically unsaturated bond is preferable. Examples of the group having an ethylenically unsaturated bond include a vinyl group, a (meth)allyl group, and a group represented by the following formula (III), with the group represented by the following formula (III) being preferred.

[0034] [ka]

[0035] In formula (III), R 200 represents a hydrogen atom or a methyl group, and is preferably a hydrogen atom. In formula (III), * represents a bonding site to another structure. In formula (III), R 201 represents an alkylene group having 2 to 12 carbon atoms, -CH2CH(OH)CH2-, or a polyalkyleneoxy group. Suitable R 201Examples of the alkyl group include an ethylene group, a propylene group, a trimethylene group, a tetramethylene group, a 1,2-butanediyl group, a 1,3-butanediyl group, a pentamethylene group, a hexamethylene group, an octamethylene group, a dodecamethylene group, -CHCH(OH)CH-, and a polyalkyleneoxy group, of which an ethylene group, a propylene group, a trimethylene group, -CHCH(OH)CH-, and a polyalkyleneoxy group are more preferable, and a polyalkyleneoxy group is even more preferable. In the present invention, the polyalkyleneoxy group refers to a group in which two or more alkyleneoxy groups are directly bonded. The alkylene groups in the multiple alkyleneoxy groups contained in the polyalkyleneoxy group may be the same or different. When the polyalkyleneoxy group contains multiple types of alkyleneoxy groups having different alkylene groups, the arrangement of the alkyleneoxy groups in the polyalkyleneoxy group may be a random arrangement, an arrangement having blocks, or an arrangement having a pattern such as alternating. The number of carbon atoms in the alkylene group (including the number of carbon atoms in the substituent when the alkylene group has a substituent) is preferably 2 or more, more preferably 2 to 10, more preferably 2 to 6, even more preferably 2 to 5, still more preferably 2 to 4, particularly preferably 2 or 3, and most preferably 2. The alkylene group may have a substituent, and preferred examples of the substituent include an alkyl group, an aryl group, and a halogen atom. The number of alkyleneoxy groups contained in the polyalkyleneoxy group (the number of repeating polyalkyleneoxy groups) is preferably 2-20, more preferably 2-10, and even more preferably 2-6. As the polyalkyleneoxy group, from the viewpoint of solvent solubility and solvent resistance, polyethyleneoxy group, polypropyleneoxy group, polytrimethyleneoxy group, polytetramethyleneoxy group, or a group in which multiple ethyleneoxy groups and multiple propyleneoxy groups are bonded is preferred, polyethyleneoxy group or polypropyleneoxy group is more preferred, and polyethyleneoxy group is even more preferred.In the group in which multiple ethyleneoxy groups and multiple propyleneoxy groups are bonded, the ethyleneoxy groups and the propyleneoxy groups may be arranged randomly, may be arranged in blocks, or may be arranged in a pattern such as alternating.The preferred embodiment of the number of repetitions of the ethyleneoxy groups etc. in these groups is as described above.

[0036] R 113 and R 114 are each independently a hydrogen atom or a monovalent organic group. Examples of the monovalent organic group include aromatic groups and aralkyl groups in which an acidic group is bonded to one, two or three, preferably one, of the carbon atoms constituting the aryl group. Specific examples include aromatic groups having 6 to 20 carbon atoms and having an acidic group, and aralkyl groups having 7 to 25 carbon atoms and having an acidic group. More specific examples include a phenyl group having an acidic group and a benzyl group having an acidic group. The acidic group is preferably an OH group. R 113 or R 114 It is also more preferable that is a hydrogen atom, 2-hydroxybenzyl, 3-hydroxybenzyl, or 4-hydroxybenzyl.

[0037] From the viewpoint of solubility in organic solvents, R 113 or R 114 is preferably a monovalent organic group. The monovalent organic group preferably contains a linear or branched alkyl group, a cyclic alkyl group, or an aromatic group, and more preferably an alkyl group substituted with an aromatic group. The number of carbon atoms of the alkyl group is preferably 1 to 30. The alkyl group may be linear, branched, or cyclic. Examples of the linear or branched alkyl group include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a nonyl group, a decyl group, a dodecyl group, a tetradecyl group, an octadecyl group, an isopropyl group, an isobutyl group, a sec-butyl group, a t-butyl group, a 1-ethylpentyl group, a 2-ethylhexyl group, a 2-(2-(2-methoxyethoxy)ethoxy)ethoxy group, a 2-(2-(2-ethoxyethoxy)ethoxy)ethoxy group, a 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy group, and a 2-(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)ethoxy group. The cyclic alkyl group may be a monocyclic cyclic alkyl group or a polycyclic cyclic alkyl group. Examples of the monocyclic cyclic alkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a cyclooctyl group. Examples of the polycyclic cyclic alkyl group include an adamantyl group, a norbornyl group, a bornyl group, a camphenyl group, a decahydronaphthyl group, a tricyclodecanyl group, a tetracyclodecanyl group, a campholoyl group, a dicyclohexyl group, and a pinenyl group. Among them, the cyclohexyl group is the most preferable from the viewpoint of compatibility with high sensitivity. In addition, the alkyl group substituted with an aromatic group is preferably a linear alkyl group substituted with an aromatic group as described below. Specific examples of the aromatic group include a substituted or unsubstituted benzene ring, a naphthalene ring, a pentalene ring, an indene ring, an azulene ring, a heptalene ring, an indacene ring, a perylene ring, a pentacene ring, an acenaphthene ring, a phenanthrene ring, an anthracene ring, a naphthacene ring, a chrysene ring, a triphenylene ring, a fluorene ring, a biphenyl ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyridine ring, a pyrazine ring, A pyrimidine ring, a pyridazine ring, an indolizine ring, an indole ring, a benzofuran ring, a benzothiophene ring, an isobenzofuran ring, a quinolizine ring, a quinoline ring, a phthalazine ring, a naphthyridine ring, a quinoxaline ring, a quinoxazoline ring, an isoquinoline ring, a carbazole ring, a phenanthridine ring, an acridine ring, a phenanthroline ring, a thianthrene ring, a chromene ring, a xanthene ring, a phenoxathiin ring, a phenothiazine ring, or a phenazine ring. A benzene ring is most preferred.

[0038] In formula (2), R 113 is a hydrogen atom, or R 114 When is a hydrogen atom, the polyimide precursor may form a counter salt with a tertiary amine compound having an ethylenically unsaturated bond. An example of such a tertiary amine compound having an ethylenically unsaturated bond is N,N-dimethylaminopropyl methacrylate.

[0039] R 113 and R 114 At least one of the groups may be a polarity conversion group such as an acid-decomposable group. The acid-decomposable group is not particularly limited as long as it is decomposed by the action of an acid to generate an alkali-soluble group such as a phenolic hydroxy group or a carboxy group, but an acetal group, a ketal group, a silyl group, a silyl ether group, a tertiary alkyl ester group, etc. are preferred, and from the viewpoint of exposure sensitivity, an acetal group is more preferred. Specific examples of the acid-decomposable group include a tert-butoxycarbonyl group, an isopropoxycarbonyl group, a tetrahydropyranyl group, a tetrahydrofuranyl group, an ethoxyethyl group, a methoxyethyl group, an ethoxymethyl group, a trimethylsilyl group, a tert-butoxycarbonylmethyl group, a trimethylsilyl ether group, etc. From the viewpoint of exposure sensitivity, an ethoxyethyl group or a tetrahydrofuranyl group is preferred.

[0040] It is also preferable that the polyimide precursor has a fluorine atom in the structural unit. The fluorine atom content in the polyimide precursor is preferably 10% by mass or more and 20% by mass or less.

[0041] In order to improve adhesion to the substrate, the polyimide precursor may be copolymerized with an aliphatic group having a siloxane structure. Specifically, the polyimide precursor may be copolymerized with bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, or the like as a diamine component.

[0042] The repeating unit represented by formula (2) is preferably a repeating unit represented by formula (2-A). That is, at least one of the polyimide precursors used in the present invention is preferably a precursor having a repeating unit represented by formula (2-A). By adopting such a structure, it is possible to further expand the width of the exposure latitude. Formula (2-A) [ka] In formula (2-A), A 1 and A 2 represents an oxygen atom, R 111 and R 112 each independently represents a divalent organic group; R 113 and R 114 each independently represents a hydrogen atom or a monovalent organic group; R 113 and R 114At least one of the groups is a group containing a polymerizable group, and it is preferable that both of the groups are polymerizable groups.

[0043] A 1 , A 2 , R 111 , R 113 and R 114 Each independently represents A in formula (2). 1 , A 2 , R 111 , R 113 and R 114 The same definition and preferred range are also the same. R 112 is R in Eq. (5). 112 The same definition and preferred range are also the same.

[0044] The polyimide precursor may contain one type of repeating structural unit represented by formula (2), or may contain two or more types. In addition, it may contain a structural isomer of the repeating unit represented by formula (2). It goes without saying that the polyimide precursor may contain other types of repeating structural units in addition to the repeating unit of formula (2).

[0045] The polyimide precursor preferably contains, as a repeating unit having at least one of a cyclic imide structure and a cyclic isoimide structure, at least one repeating unit selected from the group consisting of repeating units represented by any of the following formulas (2-1) to (2-6), and more preferably contains at least one repeating unit selected from the group consisting of repeating units represented by the following formula (2-1), repeating units represented by the following formula (2-2), and repeating units represented by the following formula (2-3). [ka] In formulas (2-1) to (2-6), R 111 , R 113 , R 114 , R 115 , A 1 and A 2 are R in the above formula (2), 111 , R113 , R 114 , R 115 , A 1 and A 2 The same applies to the preferred embodiments.

[0046] The total content of the repeating units represented by any one of formulas (2-1) to (2-6) may be set so that the total content of the cyclic imide structure and cyclic isoimide structure in the polyimide precursor falls within the above-mentioned range.

[0047] An embodiment of the polyimide precursor of the present invention is one in which the total content of the repeating unit represented by formula (2) and the repeating unit represented by any one of formulas (2-1) to (2-6) is 50 mol% or more of all repeating units. The total content is more preferably 70 mol% or more, even more preferably 90 mol% or more, and particularly preferably more than 90 mol%. There is no particular upper limit to the total content, and all repeating units in the polyimide precursor except for the terminals may be either the repeating unit represented by formula (2) or the repeating unit represented by any one of formulas (2-1) to (2-6).

[0048] The weight average molecular weight (Mw) of the polyimide precursor is preferably 18,000 to 30,000, more preferably 20,000 to 27,000, and even more preferably 22,000 to 25,000.The number average molecular weight (Mn) of the polyimide precursor is preferably 7,200 to 14,000, more preferably 8,000 to 12,000, and even more preferably 9,200 to 11,200. The polyimide precursor has a molecular weight dispersity of preferably 2.5 or more, more preferably 2.7 or more, and even more preferably 2.8 or more. The upper limit of the molecular weight dispersity of the polyimide precursor is not particularly specified, but is, for example, preferably 4.5 or less, more preferably 4.0 or less, even more preferably 3.8 or less, even more preferably 3.2 or less, even more preferably 3.1 or less, even more preferably 3.0 or less, and particularly preferably 2.95 or less. In this specification, the dispersity of molecular weight is a value calculated by weight average molecular weight / number average molecular weight.

[0049] [Polybenzoxazole precursor] The polybenzoxazole precursor used in the present invention is not particularly limited with respect to its structure, but preferably contains a repeating unit represented by the following formula (3). [ka] In formula (3), R 121 represents a divalent organic group, R 122 represents a tetravalent organic group, R 123 and R 124 each independently represents a hydrogen atom or a monovalent organic group.

[0050] In formula (3), R 123 and R 124 are R in Eq. (2), 113 In other words, it is preferable that at least one of them is a polymerizable group. In formula (3), R 121 R represents a divalent organic group. The divalent organic group is preferably a group containing at least one of an aliphatic group and an aromatic group. The aliphatic group is preferably a linear aliphatic group. 121 The dicarboxylic acid residue is preferably a dicarboxylic acid residue. Only one type of dicarboxylic acid residue may be used, or two or more types of dicarboxylic acid residues may be used.

[0051] As the dicarboxylic acid residue, a dicarboxylic acid residue containing an aliphatic group and a dicarboxylic acid residue containing an aromatic group are preferred, and a dicarboxylic acid residue containing an aromatic group is more preferred. The dicarboxylic acid containing an aliphatic group is preferably a dicarboxylic acid containing a linear or branched (preferably linear) aliphatic group, and more preferably a dicarboxylic acid consisting of a linear or branched (preferably linear) aliphatic group and two -COOH. The number of carbon atoms in the linear or branched (preferably linear) aliphatic group is preferably 2 to 30, more preferably 2 to 25, even more preferably 3 to 20, even more preferably 4 to 15, and particularly preferably 5 to 10. The linear aliphatic group is preferably an alkylene group. Dicarboxylic acids containing a linear aliphatic group include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, and 2,2,6,6-tetramethylpimelic acid. , suberic acid, dodecafluorosuberic acid, azelaic acid, sebacic acid, hexadecafluorosebacic acid, 1,9-nonanedioic acid, dodecanedioic acid, tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, eicosanediacid, heneicosanediacid, docosanediacid, tricosanediacid, tetracosanediacid, pentacosanediacid, hexacosanediacid, heptacosanediacid, octacosanediacid, nonacosanediacid, triacontanedioic acid, hentriacontanedioic acid, dotriacontanedioic acid, diglycolic acid, and further dicarboxylic acids represented by the following formula.

[0052] [ka] (In the formula, Z is a hydrocarbon group having 1 to 6 carbon atoms, and n is an integer of 1 to 6.)

[0053] As the dicarboxylic acid containing an aromatic group, the following dicarboxylic acids having an aromatic group are preferred, and the following dicarboxylic acids consisting of only an aromatic group and two -COOH groups are more preferred.

[0054] [ka] In the formula, A represents a divalent group selected from the group consisting of -CH2-, -O-, -S-, -SO2-, -CO-, -NHCO-, -C(CF3)2-, and -C(CH3)2-, and each * independently represents a bonding site to another structure.

[0055] Specific examples of dicarboxylic acids containing an aromatic group include 4,4'-carbonyldibenzoic acid and 4,4'-dicarboxydiphenyl ether, and terephthalic acid.

[0056] Also, R 121 R may be a structure derived from a dicarboxylic acid or dicarboxylic acid halide containing a benzoxazole structure. 121 By making the above structure, a benzoxazole structure is introduced into the benzoxazole precursor. Examples of the above structure include the following structures: In the following structures, each * independently represents a bonding site with another structure. [ka]

[0057] In formula (3), R 122 represents a tetravalent organic group. The tetravalent organic group is R 115 The same definition and preferred range are also the same. R 122is also preferably a group derived from a bisaminophenol derivative, and examples of the group derived from a bisaminophenol derivative include 3,3'-diamino-4,4'-dihydroxybiphenyl, 4,4'-diamino-3,3'-dihydroxybiphenyl, 3,3'-diamino-4,4'-dihydroxydiphenyl sulfone, 4,4'-diamino-3,3'-dihydroxydiphenyl sulfone, bis-(3-amino-4-hydroxyphenyl)methane, 2,2-bis(3-amino-4-hydroxyphenyl)propane, 2,2-bis-(3-amino-4-hydroxyphenyl)hexafluoropropane, 2,2-bis-(4-amino bis-(4-amino-3-hydroxyphenyl)hexafluoropropane, bis-(4-amino-3-hydroxyphenyl)methane, 2,2-bis-(4-amino-3-hydroxyphenyl)propane, 4,4'-diamino-3,3'-dihydroxybenzophenone, 3,3'-diamino-4,4'-dihydroxybenzophenone, 4,4'-diamino-3,3'-dihydroxydiphenyl ether, 3,3'-diamino-4,4'-dihydroxydiphenyl ether, 1,4-diamino-2,5-dihydroxybenzene, 1,3-diamino-2,4-dihydroxybenzene, 1,3-diamino-4,6-dihydroxybenzene, etc. These bisaminophenols may be used alone or in combination.

[0058] Among the bisaminophenol derivatives, the following bisaminophenol derivatives having an aromatic group are preferred.

[0059] [ka] In the formula, X1 represents -O-, -S-, -C(CF3)2-, -CH2-, -SO2-, or -NHCO-, and * and # each represent a bonding site with another structure. R represents a hydrogen atom or a monovalent substituent, preferably a hydrogen atom or a hydrocarbon group, and more preferably a hydrogen atom or an alkyl group. 122 It is also preferable that R is a structure represented by the above formula. 122is a structure represented by the above formula, any two of the four * and # are R 122 is a bonding site with the nitrogen atom to which it is bonded, and the other two are R 122 is preferably a bonding site with the oxygen atom to which the bond is bonded, and the two * are preferably R 122 is a bonding site with the oxygen atom to which it is bonded, and the two #'s are R 122 is a bonding site with the nitrogen atom to which it is bonded, or two * are R 122 is a bonding site with the nitrogen atom to which it is bonded, and the two #'s are R 122 is more preferably a bonding site with the oxygen atom to which the bond is bonded, and two * are 122 is a bonding site with the oxygen atom to which it is bonded, and the two #'s are R 122 It is more preferable that the nitrogen atom to which the group is bonded is the bonding site.

[0060] [ka]

[0061] In formula (As), R1 is a hydrogen atom, alkylene, substituted alkylene, -O-, -S-, -SO2-, -CO-, -NHCO-, a single bond, or an organic group selected from the group of the following formula (A-sc). R2 is any one of a hydrogen atom, an alkyl group, an alkoxy group, an acyloxy group, and a cyclic alkyl group, and may be the same or different. R3 is any one of a hydrogen atom, a linear or branched alkyl group, an alkoxy group, an acyloxy group, and a cyclic alkyl group, and may be the same or different.

[0062] [ka] (In formula (A-sc), * indicates bonding to the aromatic ring of the aminophenol group of the bisaminophenol derivative represented by the above formula (As).)

[0063] In the above formula (As), having a substituent at the ortho position of the phenolic hydroxy group, i.e., at R3, is considered to bring the distance between the carbonyl carbon of the amide bond and the hydroxy group closer, which is particularly preferred in that the effect of achieving a high cyclization rate when cured at low temperatures is further enhanced.

[0064] In addition, in the above formula (As), it is preferable that R2 is an alkyl group and R3 is an alkyl group, since this maintains the effects of high transparency to i-line and a high cyclization rate when cured at low temperature.

[0065] In the formula (As), R1 is more preferably alkylene or substituted alkylene. Specific examples of alkylene and substituted alkylene pertaining to R1 include linear or branched alkyl groups having 1 to 8 carbon atoms, among which -CH2-, -CH(CH3)-, and -C(CH3)2- are more preferred in that they can provide a well-balanced polybenzoxazole precursor having sufficient solubility in a solvent while maintaining the effects of high transparency to i-line and high cyclization rate when cured at low temperature.

[0066] For the production method of the bisaminophenol derivative represented by the above formula (As), reference can be made to, for example, paragraphs 0085 to 0094 and Example 1 (paragraphs 0189 to 0190) of JP 2013-256506 A, the contents of which are incorporated herein by reference.

[0067] Specific examples of the structure of the bisaminophenol derivative represented by the above formula (As) include those described in paragraphs 0070 to 0080 of JP 2013-256506 A, the contents of which are incorporated herein by reference. Of course, it goes without saying that the present invention is not limited to these.

[0068] The polybenzoxazole precursor may contain other types of repeating structural units in addition to the repeating unit of formula (3) above. The polybenzoxazole precursor preferably contains, as a repeating unit having a benzoxazole structure, at least one repeating unit selected from the group consisting of a repeating unit represented by the following formula (3-1), a repeating unit represented by the following formula (3-2), and a repeating unit represented by the following formula (3-3). [ka] In formulas (3-1) to (3-3), R 121 , R 122 , R 123 and R 124 are R in Eq. (3), 121 , R 122 , R 123 and R 124 The same applies to the preferred embodiments.

[0069] The contents of the repeating unit represented by formula (3-1), the repeating unit represented by formula (3-2), and the repeating unit represented by formula (3-3) may be set so that the content of the benzoxazole structure in the polybenzoxazole precursor falls within the above-mentioned range.

[0070] In addition, the polybenzoxazole precursor preferably contains a diamine residue represented by the following formula (SL) as another type of repeating structural unit, in that the occurrence of warping due to ring closure can be suppressed.

[0071] [ka] In formula (SL), Z has an a structure and a b structure, and R 1s is a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms, R 2s is a hydrocarbon group having 1 to 10 carbon atoms, and R 3s , R 4s , R 5s , R 6sAt least one of them is an aromatic group, and the rest are hydrogen atoms or organic groups having 1 to 30 carbon atoms, which may be the same or different. The polymerization of the a structure and the b structure may be block polymerization or random polymerization. The molar percentage of the Z portion is 5 to 95 mol % for the a structure, 95 to 5 mol % for the b structure, and a+b is 100 mol %.

[0072] In formula (SL), preferred Z is R in the b structure. 5s and R 6s is a phenyl group. The molecular weight of the structure represented by formula (SL) is preferably 400 to 4,000, more preferably 500 to 3,000. By setting the molecular weight within the above range, it is possible to more effectively reduce the elastic modulus of the polybenzoxazole precursor after dehydration ring closure, and to simultaneously achieve the effect of suppressing warpage and the effect of improving solvent solubility.

[0073] When the diamine residue represented by formula (SL) is contained as another type of repeating structural unit, it is also preferable that the diamine residue represented by formula (SL) further contains, as a repeating structural unit, a tetracarboxylic acid residue remaining after removal of the anhydride group from the tetracarboxylic dianhydride. 115 Examples include:

[0074] When used in a composition described later, the polybenzoxazole precursor has a weight average molecular weight (Mw) of preferably 18,000 to 30,000, more preferably 20,000 to 29,000, and even more preferably 22,000 to 28,000. Also, the number average molecular weight (Mn) is preferably 7,200 to 14,000, more preferably 8,000 to 12,000, and even more preferably 9,200 to 11,200. The polybenzoxazole precursor has a molecular weight dispersity of preferably 1.4 or more, more preferably 1.5 or more, and even more preferably 1.6 or more. The upper limit of the molecular weight dispersity of the polybenzoxazole precursor is not particularly specified, but is preferably 2.6 or less, more preferably 2.5 or less, even more preferably 2.4 or less, even more preferably 2.3 or less, and even more preferably 2.2 or less.

[0075] [Polyamide-imide precursor] The polyamideimide precursor preferably contains a repeating unit represented by the following formula (PAI-2). [ka] In formula (PAI-2), R 117 represents a trivalent organic group, R 111 represents a divalent organic group, A 2 represents an oxygen atom or -NH-; R 113 represents a hydrogen atom or a monovalent organic group.

[0076] In formula (PAI-2), R 117 is exemplified by a straight-chain or branched-chain aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaromatic group, or a group in which two or more of these are linked by a single bond or a linking group, and is preferably a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group in which two or more of these are combined by a single bond or a linking group, and more preferably an aromatic group having 6 to 20 carbon atoms, or a group in which two or more aromatic groups having 6 to 20 carbon atoms are combined by a single bond or a linking group. The above-mentioned linking group is preferably -O-, -S-, -C(=O)-, -S(=O)2-, an alkylene group, a halogenated alkylene group, an arylene group, or a linking group formed by bonding two or more of these, and more preferably -O-, -S-, an alkylene group, a halogenated alkylene group, an arylene group, or a linking group formed by bonding two or more of these. The alkylene group is preferably an alkylene group having 1 to 20 carbon atoms, more preferably an alkylene group having 1 to 10 carbon atoms, and even more preferably an alkylene group having 1 to 4 carbon atoms. The halogenated alkylene group is preferably a halogenated alkylene group having 1 to 20 carbon atoms, more preferably a halogenated alkylene group having 1 to 10 carbon atoms, and more preferably a halogenated alkylene group having 1 to 4 carbon atoms. In addition, examples of the halogen atom in the halogenated alkylene group include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, and a fluorine atom is preferred. The halogenated alkylene group may have a hydrogen atom or all of the hydrogen atoms may be substituted with halogen atoms, but it is preferred that all of the hydrogen atoms are substituted with halogen atoms. Examples of preferred halogenated alkylene groups include a (ditrifluoromethyl)methylene group. The arylene group is preferably a phenylene group or a naphthylene group, more preferably a phenylene group, and further preferably a 1,3-phenylene group or a 1,4-phenylene group.

[0077] Also, R 117 is preferably derived from a tricarboxylic acid compound in which at least one carboxy group may be halogenated. The halogenation is preferably chlorination. In the present invention, a compound having three carboxy groups is called a tricarboxylic acid compound. Of the three carboxy groups of the tricarboxylic acid compound, two of the carboxy groups may be converted into acid anhydrides. The optionally halogenated tricarboxylic acid compound used in the production of the polyamideimide precursor includes branched aliphatic, cyclic aliphatic or aromatic tricarboxylic acid compounds. These tricarboxylic acid compounds may be used alone or in combination of two or more.

[0078] Specifically, the tricarboxylic acid compound is preferably a tricarboxylic acid compound containing a linear aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group in which two or more of these are combined via a single bond or a linking group, and more preferably a tricarboxylic acid compound containing an aromatic group having 6 to 20 carbon atoms, or a group in which two or more aromatic groups having 6 to 20 carbon atoms are combined via a single bond or a linking group.

[0079] Specific examples of tricarboxylic acid compounds include 1,2,3-propanetricarboxylic acid, 1,3,5-pentanetricarboxylic acid, citric acid, trimellitic acid, 2,3,6-naphthalenetricarboxylic acid, and compounds in which phthalic acid (or phthalic anhydride) and benzoic acid are linked via a single bond, -O-, -CH2-, -C(CH3)2-, -C(CF3)2-, -SO2-, or a phenylene group. These compounds may be compounds in which two carboxy groups are anhydridized (e.g., trimellitic anhydride) or compounds in which at least one carboxy group is halogenated (e.g., trimellitic anhydride chloride).

[0080] In formula (PAI-2), R 111 , A 2 , R 113 are R in the above formula (2), 111 , A 2 , R 113 The same applies to the preferred embodiments.

[0081] The polyamideimide precursor may further comprise other repeat units. Examples of other repeating units include a repeating unit represented by the above formula (2), a repeating unit represented by any one of formulas (2-1) to (2-6), and a repeating unit represented by the following formula (PAI-1). [ka]

[0082] In formula (PAI-1), R116 represents a divalent organic group, R 111 represents a divalent organic group. In formula (PAI-1), R 116 is exemplified by a straight-chain or branched-chain aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaromatic group, or a group in which two or more of these are linked by a single bond or a linking group, and is preferably a straight-chain aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group in which two or more of these are combined by a single bond or a linking group, and more preferably an aromatic group having 6 to 20 carbon atoms, or a group in which two or more aromatic groups having 6 to 20 carbon atoms are combined by a single bond or a linking group. The above-mentioned linking group is preferably -O-, -S-, -C(=O)-, -S(=O)2-, an alkylene group, a halogenated alkylene group, an arylene group, or a linking group formed by bonding two or more of these, and more preferably -O-, -S-, an alkylene group, a halogenated alkylene group, an arylene group, or a linking group formed by bonding two or more of these. The alkylene group is preferably an alkylene group having 1 to 20 carbon atoms, more preferably an alkylene group having 1 to 10 carbon atoms, and even more preferably an alkylene group having 1 to 4 carbon atoms. The halogenated alkylene group is preferably a halogenated alkylene group having 1 to 20 carbon atoms, more preferably a halogenated alkylene group having 1 to 10 carbon atoms, and more preferably a halogenated alkylene group having 1 to 4 carbon atoms. In addition, examples of the halogen atom in the halogenated alkylene group include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, and a fluorine atom is preferred. The halogenated alkylene group may have a hydrogen atom or all of the hydrogen atoms may be substituted with halogen atoms, but it is preferred that all of the hydrogen atoms are substituted with halogen atoms. Examples of preferred halogenated alkylene groups include a (ditrifluoromethyl)methylene group. The arylene group is preferably a phenylene group or a naphthylene group, more preferably a phenylene group, and further preferably a 1,3-phenylene group or a 1,4-phenylene group.

[0083] Also, R116 is preferably derived from a dicarboxylic acid compound or a dicarboxylic acid dihalide compound. In the present invention, a compound having two carboxy groups is called a dicarboxylic acid compound, and a compound having two halogenated carboxy groups is called a dicarboxylic acid dihalide compound. The carboxy group in the dicarboxylic acid dihalide compound may be halogenated, but is preferably chlorinated, for example, i.e., the dicarboxylic acid dihalide compound is preferably a dicarboxylic acid dichloride compound. Examples of the optionally halogenated dicarboxylic acid compound or dicarboxylic acid dihalide compound used in the production of the polyamideimide precursor include linear or branched aliphatic, cyclic aliphatic or aromatic dicarboxylic acid compound or dicarboxylic acid dihalide compound. These dicarboxylic acid compounds or dicarboxylic acid dihalide compounds may be used alone or in combination of two or more.

[0084] Specifically, the dicarboxylic acid compound or dicarboxylic acid dihalide compound is preferably a dicarboxylic acid compound or dicarboxylic acid dihalide compound containing a linear aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group in which two or more of these are combined via a single bond or a linking group, and more preferably a dicarboxylic acid compound or dicarboxylic acid dihalide compound containing an aromatic group having 6 to 20 carbon atoms, or a group in which two or more aromatic groups having 6 to 20 carbon atoms are combined via a single bond or a linking group.

[0085] Specific examples of dicarboxylic acid compounds include malonic acid, dimethylmalonic acid, ethylmalonic acid, isopropylmalonic acid, di-n-butylmalonic acid, succinic acid, tetrafluorosuccinic acid, methylsuccinic acid, 2,2-dimethylsuccinic acid, 2,3-dimethylsuccinic acid, dimethylmethylsuccinic acid, glutaric acid, hexafluoroglutaric acid, 2-methylglutaric acid, 3-methylglutaric acid, 2,2-dimethylglutaric acid, 3,3-dimethylglutaric acid, 3-ethyl-3-methylglutaric acid, adipic acid, octafluoroadipic acid, 3-methyladipic acid, pimelic acid, 2,2,6,6-tetramethylpimelic acid, suberic acid, dodecafluorosuberic acid, azelaic acid, sebacic acid, and hexadecafluorosuccinic acid. Examples of the fluorosebacic acid include fluorosebacic acid, 1,9-nonanedioic acid, dodecanedioic acid, tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, eicosanediacid, heneicosanediacid, docosanediacid, tricosanediacid, tetracosanediacid, pentacosanediacid, hexacosanediacid, heptacosanediacid, octacosanediacid, nonacosanediacid, triacontanedioic acid, hentriacontanedioic acid, dotriacontanedioic acid, diglycolic acid, phthalic acid, isophthalic acid, terephthalic acid, 4,4'-biphenylcarboxylic acid, 4,4'-biphenylcarboxylic acid, 4,4'-dicarboxydiphenyl ether, and benzophenone-4,4'-dicarboxylic acid. Specific examples of the dicarboxylic acid dihalide compound include compounds having a structure in which two carboxy groups in the specific examples of the dicarboxylic acid compound are halogenated.

[0086] In formula (PAI-1), R 111 is R in the above formula (2). 111 The same applies to the preferred embodiments.

[0087] The polyamideimide precursor preferably contains a repeating unit represented by either of the following formulas (PAI-3) and (PAI-4) as a repeating unit having at least one of a cyclic imide structure and a cyclic isoimide structure, and more preferably contains a repeating unit represented by the following formula (PAI-3). [ka] In formula (PAI-3) or formula (PAI-4), R 111 and R 117 are R in formula (PAI-2), 111 and R 117 The same applies to the preferred embodiments.

[0088] The content of the repeating unit represented by either formula (PAI-3) or (PAI-4) may be such that the total content of the cyclic imide structure and cyclic isoimide structure in the polyamideimide precursor falls within the above-mentioned range.

[0089] It is also preferable that the polyamideimide precursor has a fluorine atom in the structural unit. The fluorine atom content in the polyamideimide precursor is preferably 10% by mass or more and 20% by mass or less.

[0090] In order to improve adhesion to the substrate, the polyamide-imide precursor may be copolymerized with an aliphatic group having a siloxane structure. Specifically, the polyamide-imide precursor may be copolymerized with bis(3-aminopropyl)tetramethyldisiloxane, bis(p-aminophenyl)octamethylpentasiloxane, or the like, as a diamine component.

[0091] As an embodiment of the polyamideimide precursor of the present invention, the total content of the repeating unit represented by formula (PAI-2), the repeating unit represented by formula (PAI-1), the repeating unit represented by formula (PAI-3), the repeating unit represented by formula (PAI-4), the repeating unit represented by formula (2), and the repeating unit represented by any one of formulas (2-1) to (2-6) is 50 mol% or more of the total repeating units. The total content is more preferably 70 mol% or more, even more preferably 90 mol% or more, and particularly preferably more than 90 mol%. The upper limit of the total content is not particularly limited, and all the repeating units in the polyamideimide precursor except for the terminals may be any one of the repeating units represented by formula (PAI-2), the repeating unit represented by formula (PAI-1), the repeating unit represented by any one of formulas (PAI-3) and (PAI-4), the repeating unit represented by formula (2), and the repeating unit represented by any one of formulas (2-1) to (2-6). Another embodiment of the polyamideimide precursor of the present invention is one in which the total content of the repeating units represented by formula (PAI-2), the repeating units represented by formula (PAI-1), and the repeating units represented by any one of formulas (PAI-3) and (PAI-4) is 50 mol% or more of the total repeating units. The total content is more preferably 70 mol% or more, even more preferably 90 mol% or more, and particularly preferably more than 90 mol%. The upper limit of the total content is not particularly limited, and all repeating units in the polyamideimide precursor except for the terminals may be any one of the repeating units represented by formula (PAI-2), the repeating units represented by formula (PAI-1), or the repeating units represented by any one of formulas (PAI-3) and (PAI-4).

[0092] The weight average molecular weight (Mw) of the polyamideimide precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and even more preferably 10,000 to 50,000. The number average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and even more preferably 4,000 to 25,000.

[0093] The polydispersity of the molecular weight of the polyamideimide precursor is preferably from 1.5 to 3.5, and more preferably from 2 to 3. In this specification, the dispersity of molecular weight refers to the value obtained by dividing the weight average molecular weight by the number average molecular weight (weight average molecular weight / number average molecular weight).

[0094] [Method for producing polyimide precursor, etc.] The polyimide precursor or the like can be obtained by reacting a dicarboxylic acid or a dicarboxylic acid derivative with a diamine, preferably by halogenating a dicarboxylic acid or a dicarboxylic acid derivative with a halogenating agent and then reacting the halogenated dicarboxylic acid or a dicarboxylic acid derivative with a diamine. In the method for producing a polyimide precursor or the like, it is preferable to use an organic solvent during the reaction. The organic solvent may be one type or two or more types. The organic solvent can be appropriately selected depending on the raw materials, and examples thereof include pyridine, diethylene glycol dimethyl ether (diglyme), N-methylpyrrolidone, and N-ethylpyrrolidone.

[0095] It is also preferable to synthesize using a non-halogen catalyst without using the halogenating agent. As the non-halogen catalyst, a known amidation catalyst that does not contain a halogen atom can be used without any particular limitation, and examples thereof include boroxine compounds, N-hydroxy compounds, tertiary amines, phosphoric esters, amine salts, urea compounds, and carbodiimide compounds. As the carbodiimide compounds, N,N'-diisopropylcarbodiimide, N,N'-dicyclohexylcarbodiimide, and the like can be mentioned. In the method for producing a polyimide precursor or the like, it is preferable to use an organic solvent during the reaction. The organic solvent may be one type or two or more types. The organic solvent can be appropriately selected depending on the raw materials, and examples thereof include pyridine, diethylene glycol dimethyl ether (diglyme), N-methylpyrrolidone, and N-ethylpyrrolidone.

[0096] In the synthesis of polyimide or the like, for example, the total molar content of the above-mentioned cyclic imide structure and cyclic isoimide structure, or the molar content of the above-mentioned benzoxazole structure can be adjusted by appropriately setting the reaction time, reaction temperature, and pH during the reaction of a dicarboxylic acid or a dicarboxylic acid derivative (which may be halogenated with a halogenating agent, or may not be halogenated and a non-halogen-based catalyst may be used) with a diamine.

[0097] -End capping agent- In the method for producing a polyimide precursor or the like, in order to further improve storage stability, it is preferable to cap the ends of the polyimide precursor or the like with an end-capping agent such as an acid anhydride, a monocarboxylic acid, a monoacid chloride compound, a monoactive ester compound, etc. As the end-capping agent, it is more preferable to use a monoamine, and preferred monoamine compounds include aniline, 2-ethynylaniline, 3-ethynylaniline, 4-ethynylaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxy-7-aminonaphthalene, 1-carboxy-6-aminonaphthalene, 1-carboxy-8-aminonaphthalene, 1-carboxy-9-aminonaphthalene, 1-carboxy-10-aminonaphthalene, 1-carboxy-11-aminonaphthalene, 1-carboxy-12-aminonaphthalene, 1-carboxy-13-aminonaphthalene, 1-carboxy-14-aminonaphthalene, 1-carboxy-15-aminonaphthalene, 1-carboxy-16-aminonaphthalene, 1-carboxy-17-aminonaphthalene, 1-carboxy-18-aminonaphthalene, 1-carboxy-19 ... Examples of the amino acid ester include 5-aminonaphthalene, 2-carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminothiophenol, 3-aminothiophenol, and 4-aminothiophenol. Two or more of these may be used, and a plurality of different terminal groups may be introduced by reacting a plurality of terminal blocking agents.

[0098] -Solid precipitation- The production of the polyimide precursor or the like may include a step of precipitating a solid. Specifically, the polyimide precursor or the like in the reaction solution is precipitated in water, and then dissolved in a solvent in which the polyimide precursor or the like is soluble, such as tetrahydrofuran, to precipitate the solid. Thereafter, the polyimide precursor or the like is dried to obtain a powdered polyimide precursor or the like.

[0099] [Content] The content of the specific resin in the composition of the present invention is preferably 20% by mass or more, more preferably 30% by mass or more, even more preferably 40% by mass or more, and even more preferably 50% by mass or more, based on the total solid content of the composition. The content of the resin in the composition of the present invention is preferably 99.5% by mass or less, more preferably 99% by mass or less, even more preferably 98% by mass or less, even more preferably 97% by mass or less, and even more preferably 95% by mass or less, based on the total solid content of the composition. The composition of the present invention may contain only one type of specific resin, or may contain two or more types. When two or more types are contained, the total amount is preferably within the above range.

[0100] It is also preferable that the curable resin composition of the present invention contains at least two types of resins. Specifically, the curable resin composition of the present invention may contain a total of two or more types of the specific resin and the other resin described below, or may contain two or more types of the specific resin, but it is preferable that the curable resin composition contains two or more types of the specific resin. When the curable resin composition of the present invention contains two or more specific resins, for example, a polyimide precursor having a structure derived from a dianhydride (R 115 It is preferable that the polyimide precursors include two or more different polyimide precursors. When the curable resin composition of the present invention contains two or more kinds of polyimide precursors, the total molar content of cyclic imide structures and cyclic isoimide structures contained in at least one polyimide precursor is required to be within the above-mentioned range. When the total amount of all polyimide precursors is taken as 1 g, the total molar content of cyclic imide structures and cyclic isoimide structures contained in all polyimide precursors is preferably within the above-mentioned range, and it is more preferable that each of the polyimide precursors contained in the curable resin composition contains a cyclic imide structure and a cyclic isoimide structure in the above-mentioned range. When the curable resin composition of the present invention contains two or more polybenzoxazole precursors, the molar content of the benzoxazole structure contained in at least one polybenzoxazole precursor may be within the above-mentioned range. When the total amount of all polybenzoxazole precursors is taken as 1 g, the total molar content of the benzoxazole structure contained in all polybenzoxazole precursors is preferably within the above-mentioned range. It is more preferable that each of the polyimide precursors contained in the curable resin composition contains at least one of a cyclic imide structure and a cyclic isoimide structure within the above-mentioned range. When the curable resin composition of the present invention contains two or more types of polyamideimide precursors, the total molar content of cyclic imide structures and cyclic isoimide structures contained in at least one polyamideimide precursor may be within the above-mentioned range, and it is preferable that the total molar content of cyclic imide structures and cyclic isoimide structures contained in all polyamideimide precursors is within the above-mentioned range when the total amount of all polyamideimide precursors is taken as 1 g, and it is more preferable that each of the polyamideimide precursors contained in the curable resin composition contains at least one of a cyclic imide structure and a cyclic isoimide structure in the above-mentioned range.

[0101] <Organometallic complexes> The curable resin composition of the present invention contains an organometallic complex. The organometallic complex may be an organic complex compound containing a metal atom, but is preferably a complex compound containing a metal atom and an organic group, more preferably a compound in which an organic group is coordinated to a metal atom, and further preferably a metallocene compound. In the present invention, the metallocene compound refers to an organometallic complex having two cyclopentadienyl anion derivatives, which may have a substituent, as η5-ligands. The organic group is not particularly limited, but is preferably a hydrocarbon group or a group consisting of a combination of a hydrocarbon group and a heteroatom, preferably an oxygen atom, a sulfur atom, or a nitrogen atom. In the present invention, it is preferred that at least one of the organic groups is a cyclic group, and more preferred that at least two of the organic groups are cyclic groups. The cyclic group is preferably selected from a 5-membered cyclic group and a 6-membered cyclic group, and more preferably a 5-membered cyclic group. The cyclic group may be a hydrocarbon ring or a heterocyclic ring, with a hydrocarbon ring being preferred. The five-membered cyclic group is preferably a cyclopentadienyl group. In addition, the organometallic complex used in the present invention preferably contains 2 to 4 cyclic groups in one molecule.

[0102] The metal contained in the organometallic complex is not particularly limited, but is preferably a metal corresponding to a Group 4 element, more preferably at least one metal selected from the group consisting of titanium, zirconium, and hafnium, even more preferably at least one metal selected from the group consisting of titanium and zirconium, and particularly preferably titanium.

[0103] The organometallic complex may contain two or more metal atoms or may contain only one metal atom, but preferably contains only one metal atom. When the organometallic complex contains two or more metal atoms, it may contain only one type of metal atom or may contain two or more types of metal atoms.

[0104] The organometallic complex is preferably a ferrocene compound, a titanocene compound, a zirconocene compound or a hafnocene compound, more preferably a titanocene compound, a zirconocene compound or a hafnocene compound, further preferably a titanocene compound or a zirconocene compound, and particularly preferably a titanocene compound.

[0105] An embodiment in which the organometallic complex has a photoradical polymerization initiation ability is also one of the preferred embodiments of the present invention. According to the present invention, it is believed that the use of a specific resin allows the organometallic complex to be dispersed in a nearly uniform state in the film. Therefore, when the organometallic complex has photoradical polymerization initiation ability, it is considered that local aggregation of the radical polymerization initiator due to aggregation of the organometallic complex is suppressed. It is believed that the degree of polymerization of the specific resin or crosslinking agent is likely to be uniform in the film by suppressing the aggregation of the radical polymerization initiator, which makes it less likely that development residues or breaks in the pattern will occur, and improves the resolution. In the present invention, having photoradical polymerization initiation ability means that free radicals capable of initiating radical polymerization can be generated by irradiation with light. For example, when a composition containing a radical crosslinking agent and an organometallic complex is irradiated with light in a wavelength range in which the organometallic complex absorbs light and the radical crosslinking agent does not absorb light, the presence or absence of photoradical polymerization initiation ability can be confirmed by checking whether or not the radical crosslinking agent disappears. To check whether or not the radical crosslinking agent disappears, an appropriate method can be selected depending on the type of radical crosslinking agent, and for example, it may be confirmed by IR measurement (infrared spectroscopy measurement) or HPLC measurement (high performance liquid chromatography). When the organometallic complex has photoradical polymerization initiation ability, the organometallic complex is preferably a metallocene compound, more preferably a titanocene compound, a zirconocene compound or a hafnocene compound, further preferably a titanocene compound or a zirconocene compound, and particularly preferably a titanocene compound. When the organometallic complex does not have photoradical polymerization initiation ability, the organometallic complex is preferably at least one compound selected from the group consisting of titanocene compounds, tetraalkoxytitanium compounds, titanium acylate compounds, titanium chelate compounds, zirconocene compounds, and hafnocene compounds, more preferably at least one compound selected from the group consisting of titanocene compounds, zirconocene compounds, and hafnocene compounds, even more preferably at least one compound selected from the group consisting of titanocene compounds and zirconocene compounds, and particularly preferably a titanocene compound.

[0106] The molecular weight of the organometallic complex is preferably from 50 to 2,000, and more preferably from 100 to 1,000.

[0107] Preferred examples of the organometallic complex include compounds represented by the following formula (P). [ka] In formula (P), M is a metal atom, and each R is independently a substituent. It is preferable that each R is independently selected from an aromatic group, an alkyl group, a halogen atom, and an alkylsulfonyloxy group.

[0108] In formula (P), the metal atom represented by M is preferably an iron atom, a titanium atom, a zirconium atom or a hafnium atom, more preferably a titanium atom, a zirconium atom or a hafnium atom, still more preferably a titanium atom or a zirconium atom, and particularly preferably a titanium atom. The aromatic group for R in formula (P) includes aromatic groups having 6 to 20 carbon atoms, preferably aromatic hydrocarbon groups having 6 to 20 carbon atoms, such as a phenyl group, a 1-naphthyl group, or a 2-naphthyl group. The alkyl group for R in formula (P) is preferably an alkyl group having 1 to 20 carbon atoms, more preferably an alkyl group having 1 to 10 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an octyl group, an isopropyl group, a t-butyl group, an isopentyl group, a 2-ethylhexyl group, a 2-methylhexyl group, and a cyclopentyl group. The halogen atom in R includes F, Cl, Br and I. The alkyl group constituting the alkylsulfonyloxy group in R is preferably an alkyl group having 1 to 20 carbon atoms, more preferably an alkyl group having 1 to 10 carbon atoms, and examples thereof include a methyl group, an ethyl group, a propyl group, an octyl group, an isopropyl group, a t-butyl group, an isopentyl group, a 2-ethylhexyl group, a 2-methylhexyl group, and a cyclopentyl group. The above R may further have a substituent. Examples of the substituent include a halogen atom (F, Cl, Br, I), a hydroxy group, a carboxy group, an amino group, a cyano group, an aryl group, an alkoxy group, an aryloxy group, an acyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an acyloxy group, a monoalkylamino group, a dialkylamino group, a monoarylamino group, and a diarylamino group.

[0109] Specific examples of organometallic complexes include, but are not limited to, tetraisopropoxytitanium, tetrakis(2-ethylhexyloxy)titanium, diisopropoxybis(ethylacetoacetate)titanium, diisopropoxybis(acetylacetonato)titanium, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl)titanium, pentamethylcyclopentadienyltitanium trimethoxide, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluorophenyl)titanium, and the following compounds. [ka]

[0110] In addition, compounds described in paragraphs 0078 to 0088 of WO 2018 / 025738 can also be used, but are not limited thereto.

[0111] The content of the organometallic complex is preferably 0.1 to 30% by mass based on the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 1.0% by mass or more, further preferably 1.5% by mass or more, and particularly preferably 3.0% by mass or more. The upper limit is more preferably 25% by mass or less. The organometallic complexes may be used alone or in combination of two or more. When two or more types are used, the total amount is preferably within the above range.

[0112] <Other resins> The composition of the present invention may contain the above-mentioned specific resin and another resin (hereinafter, simply referred to as "another resin") different from the specific resin. Examples of other resins include polyamideimide, polyamideimide precursors, phenolic resins, polyamides, epoxy resins, polysiloxanes, resins containing a siloxane structure, and acrylic resins. For example, by further adding an acrylic resin, a composition with excellent coatability can be obtained, and an organic film with excellent solvent resistance can be obtained. For example, by adding an acrylic resin having a high polymerizable group value and a weight-average molecular weight of 20,000 or less to the composition in place of or in addition to the crosslinking agent described later, the coatability of the composition and the solvent resistance of the organic film can be improved.

[0113] When the composition of the present invention contains other resins, the content of the other resins is preferably 0.01 mass% or more, more preferably 0.05 mass% or more, even more preferably 1 mass% or more, still more preferably 2 mass% or more, even more preferably 5 mass% or more, and even more preferably 10 mass% or more, based on the total solid content of the composition. In addition, the content of other resins in the composition of the present invention is preferably 80 mass % or less, more preferably 75 mass % or less, even more preferably 70 mass % or less, still more preferably 60 mass % or less, and even more preferably 50 mass % or less, based on the total solid content of the composition. In addition, as a preferred embodiment of the composition of the present invention, the content of the other resin may be low. In the above embodiment, the content of the other resin is preferably 20% by mass or less, more preferably 15% by mass or less, even more preferably 10% by mass or less, still more preferably 5% by mass or less, and even more preferably 1% by mass or less, based on the total solid content of the composition. The lower limit of the content is not particularly limited, and may be 0% by mass or more. The composition of the present invention may contain only one type of other resin, or may contain two or more types. When two or more types are contained, the total amount is preferably within the above range.

[0114] <Solvent> The curable resin composition of the present invention preferably contains a solvent. Any known solvent can be used as the solvent. The solvent is preferably an organic solvent. Examples of the organic solvent include compounds such as esters, ethers, ketones, cyclic hydrocarbons, sulfoxides, amides, ureas, and alcohols.

[0115] Examples of esters include ethyl acetate, n-butyl acetate, isobutyl acetate, hexyl acetate, amyl formate, isoamyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkyloxyacetates (e.g., methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), 3-alkyloxypropionic acid alkyl esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), 2-alkyloxypropionic acid alkyl esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), 3-alkyloxypropionic acid alkyl esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), 2-alkyloxypropionic acid alkyl esters (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-eth Preferred examples of the cypropionic acid alkyl esters include methyl 2-alkyloxypropionate, ethyl 2-alkyloxypropionate, and propyl 2-alkyloxypropionate (e.g., methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, and ethyl 2-ethoxypropionate), methyl 2-alkyloxy-2-methylpropionate and ethyl 2-alkyloxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutanoate, ethyl 2-oxobutanoate, ethyl hexanoate, ethyl heptanoate, dimethyl malonate, and diethyl malonate.

[0116] Suitable examples of the ethers include diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol ethyl methyl ether, and propylene glycol monopropyl ether acetate.

[0117] Suitable examples of ketones include methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 3-methylcyclohexanone, levoglucosenone, and dihydrolevoglucosenone.

[0118] Suitable examples of cyclic hydrocarbons include aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene.

[0119] A preferred example of the sulfoxides is dimethyl sulfoxide.

[0120] Preferred examples of the amides include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, N,N-dimethylisobutyramide, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide, N-formylmorpholine, and N-acetylmorpholine.

[0121] Preferred examples of the ureas include N,N,N',N'-tetramethylurea and 1,3-dimethyl-2-imidazolidinone.

[0122] Examples of alcohols include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 1-hexanol, benzyl alcohol, ethylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-ethoxyethanol, diethylene glycol monoethyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monomethyl ether, polyethylene glycol monomethyl ether, polypropylene glycol, tetraethylene glycol, ethylene glycol monobutyl ether, ethylene glycol monobenzyl ether, ethylene glycol monophenyl ether, methylphenyl carbinol, n-amyl alcohol, methylamyl alcohol, and diacetone alcohol.

[0123] From the viewpoint of improving the properties of the coated surface, it is also preferable to mix two or more kinds of solvents.

[0124] In the present invention, one solvent selected from methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl cellosolve acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, cyclohexanone, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, ethyl carbitol acetate, butyl carbitol acetate, N-methyl-2-pyrrolidone, propylene glycol methyl ether, and propylene glycol methyl ether acetate, or a mixed solvent composed of two or more of them, is preferred. The combined use of dimethyl sulfoxide and γ-butyrolactone is particularly preferred. Also preferred are combinations of N-methyl-2-pyrrolidone and ethyl lactate, N-methyl-2-pyrrolidone and ethyl lactate, diacetone alcohol and ethyl lactate, and cyclopentanone and γ-butyrolactone.

[0125] From the viewpoint of coatability, the content of the solvent is preferably an amount such that the total solids concentration of the curable resin composition of the present invention is 5 to 80 mass%, more preferably an amount such that the total solids concentration of the curable resin composition of the present invention is 5 to 75 mass%, even more preferably an amount such that the total solids concentration of the curable resin composition of the present invention is 10 to 70 mass%, and even more preferably an amount such that the total solids concentration of the curable resin composition of the present invention is 40 to 70 mass%. The content of the solvent may be adjusted according to the desired thickness of the coating film and the coating method.

[0126] The composition may contain only one type of solvent, or two or more types of solvents. When two or more types of solvents are contained, the total content thereof is preferably within the above range.

[0127] <Photosensitizer> The composition of the present invention preferably contains a photosensitizer. The photosensitizer is the above-mentioned organometallic complex, but does not include a compound having photoradical polymerization initiation ability. The composition of the present invention preferably contains a photopolymerization initiator.

[0128] [Photopolymerization initiator] The composition of the present invention preferably contains a photopolymerization initiator as a photosensitizer. The photopolymerization initiator is preferably a photoradical polymerization initiator. The photoradical polymerization initiator is not particularly limited and can be appropriately selected from known photoradical polymerization initiators. For example, a photoradical polymerization initiator having photosensitivity to light rays in the ultraviolet to visible regions is preferable. Alternatively, it may be an activator that generates active radicals by reacting with a photoexcited sensitizer.

[0129] In the present invention, the compound corresponding to the organometallic complex does not correspond to the photosensitizer and the photoradical polymerization initiator.

[0130] When the organometallic complex has photoradical polymerization initiation ability, it is also preferable that the composition of the present invention is substantially free of radical polymerization initiators other than the organometallic complex. Substantially free of radical polymerization initiators other than the organometallic complex means that the content of radical polymerization initiators other than the organometallic complex in the composition of the present invention is 5% by mass or less, preferably 3% by mass or less, more preferably 1% by mass or less, and even more preferably 0.1% by mass, based on the total mass of the organometallic complex. In addition, when the composition of the present invention contains an organometallic complex having radical polymerization initiation ability, it is also preferable that the composition of the present invention contains the organometallic complex and a photoradical polymerization initiator. According to such an embodiment, the generation of development residues and breakage of patterns can be suppressed as described above, and the exposure sensitivity can be improved. When the composition of the present invention contains an organometallic complex that does not have photoradical polymerization initiation ability, the composition of the present invention preferably contains a photoradical polymerization initiator. Since the composition of the present invention contains a specific resin, it is considered that the aggregation of the organometallic complex is suppressed. It is presumed that the aggregation of the organometallic complex that does not have photoradical polymerization initiation ability is suppressed, thereby suppressing the increase in local film plasticity due to aggregation, and also suppressing the increase in local polymerization degree at the aggregation site. As a result, it is presumed that the occurrence of sensitivity variation depending on the part of the film is suppressed, and the resolution is improved. When the composition of the present invention contains an organometallic complex and a photoradical polymerization initiator, the content of the organometallic complex relative to the total content of the organometallic complex and the photoradical polymerization initiator is preferably 20 to 80 mass%, and more preferably 30 to 70 mass%. As the photoradical polymerization initiator, an oxime compound described below is preferable.

[0131] The photoradical polymerization initiator has a wavelength of about 300 to 800 nm (preferably 330 to 500 nm) and a concentration of at least about 50 L mol -1 ·cm -1It is preferable that the composition contains at least one compound having a molar absorption coefficient of 0.01 g / L. The molar absorption coefficient of the compound can be measured using a known method. For example, it is preferable to measure the molar absorption coefficient at a concentration of 0.01 g / L using an ultraviolet-visible spectrophotometer (Varian Cary-5 spectrophotometer) using ethyl acetate as a solvent.

[0132] Any known compound can be used as the photoradical polymerization initiator. For example, halogenated hydrocarbon derivatives (e.g., compounds having a triazine skeleton, compounds having an oxadiazole skeleton, compounds having a trihalomethyl group, etc.), acylphosphine compounds such as acylphosphine oxides, hexaarylbiimidazoles, oxime compounds such as oxime derivatives, organic peroxides, thio compounds, ketone compounds, aromatic onium salts, ketoxime ethers, aminoacetophenone compounds, hydroxyacetophenones, azo compounds, azide compounds, organic boron compounds, etc. can be mentioned. For details of these, refer to the descriptions in paragraphs 0165 to 0182 of JP 2016-027357 A and paragraphs 0138 to 0151 of WO 2015 / 199219 A, the contents of which are incorporated herein by reference.

[0133] Examples of the ketone compound include the compounds described in paragraph 0087 of JP2015-087611A, the contents of which are incorporated herein by reference. As a commercially available product, Kayacure DETX (manufactured by Nippon Kayaku Co., Ltd.) is also preferably used.

[0134] In one embodiment of the present invention, as the photoradical polymerization initiator, a hydroxyacetophenone compound, an aminoacetophenone compound, and an acylphosphine compound can be suitably used. More specifically, for example, an aminoacetophenone-based initiator described in JP-A-10-291969 and an acylphosphine oxide-based initiator described in JP-A-4225898 can be used.

[0135] As the hydroxyacetophenone-based initiator, IRGACURE 184 (IRGACURE is a registered trademark), DAROCUR 1173, IRGACURE 500, IRGACURE-2959, and IRGACURE 127 (trade names: all manufactured by BASF) can be used.

[0136] As the aminoacetophenone initiator, commercially available products such as IRGACURE 907, IRGACURE 369, and IRGACURE 379 (product names: all manufactured by BASF) can be used.

[0137] As the aminoacetophenone-based initiator, the compounds described in JP-A-2009-191179, which have an absorption maximum wavelength matching a light source with a wavelength of 365 nm or 405 nm, can also be used.

[0138] Examples of the acylphosphine initiator include 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, etc. In addition, commercially available products such as IRGACURE-819 and IRGACURE-TPO (trade names: both manufactured by BASF) can be used.

[0139] As the photoradical polymerization initiator, more preferably, an oxime compound is used. By using an oxime compound, it is possible to more effectively improve the exposure latitude. The oxime compound is particularly preferred because it has a wide exposure latitude (exposure margin) and also functions as a photocuring accelerator.

[0140] Specific examples of the oxime compound that can be used include the compounds described in JP-A-2001-233842, JP-A-2000-080068, and JP-A-2006-342166.

[0141] Examples of preferred oxime compounds include compounds having the following structure, 3-benzoyloxyiminobutan-2-one, 3-acetoxyiminobutan-2-one, 3-propionyloxyiminobutan-2-one, 2-acetoxyiminopentan-3-one, 2-acetoxyimino-1-phenylpropan-1-one, 2-benzoyloxyimino-1-phenylpropan-1-one, 3-(4-toluenesulfonyloxy)iminobutan-2-one, and 2-ethoxycarbonyloxyimino-1-phenylpropan-1-one. In the composition of the present invention, it is particularly preferred to use an oxime compound (oxime-based photopolymerization initiator) as a photoradical polymerization initiator. The oxime-based photopolymerization initiator has a linking group of >C=NOC(=O)- in the molecule.

[0142] [ka]

[0143] Commercially available products include IRGACURE OXE 01, IRGACURE OXE 02, IRGACURE OXE 03, and IRGACURE OXE 04 (manufactured by BASF), and Adeka Optomer N-1919 (manufactured by ADEKA Corporation, photoradical polymerization initiator 2 described in JP 2012-014052 A). TR-PBG-304 (manufactured by Changzhou Strong Electronic New Materials Co., Ltd.), Adeka Arcles NCI-831, and Adeka Arcles NCI-930 (manufactured by ADEKA Corporation) can also be used. DFI-091 (manufactured by Daito Chemistry Co., Ltd.) can also be used. Oxime compounds having the following structure can also be used. [ka]

[0144] As the photopolymerization initiator, an oxime compound having a fluorene ring can also be used. Specific examples of the oxime compound having a fluorene ring include the compounds described in JP-A-2014-137466 and the compounds described in Japanese Patent No. 6636081.

[0145] As the photopolymerization initiator, an oxime compound having a skeleton in which at least one benzene ring of a carbazole ring is replaced with a naphthalene ring can also be used. Specific examples of such oxime compounds include the compounds described in WO 2013 / 083505.

[0146] In addition, it is also possible to use an oxime compound having a fluorine atom. Specific examples of such oxime compounds include the compounds described in JP-A-2010-262028, compounds 24, 36 to 40 described in JP-A-2014-500852, paragraph 0345, and compound (C-3) described in JP-A-2013-164471, paragraph 0101.

[0147] Most preferred examples of the oxime compound include oxime compounds having specific substituents as disclosed in JP-A-2007-269779 and oxime compounds having a thioaryl group as disclosed in JP-A-2009-191061.

[0148] From the viewpoint of exposure sensitivity, the photoradical polymerization initiator is preferably a compound selected from the group consisting of trihalomethyltriazine compounds, benzyl dimethyl ketal compounds, α-hydroxyketone compounds, α-aminoketone compounds, acylphosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazole dimers, onium salt compounds, benzothiazole compounds, benzophenone compounds, acetophenone compounds and derivatives thereof, cyclopentadiene-benzene-iron complexes and salts thereof, halomethyloxadiazole compounds, and 3-aryl substituted coumarin compounds.

[0149] More preferred photoradical polymerization initiators are trihalomethyltriazine compounds, α-aminoketone compounds, acylphosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazole dimers, onium salt compounds, benzophenone compounds, and acetophenone compounds. At least one compound selected from the group consisting of trihalomethyltriazine compounds, α-aminoketone compounds, oxime compounds, triarylimidazole dimers, and benzophenone compounds is even more preferred. It is even more preferred to use a metallocene compound or an oxime compound, and even more preferred is an oxime compound.

[0150] In addition, the photoradical polymerization initiator may be benzophenone, N,N'-tetraalkyl-4,4'-diaminobenzophenone such as N,N'-tetramethyl-4,4'-diaminobenzophenone (Michler's ketone), aromatic ketone such as 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1,2-methyl-1-[4-(methylthio)phenyl]-2-morpholino-propanone-1, quinones condensed with aromatic rings such as alkylanthraquinones, benzoin ether compounds such as benzoin alkyl ethers, benzoin compounds such as benzoin and alkylbenzoins, benzyl derivatives such as benzyl dimethyl ketal, etc. In addition, a compound represented by the following formula (I) may be used.

[0151] [ka]

[0152] In formula (I), R I00is an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms interrupted by one or more oxygen atoms, an alkoxy group having 1 to 12 carbon atoms, a phenyl group, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, a halogen atom, a cyclopentyl group, a cyclohexyl group, an alkenyl group having 2 to 12 carbon atoms, an alkyl group having 2 to 18 carbon atoms interrupted by one or more oxygen atoms, and a phenyl group substituted with at least one of an alkyl group having 1 to 4 carbon atoms, or a biphenyl; R I01 is a group represented by formula (II), or R I00 is the same group as R I02 ~R I04 each independently represents an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, or a halogen.

[0153] [ka]

[0154] In the formula, R I05 ~R I07 is R in the above formula (I). I02 ~R I04 is the same as:

[0155] In addition, the compounds described in paragraphs 0048 to 0055 of WO 2015 / 125469 can also be used as the photoradical polymerization initiator.

[0156] When a photopolymerization initiator is contained, the content thereof is preferably 0.1 to 30 mass% based on the total solid content of the composition of the present invention, more preferably 0.1 to 20 mass%, further preferably 0.5 to 15 mass%, and even more preferably 1.0 to 10 mass%. Only one type of photopolymerization initiator may be contained, or two or more types may be contained. When two or more types of photopolymerization initiators are contained, the total amount is preferably within the above range.

[0157] [Photoacid generator] The composition of the present invention also preferably contains a photoacid generator as a photosensitizer. By including a photoacid generator, for example, acid is generated in exposed areas of the photosensitive film, increasing the solubility of the exposed areas in a developer (e.g., an alkaline aqueous solution), and a positive pattern can be obtained in which the exposed areas are removed by the developer. In addition, by containing a photoacid generator and a crosslinking agent other than the radical crosslinking agent described later, for example, the crosslinking reaction of the crosslinking agent is promoted by the acid generated in the exposed area, and the exposed area is more difficult to remove by a developer than the non-exposed area. According to such an embodiment, a negative pattern can be obtained.

[0158] The photoacid generator is not particularly limited as long as it generates an acid upon exposure to light, and examples of the photoacid generator include quinone diazide compounds, onium salt compounds such as diazonium salts, phosphonium salts, sulfonium salts, and iodonium salts, and sulfonate compounds such as imide sulfonates, oxime sulfonates, diazodisulfones, disulfones, and o-nitrobenzyl sulfonate.

[0159] Examples of the quinone diazide compound include a polyhydroxy compound to which a sulfonic acid of quinone diazide is bonded via an ester bond, a polyamino compound to which a sulfonic acid of quinone diazide is bonded via a sulfonamide bond, a polyhydroxypolyamino compound to which a sulfonic acid of quinone diazide is bonded via at least one of an ester bond and a sulfonamide bond, etc. In the present invention, for example, it is preferable that 50 mol % or more of the total functional groups of these polyhydroxy compounds or polyamino compounds are substituted with quinone diazide.

[0160] In the present invention, either 5-naphthoquinone diazide sulfonyl group or 4-naphthoquinone diazide sulfonyl group is preferably used as the quinone diazide. 4-naphthoquinone diazide sulfonyl ester compound has absorption in the i-line region of a mercury lamp and is suitable for i-line exposure. 5-naphthoquinone diazide sulfonyl ester compound has absorption extending to the g-line region of a mercury lamp and is suitable for g-line exposure. In the present invention, it is preferable to select a 4-naphthoquinone diazide sulfonyl ester compound or a 5-naphthoquinone diazide sulfonyl ester compound depending on the wavelength of exposure. In addition, naphthoquinone diazide sulfonyl ester compound having a 4-naphthoquinone diazide sulfonyl group and a 5-naphthoquinone diazide sulfonyl group in the same molecule may be contained, or a 4-naphthoquinone diazide sulfonyl ester compound and a 5-naphthoquinone diazide sulfonyl ester compound may be contained.

[0161] The naphthoquinone diazide compound can be synthesized by an esterification reaction between a compound having a phenolic hydroxyl group and a quinone diazide sulfonic acid compound, and can be synthesized by a known method. The use of these naphthoquinone diazide compounds improves the resolution, sensitivity, and film remaining rate. Examples of the naphthoquinone diazide compound include 1,2-naphthoquinone-2-diazide-5-sulfonic acid, 1,2-naphthoquinone-2-diazide-4-sulfonic acid, salts or esters of these compounds.

[0162] Examples of the onium salt compound or sulfonate compound include the compounds described in paragraphs 0064 to 0122 of JP-A No. 2008-013646.

[0163] The photoacid generator is also preferably a compound containing an oxime sulfonate group (hereinafter, also simply referred to as an "oxime sulfonate compound"). The oxime sulfonate compound is not particularly limited as long as it has an oxime sulfonate group, but is preferably an oxime sulfonate compound represented by the following formula (OS-1), or the below-described formula (OS-103), formula (OS-104), or formula (OS-105).

[0164] [ka]

[0165] In formula (OS-1), X 3 represents an alkyl group, an alkoxyl group, or a halogen atom. 3 When there are a plurality of X's, they may be the same or different. 3 The alkyl group and alkoxy group in the above formula (X) may have a substituent. 3 The alkyl group in the above formula (X) is preferably a linear or branched alkyl group having 1 to 4 carbon atoms. 3 The alkoxyl group in X is preferably a linear or branched alkoxyl group having 1 to 4 carbon atoms. 3 The halogen atom in is preferably a chlorine atom or a fluorine atom. In formula (OS-1), m3 represents an integer of 0 to 3, and is preferably 0 or 1. When m3 is 2 or 3, a plurality of X 3 may be the same or different. In formula (OS-1), R 34 represents an alkyl group or an aryl group, and is preferably an alkyl group having 1 to 10 carbon atoms, an alkoxyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms, a halogenated alkoxyl group having 1 to 5 carbon atoms, a phenyl group which may be substituted with W, a naphthyl group which may be substituted with W, or an anthranyl group which may be substituted with W. W represents a halogen atom, a cyano group, a nitro group, an alkyl group having 1 to 10 carbon atoms, an alkoxyl group having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 5 carbon atoms or a halogenated alkoxyl group having 1 to 5 carbon atoms, an aryl group having 6 to 20 carbon atoms, or a halogenated aryl group having 6 to 20 carbon atoms.

[0166] In formula (OS-1), m3 is 3, and X 3 is a methyl group, and X 3 The substitution position of is the ortho position, and R 34 Particularly preferred are compounds in which R is a linear alkyl group having 1 to 10 carbon atoms, a 7,7-dimethyl-2-oxonorbornylmethyl group, or a p-tolyl group.

[0167] Specific examples of the oxime sulfonate compound represented by formula (OS-1) include the following compounds described in paragraphs 0064 to 0068 of JP2011-209692A and paragraphs 0158 to 0167 of JP2015-194674A, the contents of which are incorporated herein by reference.

[0168] [ka]

[0169] In formula (OS-103) ~ formula (OS-105), R s1 R represents an alkyl group, an aryl group, or a heteroaryl group, and may be present in plural. s2 R each independently represents a hydrogen atom, an alkyl group, an aryl group, or a halogen atom, and may be present in plurality. s6 each independently represents a halogen atom, an alkyl group, an alkyloxy group, a sulfonic acid group, an aminosulfonyl group or an alkoxysulfonyl group; Xs represents O or S; ns represents 1 or 2; and ms represents an integer of 0 to 6. In formula (OS-103) ~ formula (OS-105), R s1 The alkyl group (preferably having 1 to 30 carbon atoms), aryl group (preferably having 6 to 30 carbon atoms) or heteroaryl group (preferably having 4 to 30 carbon atoms) represented by the following formula may have a substituent T.

[0170] In formula (OS-103) ~ formula (OS-105), R s2is preferably a hydrogen atom, an alkyl group (preferably having 1 to 12 carbon atoms) or an aryl group (preferably having 6 to 30 carbon atoms), and more preferably a hydrogen atom or an alkyl group. s2 Among R, it is preferable that one or two of them are an alkyl group, an aryl group, or a halogen atom, it is more preferable that one of them is an alkyl group, an aryl group, or a halogen atom, and it is particularly preferable that one of them is an alkyl group and the remaining one is a hydrogen atom. s2 The alkyl group or aryl group represented by the following formula (I) may have a substituent T. In formula (OS-103), formula (OS-104), or formula (OS-105), Xs represents O or S, and is preferably O. In the above formulae (OS-103) to (OS-105), the ring containing Xs as a ring member is a 5-membered or 6-membered ring.

[0171] In formulae (OS-103) to (OS-105), ns represents 1 or 2. When Xs is O, ns is preferably 1; and when Xs is S, ns is preferably 2. In formula (OS-103) ~ formula (OS-105), R s6 The alkyl group (preferably having 1 to 30 carbon atoms) and alkyloxy group (preferably having 1 to 30 carbon atoms) represented by the following formula may have a substituent. In formulae (OS-103) to (OS-105), ms represents an integer of 0 to 6, is preferably an integer of 0 to 2, more preferably 0 or 1, and particularly preferably 0.

[0172] Furthermore, the compound represented by formula (OS-103) above is particularly preferably a compound represented by formula (OS-106), formula (OS-110) or formula (OS-111) below; the compound represented by formula (OS-104) above is particularly preferably a compound represented by formula (OS-107) below; and the compound represented by formula (OS-105) above is particularly preferably a compound represented by formula (OS-108) or formula (OS-109) below. [ka]

[0173] In formula (OS-106) ~ formula (OS-111), R t1 represents an alkyl group, an aryl group, or a heteroaryl group; R t7 represents a hydrogen atom or a bromine atom, R t8 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, a chloromethyl group, a bromomethyl group, a bromoethyl group, a methoxymethyl group, a phenyl group, or a chlorophenyl group; R t9 represents a hydrogen atom, a halogen atom, a methyl group, or a methoxy group; R t2 represents a hydrogen atom or a methyl group. In formula (OS-106) ~ formula (OS-111), R t7 represents a hydrogen atom or a bromine atom, and is preferably a hydrogen atom.

[0174] In formula (OS-106) ~ formula (OS-111), R t8 represents a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a halogen atom, a chloromethyl group, a bromomethyl group, a bromoethyl group, a methoxymethyl group, a phenyl group, or a chlorophenyl group, and is preferably an alkyl group having 1 to 8 carbon atoms, a halogen atom, or a phenyl group, more preferably an alkyl group having 1 to 8 carbon atoms, even more preferably an alkyl group having 1 to 6 carbon atoms, and particularly preferably a methyl group.

[0175] In formula (OS-106) ~ formula (OS-111), R t9 represents a hydrogen atom, a halogen atom, a methyl group or a methoxy group, and is preferably a hydrogen atom. R t2 represents a hydrogen atom or a methyl group, and is preferably a hydrogen atom. In the above oxime sulfonate compound, the stereochemical structure (E, Z) of the oxime may be either one or a mixture. Specific examples of the oxime sulfonate compounds represented by the above formulas (OS-103) to (OS-105) include the compounds described in paragraphs 0088 to 0095 of JP-A No. 2011-209692 and paragraphs 0168 to 0194 of JP-A No. 2015-194674, the contents of which are incorporated herein by reference.

[0176] Other preferable embodiments of the oxime sulfonate compound containing at least one oxime sulfonate group include compounds represented by the following formula (OS-101) and formula (OS-102).

[0177] [ka]

[0178] In formula (OS-101) or formula (OS-102), R u9 R represents a hydrogen atom, an alkyl group, an alkenyl group, an alkoxyl group, an alkoxycarbonyl group, an acyl group, a carbamoyl group, a sulfamoyl group, a sulfo group, a cyano group, an aryl group, or a heteroaryl group. u9 is more preferably a cyano group or an aryl group, u9 More preferably, is a cyano group, a phenyl group, or a naphthyl group. In formula (OS-101) or formula (OS-102), R u2a represents an alkyl group or an aryl group. In formula (OS-101) or formula (OS-102), Xu is -O-, -S-, -NH-, -NR u5 -, -CH2-, -CR u6 H- or CR u6 R u7 - represents R u5 ~R u7 each independently represents an alkyl group or an aryl group.

[0179] In formula (OS-101) or formula (OS-102), R u1 ~R u4R each independently represents a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, an alkoxyl group, an amino group, an alkoxycarbonyl group, an alkylcarbonyl group, an arylcarbonyl group, an amido group, a sulfo group, a cyano group, or an aryl group. u1 ~R u4 Two of the rings may be bonded to each other to form a ring. In this case, the rings may be condensed to form a condensed ring together with the benzene ring. u1 ~R u4 is preferably a hydrogen atom, a halogen atom or an alkyl group, and R u1 ~R u4 It is also preferable that at least two of R are bonded to each other to form an aryl group. u1 ~R u4 is preferably a hydrogen atom. Any of the above-mentioned substituents may further have a substituent.

[0180] The compound represented by the above formula (OS-101) is more preferably a compound represented by the formula (OS-102). In the above oxime sulfonate compound, the stereostructures (E, Z, etc.) of the oxime and benzothiazole rings may each be either one or a mixture. Specific examples of the compound represented by formula (OS-101) include the compounds described in paragraphs 0102 to 0106 of JP-A No. 2011-209692 and paragraphs 0195 to 0207 of JP-A No. 2015-194674, the contents of which are incorporated herein by reference. Among the above compounds, the following b-9, b-16, b-31, and b-33 are preferred. [ka]

[0181] In addition, commercially available photoacid generators may be used. Commercially available products include WPAG-145, WPAG-149, WPAG-170, WPAG-199, WPAG-336, WPAG-367, WPAG-370, WPAG-443, WPAG-469, WPAG-638, and WPAG-699 (all manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.), Omnicat 250 and Omnicat 270 (all manufactured by IGM Resins BV), Irgacure 250, Irgacure 270, and Irgacure 290 (all manufactured by BASF), and MBZ-101 (manufactured by Midori Chemical Industry Co., Ltd.).

[0182] Further, compounds represented by the following structural formulas are also preferred examples. [ka]

[0183] As the photoacid generator, an organic halogenated compound can also be used. Specific examples of the organic halogenated compounds include those described in Wakabayashi et al., Bull Chem. Soc Japan, vol. 42, p. 2924 (1969), U.S. Pat. No. 3,905,815, JP-B-4605, JP-A-48-36281, JP-A-55-32070, JP-A-60-239736, JP-A-61-169835, JP-A-61-169837, JP-A-62-58241, JP-A-62-212401, JP-A-63-70243, JP-A-63-298339, and M.P. Hutt, Journal of Heterocyclic Chemistry, Vol. 1 (No. 3), (1970), and in particular, oxazole compounds substituted with a trihalomethyl group: S-triazine compounds. More preferably, an s-triazine derivative having at least one mono-, di-, or trihalogen-substituted methyl group bonded to the s-triazine ring, specifically, for example, 2,4,6-tris(monochloromethyl)-s-triazine, 2,4,6-tris(dichloromethyl)-s-triazine, 2,4,6-tris(trichloromethyl)-s-triazine, 2-methyl-4,6-bis(trichloromethyl)-s-triazine, 2-n-propyl-4,6-bis(trichloromethyl)-s-triazine, Azine, 2-(α,α,β-trichloroethyl)-4,6-bis(trichloromethyl)-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(3,4-epoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-chlorophenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-[1-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, phenyl)-2,4-butadienyl]-4,6-bis(trichloromethyl)-s-triazine, 2-styryl-4,6-bis(trichloromethyl)-s-triazine, 2-(p-methoxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2-(pi-propyloxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-nathoxynaphthyl)-4,6- Examples of the bis(trichloromethyl)-s-triazine include bis(trichloromethyl)-s-triazine, 2-phenylthio-4,6-bis(trichloromethyl)-s-triazine, 2-benzylthio-4,6-bis(trichloromethyl)-s-triazine, 2,4,6-tris(dibromomethyl)-s-triazine, 2,4,6-tris(tribromomethyl)-s-triazine, 2-methyl-4,6-bis(tribromomethyl)-s-triazine, and 2-methoxy-4,6-bis(tribromomethyl)-s-triazine.

[0184] As the photoacid generator, an organic borate compound can also be used. Examples of the organic borate compound include those described in JP-A-62-143044, JP-A-62-150242, JP-A-9-188685, JP-A-9-188686, JP-A-9-188710, JP-A-2000-131837, JP-A-2002-107916, Japanese Patent No. 2764769, and Japanese Patent Application No. 2000-310808, and those described in Kunz, Martin, "Rad Tech'98. Proceedings of April 1999, Vol. 1, No. 2, pp. 1111-1115, 1999. 19-22, 1998, Chicago", etc.; organoboron sulfonium complexes or organoboron oxosulfonium complexes described in JP-A-6-157623, JP-A-6-175564, and JP-A-6-175561; organoboron iodonium complexes described in JP-A-6-175554 and JP-A-6-175553; organoboron phosphonium complexes described in JP-A-9-188710; and organoboron transition metal coordination complexes described in JP-A-6-348011, JP-A-7-128785, JP-A-7-140589, JP-A-7-306527, JP-A-7-292014, etc., are specifically exemplified.

[0185] As the photoacid generator, a disulfone compound can also be used. Examples of the disulfone compound include compounds described in JP-A-61-166544 and JP-A-2001-132318, and diazodisulfone compounds.

[0186] Examples of the onium salt compound include diazonium salts described in SI Schlesinger, Photogr. Sci. Eng., 18, 387 (1974) and TSBal et al., Polymer, 21, 423 (1980); ammonium salts described in U.S. Pat. No. 4,069,055 and JP-A-4-365049; phosphonium salts described in U.S. Pat. Nos. 4,069,055 and 4,069,056; and iodonium salts described in European Patent Nos. 104 and 143, U.S. Pat. Nos. 339,049 and 410,201, JP-A-2-150848 and JP-A-2-296514. sulfonium salts described in the specifications of European Patent Nos. 370,693, 390,214, 233,567, 297,443, and 297,442, U.S. Patent Nos. 4,933,377, 161,811, 410,201, 339,049, 4,760,013, 4,734,444, and 2,833,827, German Patent Nos. 2,904,626, 3,604,580, and 3,604,581; selenonium salts described in JV Crivello et al., J. Polymer Sci., Polymer Chem. Ed., 17, 1047(1979); arsonium salts described in C.S. Wen et al., Teh., Proc. Conf. Rad. Curing ASIA, p478, Tokyo, Oct. (1988); and onium salts such as pyridinium salts.

[0187] The onium salt includes onium salts represented by the following general formulas (RI-I) to (RI-III). [ka] In formula (RI-I), Ar 11represents an aryl group having 20 or less carbon atoms which may have 1 to 6 substituents, and preferred substituents include an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 1 to 12 carbon atoms, an alkynyl group having 1 to 12 carbon atoms, an aryl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, an aryloxy group having 1 to 12 carbon atoms, a halogen atom, an alkylamino group having 1 to 12 carbon atoms, a dialkylamino group having 1 to 12 carbon atoms, an alkylamide group or an arylamide group having 1 to 12 carbon atoms, a carbonyl group, a carboxyl group, a cyano group, a sulfonyl group, a thioalkyl group having 1 to 12 carbon atoms, and a thioaryl group having 1 to 12 carbon atoms. - represents a monovalent anion, and is a halogen ion, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, a sulfinate ion, a thiosulfonate ion, or a sulfate ion. From the viewpoint of stability, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, or a sulfinate ion is preferred. 21 , Ar 22 each independently represents an aryl group having 20 or less carbon atoms which may have 1 to 6 substituents, and preferred substituents include an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 1 to 12 carbon atoms, an alkynyl group having 1 to 12 carbon atoms, an aryl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, an aryloxy group having 1 to 12 carbon atoms, a halogen atom, an alkylamino group having 1 to 12 carbon atoms, a dialkylamino group having 1 to 12 carbon atoms, an alkylamide group or an arylamide group having 1 to 12 carbon atoms, a carbonyl group, a carboxyl group, a cyano group, a sulfonyl group, a thioalkyl group having 1 to 12 carbon atoms, and a thioaryl group having 1 to 12 carbon atoms. Z 21 - represents a monovalent anion, and is a halogen ion, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, a sulfinate ion, a thiosulfonate ion, or a sulfate ion. From the standpoint of stability and reactivity, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, a sulfinate ion, or a carboxylate ion is preferred. 31, R 32 , R 33 Z31 each independently represents an aryl group, alkyl group, alkenyl group, or alkynyl group having 20 or less carbon atoms, which may have 1 to 6 substituents, and is preferably an aryl group in terms of reactivity and stability. Preferred substituents include an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 1 to 12 carbon atoms, an alkynyl group having 1 to 12 carbon atoms, an aryl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, an aryloxy group having 1 to 12 carbon atoms, a halogen atom, an alkylamino group having 1 to 12 carbon atoms, a dialkylamino group having 1 to 12 carbon atoms, an alkylamide group or an arylamide group having 1 to 12 carbon atoms, a carbonyl group, a carboxyl group, a cyano group, a sulfonyl group, a thioalkyl group having 1 to 12 carbon atoms, and a thioaryl group having 1 to 12 carbon atoms. - represents a monovalent anion, such as a halogen ion, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, a sulfinate ion, a thiosulfonate ion, or a sulfate ion, and from the standpoint of stability and reactivity, a perchlorate ion, a hexafluorophosphate ion, a tetrafluoroborate ion, a sulfonate ion, a sulfinate ion, or a carboxylate ion is preferred.

[0188] Specific examples include the following: [ka] [ka] [ka] [ka]

[0189] When a photoacid generator is contained, its content is preferably 0.1 to 30 mass % based on the total solid content of the composition of the present invention, more preferably 0.1 to 20 mass %, and even more preferably 2 to 15 mass %. Only one type of photoacid generator may be contained, or two or more types may be contained. When two or more types of photoacid generators are contained, the total content is preferably within the above range.

[0190] [Photobase Generator] The curable resin composition of the present invention may contain a photobase generator as a photosensitizer. By containing a photobase generator and a crosslinking agent described later, the curable resin composition can be configured such that, for example, the base generated in the exposed area promotes cyclization of a specific resin, the crosslinking reaction of the crosslinking agent is promoted, etc., so that the exposed area is more difficult to remove by a developer than the non-exposed area. According to such an embodiment, a negative relief pattern can be obtained.

[0191] The photobase generator is not particularly limited as long as it generates a base upon exposure to light, and any known photobase generator can be used. For example, M. Shirai, and M. Tsunooka, Prog. Polym. Sci., 21, 1 (1996); Masahiro Kadooka, Polymer Processing, 46, 2 (1997); C. Kutal, Coord. Chem. Rev., 211, 353 (2001); Y. Kaneko, A. Sarker, and D. Neckers, Chem. Mater., 11, 170 (1999); H. Tachi, M. Shirai, and M. Tsunooka, J. Photopolym. Sci. Technol., 13, 153 (2000); M. Winkle, and K. Graziano, J. Photopolym. Sci. Technol., 3, 419 (1990); M. Tsunooka, H. Tachi, and As described in S. Yoshitaka, J. Photopolym. Sci. Technol., 9, 13 (1996); K. Suyama, H. Araki, M. Shirai, J. Photopolym. Sci. Technol., 19, 81 (2006), examples of the compound include ionic compounds in which the base component is neutralized by forming a salt, such as transition metal compound complexes, compounds having an ammonium salt structure, and compounds in which the amidine moiety is rendered latent by forming a salt with a carboxylic acid, and nonionic compounds in which the base component is rendered latent by a urethane bond or oxime bond, such as carbamate derivatives, oxime ester derivatives, and acyl compounds. In the present invention, preferred examples of the photobase generator include carbamate derivatives, amide derivatives, imide derivatives, α-cobalt complexes, imidazole derivatives, cinnamic acid amide derivatives, and oxime derivatives.

[0192] The basic substance generated from the photobase generator is not particularly limited, but examples thereof include compounds having an amino group, particularly monoamines, polyamines such as diamines, and amidines. From the viewpoint of the imidization rate, the basic substance preferably has a large pKa in DMSO (dimethyl sulfoxide) of the conjugate acid. The pKa is preferably 1 or more, more preferably 3 or more. The upper limit of the pKa is not particularly limited, but is preferably 20 or less. Here, the pKa refers to the logarithm of the reciprocal of the first dissociation constant of an acid, and can be found in Determination of Organic Structures by Physical Methods (authors: Brown, HC, McDaniel, DH, Hafliger, O., Nachod, FC; editors: Braude, EA, Nachod, FC; Academic Press, New York, 1955) and Data for Biochemical Research (authors: Dawson, RMC et al; Oxford, Clarendon Press, 1959). For compounds not described in these documents, the value calculated from the structural formula using ACD / pKa (ACD / Labs) software is used as the pKa.

[0193] From the viewpoint of storage stability of the curable resin composition, the photobase generator is preferably a photobase generator that does not contain a salt in the structure, and preferably has no charge on the nitrogen atom of the base portion generated in the photobase generator. The photobase generator is preferably one in which the base generated is made latent using a covalent bond, and the base generation mechanism is preferably one in which the covalent bond between the nitrogen atom of the base portion generated and the adjacent atom is broken to generate the base. If the photobase generator does not contain a salt in the structure, the photobase generator can be neutralized, so that the solvent solubility is better and the pot life is improved. For these reasons, the amine generated from the photobase generator used in the present invention is preferably a primary amine or a secondary amine. From the viewpoint of the chemical resistance of the pattern, the photobase generator is preferably a photobase generator containing a salt in its structure.

[0194] For the reasons mentioned above, it is preferable that the photobase generator generates a base in a latent form using a covalent bond as described above, and it is preferable that the generated base is latent using an amide bond, a carbamate bond, or an oxime bond. Examples of the photobase generator according to the present invention include photobase generators having a cinnamic acid amide structure as disclosed in JP 2009-080452 A and WO 2009 / 123122 A, photobase generators having a carbamate structure as disclosed in JP 2006-189591 A and JP 2008-247747 A, photobase generators having an oxime structure or a carbamoyloxime structure as disclosed in JP 2007-249013 A and JP 2008-003581 A, but are not limited to these, and other known photobase generator structures can also be used.

[0195] Other examples of the photobase generator include the compounds described in JP2012-093746A, paragraphs

[0185] to

[0188] ,

[0199] to

[0200] , and

[0202] , the compounds described in JP2013-194205A, paragraphs

[0022] to

[0069] , the compounds described in JP2013-204019A, paragraphs

[0026] to

[0074] , and the compound described in WO2010 / 064631A, paragraph

[0052] .

[0196] In addition, commercially available products may be used as the photobase generator. Commercially available products include WPBG-266, WPBG-300, WPGB-345, WPGB-140, WPBG-165, WPBG-027, WPBG-018, WPGB-015, WPBG-041, WPGB-172, WPGB-174, WPBG-166, WPGB-158, WPGB-025, WPGB-168, WPGB-167, and WPBG-082 (all manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.), A2502, B5085, N0528, N1052, O0396, O0447, and O0448 (manufactured by Tokyo Chemical Industry Co., Ltd.).

[0197] When a photobase generator is contained, the content thereof is preferably 0.1 to 30 mass% based on the total solid content of the curable resin composition of the present invention, more preferably 0.1 to 20 mass%, and even more preferably 2 to 15 mass%. Only one type of photobase generator may be contained, or two or more types may be contained. When two or more types of photobase generators are contained, the total amount is preferably within the above range.

[0198] <Thermal polymerization initiator> The composition of the present invention may contain a thermal polymerization initiator, and in particular may contain a thermal radical polymerization initiator. The thermal radical polymerization initiator is a compound that generates radicals by thermal energy and initiates or promotes the polymerization reaction of a polymerizable compound. By adding the thermal radical polymerization initiator, the polymerization reaction of the resin and the crosslinking agent can also be advanced in the heating step described below, so that the solvent resistance can be further improved.

[0199] Specific examples of the thermal radical polymerization initiator include the compounds described in paragraphs 0074 to 0118 of JP-A No. 2008-063554.

[0200] When a thermal polymerization initiator is contained, the content is preferably 0.1 to 30 mass% based on the total solid content of the composition of the present invention, more preferably 0.1 to 20 mass%, and even more preferably 0.5 to 15 mass%. Only one type of thermal polymerization initiator may be contained, or two or more types may be contained. When two or more types of thermal polymerization initiators are contained, the total amount is preferably within the above range.

[0201] <Thermal acid generator> The compositions of the present invention may also include a thermal acid generator. The thermal acid generator generates an acid upon heating, and has the effect of promoting the crosslinking reaction of at least one compound selected from a compound having a hydroxymethyl group, an alkoxymethyl group, or an acyloxymethyl group, an epoxy compound, an oxetane compound, and a benzoxazine compound.

[0202] The thermal decomposition starting temperature of the thermal acid generator is preferably 50° C. to 270° C., more preferably 50° C. to 250° C. In addition, it is preferable to select as the thermal acid generator a material that does not generate acid during drying (pre-baking: about 70 to 140° C.) after the composition is applied to a substrate, but generates acid during final heating (cure: about 100 to 400° C.) after patterning by subsequent exposure and development, because this can suppress a decrease in sensitivity during development. The thermal decomposition onset temperature is determined as the lowest exothermic peak temperature when the thermal acid generator is heated to 500° C. at 5° C. / min in a pressure-resistant capsule. An example of an instrument used to measure the thermal decomposition onset temperature is Q2000 (manufactured by TA Instruments).

[0203] The acid generated from the thermal acid generator is preferably a strong acid, for example, an arylsulfonic acid such as p-toluenesulfonic acid or benzenesulfonic acid, an alkylsulfonic acid such as methanesulfonic acid, ethanesulfonic acid or butanesulfonic acid, or a haloalkylsulfonic acid such as trifluoromethanesulfonic acid, etc. Examples of such thermal acid generators include those described in paragraph 0055 of JP2013-072935A.

[0204] Among these, from the viewpoint of being less likely to remain in the organic film and being less likely to deteriorate the physical properties of the organic film, those which generate alkylsulfonic acids having 1 to 4 carbon atoms or haloalkylsulfonic acids having 1 to 4 carbon atoms are more preferred, and examples thereof include (4-hydroxyphenyl)dimethylsulfonium methanesulfonate, (4-((methoxycarbonyl)oxy)phenyl)dimethylsulfonium methanesulfonate, benzyl(4-hydroxyphenyl)methylsulfonium methanesulfonate, benzyl(4-((methoxycarbonyl)oxy)phenyl)methylsulfonium methanesulfonate, (4-hydroxyphenyl)methyl((2-methylphenyl)methyl)sulfonium methanesulfonate, (4-hydroxyphenyl)dimethylsulfonium trifluoromethanesulfonate, and the like. As the thermal acid generator, preferred are fluorine, (4-((methoxycarbonyl)oxy)phenyl)dimethylsulfonium trifluoromethanesulfonate, benzyl(4-hydroxyphenyl)methylsulfonium trifluoromethanesulfonate, benzyl(4-((methoxycarbonyl)oxy)phenyl)methylsulfonium trifluoromethanesulfonate, (4-hydroxyphenyl)methyl((2-methylphenyl)methyl)sulfonium trifluoromethanesulfonate, 3-(5-(((propylsulfonyl)oxy)imino)thiophene-2(5H)-ylidene)-2-(o-tolyl)propanenitrile, and 2,2-bis(3-(methanesulfonylamino)-4-hydroxyphenyl)hexafluoropropane.

[0205] In addition, the compounds described in paragraph 0059 of JP-A-2013-167742 are also preferred as thermal acid generators.

[0206] The content of the thermal acid generator is preferably 0.01 parts by mass or more, more preferably 0.1 parts by mass or more, relative to 100 parts by mass of the specific resin. By containing 0.01 parts by mass or more, the crosslinking reaction is promoted, so that the mechanical properties and solvent resistance of the organic film can be further improved. In addition, from the viewpoint of the electrical insulation of the organic film, the content is preferably 20 parts by mass or less, more preferably 15 parts by mass or less, and even more preferably 10 parts by mass or less.

[0207] <Onium salt> The curable resin composition of the present invention may further contain an onium salt. In particular, when the curable resin composition of the present invention contains a polyimide precursor or a polybenzoxazole precursor as the specific resin, it preferably contains an onium salt. The type of onium salt is not particularly limited, but preferred examples include ammonium salts, iminium salts, sulfonium salts, iodonium salts and phosphonium salts. Among these, ammonium salts or iminium salts are preferred from the viewpoint of high thermal stability, and sulfonium salts, iodonium salts or phosphonium salts are preferred from the viewpoint of compatibility with the polymer.

[0208] Furthermore, an onium salt is a salt of a cation and an anion having an onium structure, and the cation and anion may or may not be bonded via a covalent bond. That is, the onium salt may be an intramolecular salt having a cationic moiety and an anionic moiety in the same molecular structure, or an intermolecular salt in which a cationic molecule and an anionic molecule, which are separate molecules, are ionic-bonded, but an intermolecular salt is preferable. In addition, in the curable resin composition of the present invention, the cationic moiety or cationic molecule and the anionic moiety or anionic molecule may be bonded by an ionic bond or may be dissociated. The cation in the onium salt is preferably an ammonium cation, a pyridinium cation, a sulfonium cation, an iodonium cation or a phosphonium cation, and more preferably at least one cation selected from the group consisting of a tetraalkylammonium cation, a sulfonium cation and an iodonium cation.

[0209] The onium salt used in the present invention may be a thermal base generator, which will be described later. The thermal base generator refers to a compound that generates a base when heated, and examples thereof include compounds that generate a base when heated to 40° C. or higher. Examples of the onium salt include the onium salts described in paragraphs 0122 to 0138 of WO 2018 / 043262. In addition, onium salts used in the field of polyimide precursors can be used without particular limitation.

[0210] When the curable resin composition of the present invention contains an onium salt, the content of the onium salt is preferably 0.1 to 50 mass% based on the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 0.5 mass% or more, even more preferably 0.85 mass% or more, and even more preferably 1 mass% or more. The upper limit is more preferably 30 mass% or less, even more preferably 20 mass% or less, and even more preferably 10 mass% or less, and may be 5 mass% or less, or may be 4 mass% or less. The onium salt may be used alone or in combination of two or more. When two or more types are used, the total amount is preferably within the above range.

[0211] <Thermal base generator> The curable resin composition of the present invention may further contain a thermal base generator. In particular, when the curable resin composition of the present invention contains a polyimide precursor or a polybenzoxazole precursor as the specific resin, it preferably contains a thermal base generator. The other thermal base generator may be a compound corresponding to the above-mentioned onium salt, or may be a thermal base generator other than the above-mentioned onium salt. Examples of thermal base generators other than the above-mentioned onium salts include nonionic thermal base generators. Examples of the nonionic thermal base generator include compounds represented by formula (B1) or formula (B2). [ka]

[0212] In formula (B1) and formula (B2), Rb 1 , Rb 2 and Rb 3 are each independently an organic group not having a tertiary amine structure, a halogen atom, or a hydrogen atom. 1and Rb 2 cannot be hydrogen atoms at the same time. 1 , Rb 2 and Rb 3 None of the above has a carboxy group. In this specification, the term "tertiary amine structure" refers to a structure in which all three bonds of a trivalent nitrogen atom are covalently bonded to a hydrocarbon carbon atom. Therefore, this does not apply to cases in which the bonded carbon atom is a carbon atom that forms a carbonyl group, that is, when the bonded carbon atom forms an amide group together with the nitrogen atom.

[0213] In formulas (B1) and (B2), Rb 1 , Rb 2 and Rb 3 At least one of these preferably contains a cyclic structure, and more preferably at least two of them contain a cyclic structure. The cyclic structure may be either a monocyclic ring or a condensed ring, and is preferably a monocyclic ring or a condensed ring in which two monocyclic rings are condensed. The monocyclic ring is preferably a 5-membered or 6-membered ring, and more preferably a 6-membered ring. The monocyclic ring is preferably a cyclohexane ring or a benzene ring, and more preferably a cyclohexane ring.

[0214] More specifically, Rb 1 and Rb 2 is preferably a hydrogen atom, an alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and even more preferably having 6 to 10 carbon atoms), or an arylalkyl group (preferably having 7 to 25 carbon atoms, more preferably having 7 to 19 carbon atoms, and even more preferably having 7 to 12 carbon atoms). These groups may have a substituent within the range in which the effects of the present invention are exhibited. Rb 1 and Rb 2 Rb may be bonded to each other to form a ring. The ring formed is preferably a 4- to 7-membered nitrogen-containing heterocycle. 1 and Rb 2is particularly preferably a linear, branched or cyclic alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms) which may have a substituent, more preferably a cycloalkyl group (preferably having 3 to 24 carbon atoms, more preferably having 3 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms) which may have a substituent, and even more preferably a cyclohexyl group which may have a substituent.

[0215] Rb 3 Examples of the group include an alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and more preferably having 3 to 12 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 10 carbon atoms), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably having 2 to 12 carbon atoms, and more preferably having 2 to 6 carbon atoms), an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 12 carbon atoms), an arylalkenyl group (preferably having 8 to 24 carbon atoms, more preferably having 8 to 20 carbon atoms, and more preferably having 8 to 16 carbon atoms), an alkoxy group (preferably having 1 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and more preferably having 3 to 12 carbon atoms), an aryloxy group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 12 carbon atoms), and an arylalkyloxy group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 12 carbon atoms). Among these, a cycloalkyl group (preferably having 3 to 24 carbon atoms, more preferably having 3 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms), an arylalkenyl group, and an arylalkyloxy group are preferable. 3 may further have a substituent within the range in which the effects of the present invention are exhibited.

[0216] The compound represented by formula (B1) is preferably a compound represented by the following formula (B1-1) or (B1-2). [ka]

[0217] In the formula, Rb 11 and Rb 12 , and Rb 31 and Rb32 respectively represent Rb in formula (B1). 1 and Rb 2 is the same as: Rb 13 is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably having 2 to 18 carbon atoms, and even more preferably having 3 to 12 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and even more preferably having 6 to 12 carbon atoms), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and even more preferably having 7 to 12 carbon atoms), and may have a substituent within the range in which the effects of the present invention can be achieved. 13 is preferably an arylalkyl group.

[0218] Rb 33 and Rb 34 each independently represents a hydrogen atom, an alkyl group (preferably having 1 to 12 carbon atoms, more preferably having 1 to 8 carbon atoms, and more preferably having 1 to 3 carbon atoms), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably having 2 to 8 carbon atoms, and more preferably having 2 to 3 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 10 carbon atoms), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 11 carbon atoms), and a hydrogen atom is preferable.

[0219] Rb 35 is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 1 to 12 carbon atoms, and more preferably having 3 to 8 carbon atoms), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably having 2 to 10 carbon atoms, and more preferably having 3 to 8 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 12 carbon atoms), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 12 carbon atoms), and an aryl group is preferable.

[0220] The compound represented by formula (B1-1) is also preferably a compound represented by formula (B1-1a). [ka]

[0221] Rb 11 and Rb 12 is Rb in formula (B1-1). 11 and Rb 12 is synonymous with. Rb 15 and Rb 16 represents a hydrogen atom, an alkyl group (preferably having 1 to 12 carbon atoms, more preferably having 1 to 6 carbon atoms, and more preferably having 1 to 3 carbon atoms), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably having 2 to 6 carbon atoms, and more preferably having 2 to 3 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 10 carbon atoms), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 11 carbon atoms), and preferably a hydrogen atom or a methyl group. Rb 17 is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably having 1 to 12 carbon atoms, and more preferably having 3 to 8 carbon atoms), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably having 2 to 10 carbon atoms, and more preferably having 3 to 8 carbon atoms), an aryl group (preferably having 6 to 22 carbon atoms, more preferably having 6 to 18 carbon atoms, and more preferably having 6 to 12 carbon atoms), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably having 7 to 19 carbon atoms, and more preferably having 7 to 12 carbon atoms), and among these, an aryl group is preferable.

[0222] The molecular weight of the nonionic thermal base generator is preferably 800 or less, more preferably 600 or less, and even more preferably 500 or less. The lower limit is preferably 100 or more, more preferably 200 or more, and even more preferably 300 or more.

[0223] Among the above-mentioned onium salts, specific examples of compounds that are thermal base generators, or specific examples of thermal base generators other than the above-mentioned onium salts, include the following compounds.

[0224] [ka]

[0225] [ka]

[0226] [ka]

[0227] The content of the other thermal base generator is preferably 0.1 to 50% by mass based on the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 0.5% by mass or more, and even more preferably 1% by mass or more. The upper limit is more preferably 30% by mass or less, and even more preferably 20% by mass or less. One or more types of thermal base generators can be used. When two or more types are used, the total amount is preferably within the above range.

[0228] <Crosslinking agent> The curable resin composition of the present invention preferably contains a crosslinking agent. The crosslinking agent may be a radical crosslinking agent or other crosslinking agent.

[0229] <Radical crosslinking agent> The curable resin composition of the present invention preferably further contains a radical crosslinking agent. The radical crosslinking agent is a compound having a radical polymerizable group. The radical polymerizable group is preferably a group having an ethylenically unsaturated bond. The group having an ethylenically unsaturated bond includes a group having an ethylenically unsaturated bond such as a vinyl group, an allyl group, a vinylphenyl group, and a (meth)acryloyl group. Among these, the group containing an ethylenically unsaturated bond is preferably a (meth)acryloyl group, and from the viewpoint of reactivity, a (meth)acryloxy group is more preferable.

[0230] The radical crosslinking agent may be a compound having one or more ethylenically unsaturated bonds, and more preferably a compound having two or more ethylenically unsaturated bonds. The compound having two ethylenically unsaturated bonds is preferably a compound having two of the above groups containing an ethylenically unsaturated bond. From the viewpoint of the film strength of the obtained pattern, the curable resin composition of the present invention preferably contains a compound having 3 or more ethylenically unsaturated bonds as a radical crosslinking agent. The compound having 3 or more ethylenically unsaturated bonds is preferably a compound having 3 to 15 ethylenically unsaturated bonds, more preferably a compound having 3 to 10 ethylenically unsaturated bonds, and even more preferably a compound having 3 to 6 ethylenically unsaturated bonds. Furthermore, the compound having three or more ethylenically unsaturated bonds is preferably a compound having three or more groups containing the ethylenically unsaturated bonds, more preferably a compound having 3 to 15 such bonds, even more preferably a compound having 3 to 10 such bonds, and particularly preferably a compound having 3 to 6 such bonds. From the viewpoint of the film strength of the obtained pattern, it is also preferable that the curable resin composition of the present invention contains a compound having two ethylenically unsaturated bonds and the compound having three or more ethylenically unsaturated bonds.

[0231] The molecular weight of the radical crosslinking agent is preferably 2,000 or less, more preferably 1,500 or less, and even more preferably 900 or less. The lower limit of the molecular weight of the radical crosslinking agent is preferably 100 or more.

[0232] Specific examples of the radical crosslinking agent include unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, crotonic acid, isocrotonic acid, maleic acid, etc.) and their esters and amides, preferably esters of unsaturated carboxylic acids and polyhydric alcohol compounds, and amides of unsaturated carboxylic acids and polyvalent amine compounds. In addition, addition reaction products of unsaturated carboxylic acid esters or amides having nucleophilic substituents such as hydroxyl groups, amino groups, and sulfanyl groups with monofunctional or polyfunctional isocyanates or epoxies, and dehydration condensation reaction products of monofunctional or polyfunctional carboxylic acids are also preferably used. In addition, addition reaction products of unsaturated carboxylic acid esters or amides having electrophilic substituents such as isocyanate groups and epoxy groups with monofunctional or polyfunctional alcohols, amines, and thiols, and substitution reaction products of unsaturated carboxylic acid esters or amides having eliminable substituents such as halogeno groups and tosyloxy groups with monofunctional or polyfunctional alcohols, amines, and thiols are also suitable. As another example, it is also possible to use a compound group in which the above unsaturated carboxylic acid is replaced with an unsaturated phosphonic acid, a vinylbenzene derivative such as styrene, a vinyl ether, an allyl ether, etc. As specific examples, the description in paragraphs 0113 to 0122 of JP2016-027357A can be referred to, and the contents of these are incorporated herein by reference.

[0233] In addition, the radical crosslinking agent is preferably a compound having a boiling point of 100° C. or more under normal pressure. Examples of such a compound include polyethylene glycol di(meth)acrylate, trimethylolethane tri(meth)acrylate, neopentyl glycol di(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, hexanediol (meth)acrylate, trimethylolpropane tri(acryloyloxypropyl)ether, tri(acryloyloxyethyl)isocyanurate, glycerin, trimethylolethane, and many other compounds. Examples of the compound include polyfunctional acrylates and methacrylates such as compounds obtained by adding ethylene oxide or propylene oxide to a functional alcohol and then (meth)acrylating the compound, urethane (meth)acrylates as described in JP-B-48-041708, JP-B-50-006034, and JP-A-51-037193, polyester acrylates as described in JP-A-48-064183, JP-B-49-043191, and JP-A-52-030490, and epoxy acrylates which are reaction products of epoxy resins and (meth)acrylic acid, and mixtures thereof. Compounds described in paragraphs 0254 to 0257 of JP-A-2008-292970 are also suitable. Further, there can be mentioned polyfunctional (meth)acrylates obtained by reacting a polyfunctional carboxylic acid with a compound having a cyclic ether group and an ethylenically unsaturated bond, such as glycidyl (meth)acrylate.

[0234] In addition, as preferred radical crosslinking agents other than those described above, compounds having a fluorene ring and two or more groups having an ethylenically unsaturated bond, as described in JP-A-2010-160418, JP-A-2010-129825, Japanese Patent No. 4364216, etc., and cardo resins can also be used.

[0235] Other examples include specific unsaturated compounds described in JP-B-46-043946, JP-B-01-040337, and JP-B-01-040336, and vinylphosphonic acid compounds described in JP-A-02-025493. Compounds containing perfluoroalkyl groups described in JP-A-61-022048 can also be used. Furthermore, those introduced as photopolymerizable monomers and oligomers in the Journal of the Japan Adhesion Association, Vol. 20, No. 7, pages 300-308 (1984) can also be used.

[0236] In addition to the above, the compounds described in paragraphs 0048 to 0051 of JP 2015-034964 A and the compounds described in paragraphs 0087 to 0131 of WO 2015 / 199219 A can also be preferably used, the contents of which are incorporated herein by reference.

[0237] In addition, compounds obtained by adding ethylene oxide or propylene oxide to a polyfunctional alcohol and then (meth)acrylating the resulting compound, which are described in JP-A-10-062986 as formula (1) and formula (2) together with specific examples thereof, can also be used as radical crosslinking agents.

[0238] Furthermore, the compounds described in paragraphs 0104 to 0131 of JP-A-2015-187211 can also be used as radical crosslinking agents, the contents of which are incorporated herein by reference.

[0239] As the radical crosslinking agent, dipentaerythritol triacrylate (commercially available products include KAYARAD D-330, manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol tetraacrylate (commercially available products include KAYARAD D-320, manufactured by Nippon Kayaku Co., Ltd., and A-TMMT, manufactured by Shin-Nakamura Chemical Co., Ltd.), dipentaerythritol penta(meth)acrylate (commercially available products include KAYARAD D-310, manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol hexa(meth)acrylate (commercially available products include KAYARAD DPHA, manufactured by Nippon Kayaku Co., Ltd., and A-DPH, manufactured by Shin-Nakamura Chemical Co., Ltd.), and structures in which these (meth)acryloyl groups are bonded via ethylene glycol residues or propylene glycol residues are preferred. Oligomer types of these may also be used.

[0240] Commercially available radical crosslinking agents include, for example, SR-494, a tetrafunctional acrylate having four ethyleneoxy chains, manufactured by Sartomer Corporation; SR-209, 231, and 239, difunctional methacrylates having four ethyleneoxy chains, manufactured by Sartomer Corporation; DPCA-60, a hexafunctional acrylate having six pentyleneoxy chains, TPA-330, a trifunctional acrylate having three isobutyleneoxy chains, manufactured by Nippon Kayaku Co., Ltd.; and urethane Examples of such oligomers include UAS-10 and UAB-140 (manufactured by Nippon Paper Industries Co., Ltd.), NK Ester M-40G, NK Ester 4G, NK Ester M-9300, NK Ester A-9300, and UA-7200 (manufactured by Shin-Nakamura Chemical Co., Ltd.), DPHA-40H (manufactured by Nippon Kayaku Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, and AI-600 (manufactured by Kyoeisha Chemical Co., Ltd.), and Blenmer PME400 (manufactured by NOF Corporation).

[0241] As the radical crosslinking agent, urethane acrylates as described in JP-B-48-041708, JP-A-51-037193, JP-B-02-032293, and JP-B-02-016765, and urethane compounds having an ethylene oxide skeleton as described in JP-B-58-049860, JP-B-56-017654, JP-B-62-039417, and JP-B-62-039418 are also suitable. Furthermore, as the radical crosslinking agent, compounds having an amino structure or a sulfide structure in the molecule as described in JP-A-63-277653, JP-A-63-260909, and JP-A-01-105238 can also be used.

[0242] The radical crosslinking agent may be a radical crosslinking agent having an acid group such as a carboxy group or a phosphoric acid group. The radical crosslinking agent having an acid group is preferably an ester of an aliphatic polyhydroxy compound and an unsaturated carboxylic acid, and more preferably a radical crosslinking agent in which an acid group is provided by reacting a non-aromatic carboxylic anhydride with an unreacted hydroxy group of an aliphatic polyhydroxy compound. Particularly preferred is a compound in which the aliphatic polyhydroxy compound is pentaerythritol or dipentaerythritol in a radical crosslinking agent in which an acid group is provided by reacting a non-aromatic carboxylic anhydride with an unreacted hydroxy group of an aliphatic polyhydroxy compound. Examples of commercially available products include M-510, M-520, etc., as polybasic acid modified acrylic oligomers manufactured by Toagosei Co., Ltd.

[0243] The acid value of the radical crosslinking agent having an acid group is preferably 0.1 to 40 mgKOH / g, and particularly preferably 5 to 30 mgKOH / g. If the acid value of the radical crosslinking agent is within the above range, the handling property during production is excellent, and furthermore, the developability is excellent. Also, the polymerizability is good. On the other hand, from the viewpoint of the development speed in the case of alkali development, the acid value of the radical crosslinking agent having an acid group is preferably 0.1 to 300 mgKOH / g, and particularly preferably 1 to 100 mgKOH / g. The acid value is measured in accordance with the description of JIS K 0070:1992.

[0244] In the curable resin composition of the present invention, it is preferable to use a bifunctional methacrylate or acrylate from the viewpoints of pattern resolution and film elasticity. Specific compounds include triethylene glycol diacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, PEG200 diacrylate, PEG200 dimethacrylate, PEG600 diacrylate, PEG600 dimethacrylate, polytetraethylene glycol diacrylate, polytetraethylene glycol dimethacrylate, neopentyl glycol diacrylate, neopentyl glycol dimethacrylate, 3-methyl-1,5-pentanediol diacrylate, and 1,6-hexanediol diacrylate. , 1,6-hexanediol dimethacrylate, dimethylol-tricyclodecane diacrylate, dimethylol-tricyclodecane dimethacrylate, EO adduct diacrylate of bisphenol A, EO adduct dimethacrylate of bisphenol A, PO adduct diacrylate of bisphenol A, PO adduct dimethacrylate of bisphenol A, 2-hydroxy-3-acryloyloxypropyl methacrylate, isocyanuric acid EO modified diacrylate, isocyanuric acid modified dimethacrylate, other bifunctional acrylates having urethane bonds, bifunctional methacrylates having urethane bonds can be used. These can be used by mixing two or more kinds as necessary. For example, PEG200 diacrylate is a polyethylene glycol diacrylate with a formula weight of about 200 for the polyethylene glycol chain. In addition, from the viewpoint of suppressing warpage associated with controlling the elastic modulus of the pattern, a monofunctional radical crosslinking agent can be preferably used as the radical crosslinking agent.As the monofunctional radical crosslinking agent, n-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, butoxyethyl (meth)acrylate, carbitol (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, N-methylol (meth)acrylamide, glycidyl (meth)acrylate, polyethylene glycol mono(meth)acrylate, polypropylene glycol mono(meth)acrylate, and other (meth)acrylic acid derivatives, N-vinyl compounds such as N-vinylpyrrolidone and N-vinylcaprolactam, and allyl compounds such as allyl glycidyl ether, diallyl phthalate, and triallyl trimellitate are preferably used. As the monofunctional radical crosslinking agent, a compound having a boiling point of 100° C. or more under normal pressure is also preferred in order to suppress volatilization before exposure.

[0245] When the radical crosslinking agent is contained, the content thereof is preferably more than 0 mass% and 60 mass% or less based on the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 5 mass% or more. The upper limit is more preferably 50 mass% or less, and even more preferably 30 mass% or less.

[0246] The radical crosslinking agent may be used alone or in combination of two or more. When two or more types are used in combination, the total amount is preferably within the above range.

[0247] <Other crosslinking agents> The curable resin composition of the present invention preferably contains a crosslinking agent other than the above-mentioned radical crosslinking agent. In the present invention, the other crosslinking agent refers to a crosslinking agent other than the above-mentioned radical crosslinking agent, and is preferably a compound having, in its molecule, a plurality of groups that promote a reaction to form a covalent bond with another compound in the composition or a reaction product thereof upon exposure to light by the above-mentioned photosensitizer, and is preferably a compound having, in its molecule, a plurality of groups that promote a reaction to form a covalent bond with another compound in the composition or a reaction product thereof upon the action of an acid or a base. The acid or base is preferably an acid or base generated from a photoacid generator or photobase generator, which is a photosensitizer, in the exposure step. As the other crosslinking agent, a compound having at least one group selected from the group consisting of a methylol group and an alkoxymethyl group is preferred, and a compound having a structure in which at least one group selected from the group consisting of a methylol group and an alkoxymethyl group is directly bonded to a nitrogen atom is more preferred. Other crosslinking agents include compounds having a structure in which an amino group-containing compound such as melamine, glycoluril, urea, alkylene urea, or benzoguanamine is reacted with formaldehyde or formaldehyde and alcohol, and the hydrogen atom of the amino group is replaced with a methylol group or an alkoxymethyl group.The method for producing these compounds is not particularly limited, and they may be compounds having the same structure as the compounds produced by the above method.In addition, they may be oligomers formed by self-condensation of the methylol groups of these compounds. As the above amino group-containing compound, a crosslinking agent using melamine is called a melamine-based crosslinking agent, a crosslinking agent using glycoluril, urea or alkylene urea is called a urea-based crosslinking agent, a crosslinking agent using alkylene urea is called an alkylene urea-based crosslinking agent, and a crosslinking agent using benzoguanamine is called a benzoguanamine-based crosslinking agent. Among these, the curable resin composition of the present invention preferably contains at least one compound selected from the group consisting of urea-based crosslinking agents and melamine-based crosslinking agents, and more preferably contains at least one compound selected from the group consisting of glycoluril-based crosslinking agents and melamine-based crosslinking agents described below.

[0248] Specific examples of the melamine-based crosslinking agent include hexamethoxymethylmelamine, hexaethoxymethylmelamine, hexapropoxymethylmelamine, and hexabutoxybutylmelamine.

[0249] Specific examples of urea-based crosslinking agents include glycoluril-based crosslinking agents such as monohydroxymethylated glycoluril, dihydroxymethylated glycoluril, trihydroxymethylated glycoluril, tetrahydroxymethylated glycoluril, monomethoxymethylated glycoluril, dimethoxymethylated glycoluril, trimethoxymethylated glycoluril, tetramethoxymethylated glycoluril, monomethoxymethylated glycoluril, dimethoxymethylated glycoluril, trimethoxymethylated glycoluril, tetraethoxymethylated glycoluril, monopropoxymethylated glycoluril, dipropoxymethylated glycoluril, tripropoxymethylated glycoluril, tetrapropoxymethylated glycoluril, monobutoxymethylated glycoluril, dibutoxymethylated glycoluril, tributoxymethylated glycoluril, and tetrabutoxymethylated glycoluril; Urea-based crosslinking agents such as bismethoxymethylurea, bisethoxymethylurea, bispropoxymethylurea, and bisbutoxymethylurea; ethyleneurea-based crosslinking agents such as monohydroxymethylated ethyleneurea or dihydroxymethylated ethyleneurea, monomethoxymethylated ethyleneurea, dimethoxymethylated ethyleneurea, monoethoxymethylated ethyleneurea, diethoxymethylated ethyleneurea, monopropoxymethylated ethyleneurea, dipropoxymethylated ethyleneurea, monobutoxymethylated ethyleneurea, or dibutoxymethylated ethyleneurea; propylene urea-based crosslinking agents such as monohydroxymethylated propylene urea, dihydroxymethylated propylene urea, monomethoxymethylated propylene urea, dimethoxymethylated propylene urea, monodiethoxymethylated propylene urea, diethoxymethylated propylene urea, monopropoxymethylated propylene urea, dipropoxymethylated propylene urea, monobutoxymethylated propylene urea, or dibutoxymethylated propylene urea; Examples include 1,3-di(methoxymethyl)-4,5-dihydroxy-2-imidazolidinone and 1,3-di(methoxymethyl)-4,5-dimethoxy-2-imidazolidinone.

[0250] Specific examples of benzoguanamine-based crosslinking agents include monohydroxymethylated benzoguanamine, dihydroxymethylated benzoguanamine, trihydroxymethylated benzoguanamine, tetrahydroxymethylated benzoguanamine, monomethoxymethylated benzoguanamine, dimethoxymethylated benzoguanamine, trimethoxymethylated benzoguanamine, tetramethoxymethylated benzoguanamine, monomethoxymethylated benzoguanamine, dimethoxymethylated benzoguanamine, trimethoxymethylated benzoguanamine, tetraethoxymethylated benzoguanamine, monopropoxymethylated benzoguanamine, dipropoxymethylated benzoguanamine, tripropoxymethylated benzoguanamine, tetrapropoxymethylated benzoguanamine, monobutoxymethylated benzoguanamine, dibutoxymethylated benzoguanamine, tributoxymethylated benzoguanamine, and tetrabutoxymethylated benzoguanamine.

[0251] In addition, as the compound having at least one group selected from the group consisting of a methylol group and an alkoxymethyl group, a compound in which at least one group selected from the group consisting of a methylol group and an alkoxymethyl group is directly bonded to an aromatic ring (preferably a benzene ring) is also preferably used. Specific examples of such compounds include benzenedimethanol, bis(hydroxymethyl)cresol, bis(hydroxymethyl)dimethoxybenzene, bis(hydroxymethyl)diphenyl ether, bis(hydroxymethyl)benzophenone, hydroxymethylphenyl hydroxymethylbenzoate, bis(hydroxymethyl)biphenyl, dimethylbis(hydroxymethyl)biphenyl, bis(methoxymethyl)benzene, bis(methoxymethyl)cresol, bis(methoxymethyl)dimethoxybenzene, bis(methoxymethyl)diphenyl ether, bis(methoxymethyl)benzophenone, methoxymethylphenyl methoxymethylbenzoate, bis(methoxymethyl)biphenyl, dimethylbis(methoxymethyl)biphenyl, 4,4',4''-ethylidene tris[2,6-bis(methoxymethyl)phenol], 5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[2-hydroxy-1,3-benzenedimethanol], and 3,3',5,5'-tetrakis(methoxymethyl)-1,1'-biphenyl-4,4'-diol.

[0252] As the other crosslinking agent, commercially available products may be used, and suitable commercially available products include 46DMOC, 46DMOEP (both manufactured by Asahi Organic Chemicals Co., Ltd.), DML-PC, DML-PEP, DML-OC, DML-OEP, DML-34X, DML-PTBP, DML-PCHP, DML-OCHP, DML-PFP, DML-PSBP, DML-POP, DML-MBOC, DML-MBPC, DML-MTrisPC, DML-BisOC-Z, DML-BisOCHP-Z, DML-BPC, DMLBisOC-P, DMOM-PC, DMOM-PTBP, DMOM-MBPC, TriML-P, and TriML-35XL. , TML-HQ, TML-BP, TML-pp-BPF, TML-BPE, TML-BPA, TML-BPAF, TML-BPAP, TMOM-BP, TMOM-BPE, TMOM-BPA, TMOM-BPAF, TMOM-BPAP, HML-TPPHBA, HML-TPHAP, HMOM-TPPHBA, HMOM-TPHAP (all manufactured by Honshu Chemical Industry Co., Ltd.), Nikalac (registered trademark, the same applies below) MX-290, Nikalac MX-280, Nikalac MX-270, Nikalac MX-279, Nikalac MW-100LM, Nikalac MX-750LM (all manufactured by Sanwa Chemical Co., Ltd.), and the like.

[0253] The curable resin composition of the present invention also preferably contains, as another crosslinking agent, at least one compound selected from the group consisting of epoxy compounds, oxetane compounds, and benzoxazine compounds.

[0254] [Epoxy compounds (compounds having an epoxy group)] The epoxy compound is preferably a compound having two or more epoxy groups in one molecule. The epoxy group undergoes a crosslinking reaction at 200°C or less, and does not undergo a dehydration reaction due to crosslinking, so film shrinkage is unlikely to occur. Therefore, the inclusion of the epoxy compound is effective in curing the curable resin composition at low temperatures and suppressing warping.

[0255] The epoxy compound preferably contains a polyethylene oxide group. This further reduces the elastic modulus and suppresses warping. The polyethylene oxide group refers to a group having 2 or more repeating ethylene oxide units, and the number of repeating units is preferably 2 to 15.

[0256] Examples of epoxy compounds include, but are not limited to, bisphenol A type epoxy resins; bisphenol F type epoxy resins; alkylene glycol type epoxy resins or polyhydric alcohol hydrocarbon type epoxy resins such as propylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, ethylene glycol diglycidyl ether, butylene glycol diglycidyl ether, hexamethylene glycol diglycidyl ether, and trimethylolpropane triglycidyl ether; polyalkylene glycol type epoxy resins such as polypropylene glycol diglycidyl ether; and epoxy group-containing silicones such as polymethyl(glycidyloxypropyl)siloxane.Specifically, Epicron (registered trademark) 850-S, Epicron (registered trademark) HP-4032, Epicron (registered trademark) HP-7200, Epicron (registered trademark) HP-820, Epicron (registered trademark) HP-4700, Epicron (registered trademark) EXA-4710, Epicron (registered trademark) HP-4770, Epicron (registered trademark) EXA-859CRP, Epicron (registered trademark) EXA-1514, Epicron (registered trademark) EXA-4880, Epicron (registered trademark) EXA-4850-15 0, Epicron EXA-4850-1000, Epicron (registered trademark) EXA-4816, Epicron (registered trademark) EXA-4822, Epicron (registered trademark) EXA-830LVP, Epicron (registered trademark) EXA-8183, Epicron (registered trademark) EXA-8169, Epicron (registered trademark) N-660, Epicron (registered trademark) N-665-EXP-S, Epicron (registered trademark) N-740, Likaresin (registered trademark) BEO-20E (all trade names, manufactured by DIC Corporation), Likaresin (registered trademark) (registered trademark) BEO-60E, Likaresin (registered trademark) HBE-100, Likaresin (registered trademark) DME-100, Likaresin (registered trademark) L-200 (product name, New Japan Chemical Co., Ltd.), EP-4003S, EP-4000S, EP-4088S, EP-3950S (all product names, manufactured by ADEKA Corporation), Celoxide 2021P, 2081, 2000, 3000, EHPE3150, Epolead GT400, Cellvinars B0134, B0177 (all product names, manufactured by Daicel Corporation), NC-300 0, NC-3000-L, NC-3000-H, NC-3000-FH-75M, NC-3100, CER-3000-L, NC-2000-L, XD-1000, NC-7000L, NC-7300L, EPPN-501H, EPPN-501HY, EPPN-502H, EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, CER-1020, EPPN-201, BREN-S, BREN-10S (all trade names, manufactured by Nippon Kayaku Co., Ltd.).

[0257] [Oxetane compounds (compounds having an oxetanyl group)] Examples of the oxetane compound include compounds having two or more oxetane rings in one molecule, 3-ethyl-3-hydroxymethyloxetane, 1,4-bis{[(3-ethyl-3-oxetanyl)methoxy]methyl}benzene, 3-ethyl-3-(2-ethylhexylmethyl)oxetane, 1,4-benzenedicarboxylic acid-bis[(3-ethyl-3-oxetanyl)methyl]ester, etc. Specific examples include the Aron Oxetane series (e.g., OXT-121, OXT-221, OXT-191, OXT-223) manufactured by Toagosei Co., Ltd., which may be used alone or in combination of two or more kinds.

[0258] [Benzoxazine compounds (compounds having a benzoxazolyl group)] Benzoxazine compounds are preferred because they undergo a crosslinking reaction derived from a ring-opening addition reaction, so that degassing does not occur during curing, and further, they reduce thermal shrinkage and suppress the occurrence of warping.

[0259] Preferred examples of benzoxazine compounds include Ba-type benzoxazine, Bm-type benzoxazine, Pd-type benzoxazine, Fa-type benzoxazine (all trade names, manufactured by Shikoku Chemical Industry Co., Ltd.), benzoxazine adducts of polyhydroxystyrene resins, and phenol novolac-type dihydrobenzoxazine compounds. These may be used alone or in combination of two or more.

[0260] The content of the other crosslinking agent is preferably 0.1 to 30 mass% based on the total solid content of the curable resin composition of the present invention, more preferably 0.1 to 20 mass%, further preferably 0.5 to 15 mass%, and particularly preferably 1.0 to 10 mass%. Only one type of other crosslinking agent may be contained, or two or more types may be contained. When two or more types of other crosslinking agents are contained, the total is preferably within the above range.

[0261] <Compounds having a sulfonamide structure, compounds having a thiourea structure> From the viewpoint of improving the adhesion of the obtained pattern to a substrate, it is preferable that the curable resin composition of the present invention further contains at least one compound selected from the group consisting of compounds having a sulfonamide structure and compounds having a thiourea structure.

[0262] [Compounds having a sulfonamide structure] The sulfonamide structure is a structure represented by the following formula (S-1). [ka] In formula (S-1), R represents a hydrogen atom or an organic group, R may bond to another structure to form a ring structure, and each * independently represents a bonding site to another structure. The above R is R in the following formula (S-2): 2 It is preferable that the group is the same as the following group. The compound having a sulfonamide structure may be a compound having two or more sulfonamide structures, but is preferably a compound having one sulfonamide structure.

[0263] The compound having a sulfonamide structure is preferably a compound represented by the following formula (S-2). [ka] In formula (S-2), R 1 , R 2 and R 3 each independently represents a hydrogen atom or a monovalent organic group; R 1 , R 2 and R 3 Two or more of these may be bonded to each other to form a ring structure. R 1 , R 2 and R 3 is preferably each independently a monovalent organic group. R 1 , R 2 and R 3Examples of the alkyl group include a hydrogen atom, an alkyl group, a cycloalkyl group, an alkoxy group, an alkyl ether group, an alkylsilyl group, an alkoxysilyl group, an aryl group, an aryl ether group, a carboxy group, a carbonyl group, an allyl group, a vinyl group, a heterocyclic group, or a combination of two or more of these groups. The alkyl group is preferably an alkyl group having 1 to 10 carbon atoms, and more preferably an alkyl group having 1 to 6 carbon atoms. Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, an isopropyl group, and a 2-ethylhexyl group. The above cycloalkyl group is preferably a cycloalkyl group having 5 to 10 carbon atoms, more preferably a cycloalkyl group having 6 to 10 carbon atoms. Examples of the above cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group. The above alkoxy group is preferably an alkoxy group having 1 to 10 carbon atoms, and more preferably an alkoxy group having 1 to 5 carbon atoms. Examples of the above alkoxy group include a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a pentoxy group. The above alkoxysilyl group is preferably an alkoxysilyl group having 1 to 10 carbon atoms, and more preferably an alkoxysilyl group having 1 to 4 carbon atoms. Examples of the above alkoxysilyl group include a methoxysilyl group, an ethoxysilyl group, a propoxysilyl group, and a butoxysilyl group. The aryl group is preferably an aryl group having 6 to 20 carbon atoms, more preferably an aryl group having 6 to 12 carbon atoms. The aryl group may have a substituent such as an alkyl group. Examples of the aryl group include a phenyl group, a tolyl group, a xylyl group, and a naphthyl group. Examples of the heterocyclic group include a triazole ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, an isoxazole ring, an isothiazole ring, a tetrazole ring, a pyridine ring, a pyridazine ring, a pyrimididine ring, a pyrazine ring, a piperidine ring, a piperazine ring, a morpholine ring, a dihydropyran ring, a tetrahydropyran group, and a group in which one hydrogen atom has been removed from a heterocyclic structure such as a triazine ring.

[0264] Among these, R 1 is an aryl group, and R 2 and R 3 are each independently a hydrogen atom or an alkyl group.

[0265] Examples of compounds having a sulfonamide structure include benzenesulfonamide, dimethylbenzenesulfonamide, N-butylbenzenesulfonamide, sulfanilamide, o-toluenesulfonamide, p-toluenesulfonamide, hydroxynaphthalenesulfonamide, naphthalene-1-sulfonamide, naphthalene-2-sulfonamide, m-nitrobenzenesulfonamide, p-chlorobenzenesulfonamide, methanesulfonamide, N,N-dimethylmethanesulfonamide, N,N-dimethylethanesulfonamide, N,N-diethylmethanesulfonamide, N-methoxymethanesulfonamide, N-dodecylmethanesulfonamide, N-cyclohexyl-1-butanesulfonamide, and 2-aminoethanesulfonamide.

[0266] [Compounds having a thiourea structure] The thiourea structure is a structure represented by the following formula (T-1). [ka] In formula (T-1), R 4 and R 5 each independently represents a hydrogen atom or a monovalent organic group; R 4 and R 5may be bonded to form a ring structure, R 4 may combine with another structure to which * is bonded to form a ring structure, R 5 may bond to another structure to which the * is bonded to form a ring structure, and each * independently represents a bonding site to another structure.

[0267] R 4 and R 5 are each preferably independently a hydrogen atom. R 4 and R 5 Examples of the alkyl group include a hydrogen atom, an alkyl group, a cycloalkyl group, an alkoxy group, an alkyl ether group, an alkylsilyl group, an alkoxysilyl group, an aryl group, an aryl ether group, a carboxy group, a carbonyl group, an allyl group, a vinyl group, a heterocyclic group, or a combination of two or more of these groups. The alkyl group is preferably an alkyl group having 1 to 10 carbon atoms, and more preferably an alkyl group having 1 to 6 carbon atoms. Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, an isopropyl group, and a 2-ethylhexyl group. The above cycloalkyl group is preferably a cycloalkyl group having 5 to 10 carbon atoms, more preferably a cycloalkyl group having 6 to 10 carbon atoms. Examples of the above cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group. The above alkoxy group is preferably an alkoxy group having 1 to 10 carbon atoms, and more preferably an alkoxy group having 1 to 5 carbon atoms. Examples of the above alkoxy group include a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a pentoxy group. The above alkoxysilyl group is preferably an alkoxysilyl group having 1 to 10 carbon atoms, and more preferably an alkoxysilyl group having 1 to 4 carbon atoms. Examples of the above alkoxysilyl group include a methoxysilyl group, an ethoxysilyl group, a propoxysilyl group, and a butoxysilyl group. The aryl group is preferably an aryl group having 6 to 20 carbon atoms, more preferably an aryl group having 6 to 12 carbon atoms. The aryl group may have a substituent such as an alkyl group. Examples of the aryl group include a phenyl group, a tolyl group, a xylyl group, and a naphthyl group. Examples of the heterocyclic group include a triazole ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, an isoxazole ring, an isothiazole ring, a tetrazole ring, a pyridine ring, a pyridazine ring, a pyrimididine ring, a pyrazine ring, a piperidine ring, a piperazine ring, a morpholine ring, a dihydropyran ring, a tetrahydropyran group, and a group in which one hydrogen atom has been removed from a heterocyclic structure such as a triazine ring. The compound having a thiourea structure may be a compound having two or more thiourea structures, but is preferably a compound having one thiourea structure.

[0268] The compound having a thiourea structure is preferably a compound represented by the following formula (T-2). [ka] In formula (T-2), R 4 ~R 7 each independently represents a hydrogen atom or a monovalent organic group; R 4 ~R 7 At least two of these may be bonded to each other to form a ring structure.

[0269] In formula (T-2), R 4 and R 5 is R in formula (T-1) 4 and R 5 The same applies to the preferred embodiments. In formula (T-2), R 6 and R 7 is preferably each independently a monovalent organic group. In formula (T-2), R 6 and R 7 A preferred embodiment of the monovalent organic group in formula (T-1) is4 and R 5 The preferred embodiments are the same as those of the monovalent organic group in the above.

[0270] Examples of compounds having a thiourea structure include N-acetylthiourea, N-allylthiourea, N-allyl-N'-(2-hydroxyethyl)thiourea, 1-adamantylthiourea, N-benzoylthiourea, N,N'-diphenylthiourea, 1-benzyl-phenylthiourea, 1,3-dibutylthiourea, 1,3-diisopropylthiourea, 1,3-dicyclohexylthiourea, 1-(3-(trimethoxysilyl)propyl)-3-methylthiourea, trimethylthiourea, tetramethylthiourea, N,N-diphenylthiourea, ethylenethiourea (2-imidazolinethione), carbimazole, and 1,3-dimethyl-2-thiohydantoin.

[0271] [Content] The total content of the compound having a sulfonamide structure and the compound having a thiourea structure relative to the total mass of the curable resin composition of the present invention is preferably 0.05 to 10 mass%, more preferably 0.1 to 5 mass%, and further preferably 0.2 to 3 mass%. The curable resin composition of the present invention may contain only one compound selected from the group consisting of compounds having a sulfonamide structure and compounds having a thiourea structure, or may contain two or more compounds. When only one compound is contained, the content of the compound is preferably within the above range, and when two or more compounds are contained, the total amount is preferably within the above range.

[0272] <Migration inhibitor> The curable resin composition of the present invention preferably further contains a migration inhibitor, which makes it possible to effectively suppress the migration of metal ions originating from the metal layer (metal wiring) into the photosensitive film.

[0273] The migration inhibitor is not particularly limited, but includes compounds having a heterocycle (pyrrole ring, furan ring, thiophene ring, imidazole ring, triazole ring, oxazole ring, thiazole ring, pyrazole ring, isoxazole ring, isothiazole ring, tetrazole ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, piperidine ring, piperazine ring, morpholine ring, 2H-pyran ring and 6H-pyran ring, triazine ring), compounds having thioureas and sulfanyl groups, hindered phenol compounds, salicylic acid derivative compounds, and hydrazide derivative compounds. In particular, triazole compounds such as 1,2,4-triazole and benzotriazole, and tetrazole compounds such as 1H-tetrazole and 5-phenyltetrazole can be preferably used.

[0274] Alternatively, an ion trapping agent that traps anions such as halogen ions can be used.

[0275] Other examples of the migration inhibitor include the rust inhibitor described in paragraph 0094 of JP-A-2013-015701, the compounds described in paragraphs 0073 to 0076 of JP-A-2009-283711, the compounds described in paragraph 0052 of JP-A-2011-059656, the compounds described in paragraphs 0114, 0116 and 0118 of JP-A-2012-194520, and the compounds described in paragraph 0166 of WO 2015 / 199219.

[0276] Specific examples of the migration inhibitor include the following compounds.

[0277] [ka]

[0278] When the curable resin composition contains a migration inhibitor, the content of the migration inhibitor is preferably 0.01 to 5.0 mass%, more preferably 0.05 to 2.0 mass%, and even more preferably 0.1 to 1.0 mass%, based on the total solid content of the curable resin composition.

[0279] The migration inhibitor may be one type or two or more types. When two or more types of migration inhibitors are used, the total amount is preferably within the above range.

[0280] <Polymerization inhibitor> The curable resin composition of the present invention preferably contains a polymerization inhibitor.

[0281] Examples of the polymerization inhibitor include hydroquinone, o-methoxyphenol, methoxyhydroquinone, p-methoxyphenol, di-tert-butyl-p-cresol, pyrogallol, p-tert-butylcatechol (t-butylcatechol), 1,4-benzoquinone, diphenyl-p-benzoquinone, 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-tert-butylphenol), N-nitrophenyl-p-benzoquinone, and the like. Nitroso-N-phenylhydroxyamine aluminum salt, phenothiazine, N-nitrosodiphenylamine, N-phenylnaphthylamine, ethylenediaminetetraacetic acid, 1,2-cyclohexanediaminetetraacetic acid, glycol ether diaminetetraacetic acid, 2,6-di-tert-butyl-4-methylphenol, 5-nitroso-8-hydroxyquinoline, 1-nitroso-2-naphthol, 2-nitroso-1-naphthol, 2-nitroso-5-(N-ethyl-N-sulfopropionate), (p-amino)phenol, N-nitrosophenylhydroxyamine cerium salt, N-nitroso-N-(1-naphthyl)hydroxyamine ammonium salt, bis(4-hydroxy-3,5-tert-butyl)phenylmethane, 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-on Xyl free radical, phenothiazine, 1,1-diphenyl-2-picrylhydrazyl, dibutyldithiocarbamate copper (II), nitrobenzene, N-nitroso-N-phenylhydroxylamine aluminum salt, N-nitroso-N-phenylhydroxylamine ammonium salt N,N'-diphenyl-p-phenylenediamine, 2,4-di-tert-butylphenol, di-t-butylhydroxytoluene, 1,4-naphthoquinone, etc. can be suitably used. In addition, the polymerization inhibitor described in paragraph 0060 of JP2015-127817A and the compounds described in paragraphs 0031 to 0046 of WO2015 / 125469A can also be used.

[0282] In addition, the following compounds can be used.

[0283] [ka]

[0284] When the curable resin composition of the present invention contains a polymerization inhibitor, the content of the polymerization inhibitor is, for example, 0.01 to 20.0 mass%, preferably 0.01 to 5 mass%, more preferably 0.02 to 3 mass%, and even more preferably 0.05 to 2.5 mass%, relative to the total solid content of the curable resin composition of the present invention.

[0285] The polymerization inhibitor may be one type or two or more types. When two or more types of polymerization inhibitors are used, the total amount thereof is preferably within the above range.

[0286] <Metal adhesion improver> The curable resin composition of the present invention preferably contains a metal adhesion improver for improving adhesion to metal materials used in electrodes, wiring, etc. Examples of the metal adhesion improver include silane coupling agents, aluminum-based adhesion aids, titanium-based adhesion aids, compounds having a sulfonamide structure, compounds having a thiourea structure, phosphoric acid derivative compounds, β-ketoester compounds, amino compounds, and the like.

[0287] Examples of the silane coupling agent include the compounds described in paragraph 0167 of WO 2015 / 199219, the compounds described in paragraphs 0062-0073 of JP 2014-191002 A, the compounds described in paragraphs 0063-0071 of WO 2011 / 080992 A, the compounds described in paragraphs 0060-0061 of JP 2014-191252 A, the compounds described in paragraphs 0045-0052 of JP 2014-041264 A, and the compounds described in paragraph 0055 of WO 2014 / 097594 A. It is also preferable to use two or more different silane coupling agents as described in paragraphs 0050-0058 of JP 2011-128358 A. It is also preferable to use the following compounds as the silane coupling agent. In the following formula, Et represents an ethyl group.

[0288] [ka] Other silane coupling agents include, for example, vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, p-styryltrimethoxysilane, 3-methacryloxypropylmethyldimethoxysilane, 3-methacryloxypropyl Examples of the silane include pyryltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, tris-(trimethoxysilylpropyl)isocyanurate, 3-ureidopropyltrialkoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane, and 3-trimethoxysilylpropylsuccinic anhydride. These can be used alone or in combination of two or more.

[0289] [Aluminum-based adhesion promoter] Examples of aluminum-based adhesion promoters include aluminum tris(ethylacetoacetate), aluminum tris(acetylacetonate), and ethylacetoacetate aluminum diisopropylate.

[0290] As the metal adhesion improver, the compounds described in paragraphs 0046 to 0049 of JP-A No. 2014-186186 and the sulfide-based compounds described in paragraphs 0032 to 0043 of JP-A No. 2013-072935 can also be used.

[0291] The content of the metal adhesion improver is preferably 0.1 to 30 parts by mass, more preferably 0.5 to 15 parts by mass, and even more preferably 0.5 to 5 parts by mass, relative to 100 parts by mass of the specific resin. By making it equal to or more than the lower limit, the adhesion between the pattern and the metal layer becomes good, and by making it equal to or less than the upper limit, the heat resistance and mechanical properties of the pattern become good. The metal adhesion improver may be of only one type, or of two or more types. When two or more types are used, the total is preferably within the above range.

[0292] <Metal adhesion improver> The curable resin composition of the present invention preferably contains a metal adhesion improver for improving adhesion to metal materials used in electrodes, wiring, etc. As the metal adhesion improver, the compounds described in paragraphs 0046 to 0049 of JP2014-186186A and the sulfide-based compounds described in paragraphs 0032 to 0043 of JP2013-072935A can also be used.

[0293] The content of the metal adhesion improver is preferably 0.1 to 30 parts by mass, more preferably 0.5 to 15 parts by mass, and even more preferably 0.5 to 5 parts by mass, relative to 100 parts by mass of the heterocycle-containing polymer precursor. By making it equal to or more than the lower limit, the adhesion between the pattern and the metal layer after the heating step is improved, and by making it equal to or less than the upper limit, the heat resistance and mechanical properties of the cured product after the heating step are improved. The metal adhesion improver may be one type or two or more types. When two or more types are used, the total is preferably within the above range.

[0294] <Other additives> The curable resin composition of the present invention may contain various additives, such as a sensitizer, a chain transfer agent, a surfactant, a higher fatty acid derivative, inorganic particles, a curing agent, a curing catalyst, a filler, an antioxidant, an ultraviolet absorber, an anti-aggregation agent, etc., as necessary, within the range in which the effects of the present invention can be obtained. When these additives are added, the total amount of the additives is preferably 3% by mass or less of the solid content of the curable resin composition.

[0295] [Sensitizer] The curable resin composition of the present invention may contain a sensitizer. The sensitizer absorbs specific active radiation and becomes electronically excited. The sensitizer in the electronically excited state comes into contact with a thermal curing accelerator, a thermal radical polymerization initiator, a photoradical polymerization initiator, or the like, and effects such as electron transfer, energy transfer, and heat generation occur. As a result, the thermal curing accelerator, the thermal radical polymerization initiator, and the photoradical polymerization initiator undergo a chemical change and decompose, generating a radical, an acid, or a base. Examples of the sensitizer include Michler's ketone, 4,4'-bis(diethylamino)benzophenone, 2,5-bis(4'-diethylaminobenzal)cyclopentane, 2,6-bis(4'-diethylaminobenzal)cyclohexanone, 2,6-bis(4'-diethylaminobenzal)-4-methylcyclohexanone, 4,4'-bis(dimethylamino)chalcone, 4,4'-bis(diethylamino)chalcone, p-dimethylaminocinnamylideneindanone, p-dimethylaminobenzylamine ... Dilidene indanone, 2-(p-dimethylaminophenylbiphenylene)-benzothiazole, 2-(p-dimethylaminophenylvinylene)benzothiazole, 2-(p-dimethylaminophenylvinylene)isonaphthothiazole, 1,3-bis(4'-dimethylaminobenzal)acetone, 1,3-bis(4'-diethylaminobenzal)acetone, 3,3'-carbonyl-bis(7-diethylaminocoumarin), 3-acetyl-7-dimethylaminocoumarin, 3-ethoxycarbo N-phenyl-7-dimethylaminocoumarin, 3-benzyloxycarbonyl-7-dimethylaminocoumarin, 3-methoxycarbonyl-7-diethylaminocoumarin, 3-ethoxycarbonyl-7-diethylaminocoumarin, N-phenyl-N'-ethylethanolamine, N-phenyldiethanolamine, Np-tolyldiethanolamine, N-phenylethanolamine, 4-morpholinobenzophenone, isoamyl dimethylaminobenzoate, isoamyl diethylaminobenzoate, 2-methylaminobenzoate, Examples of the mercaptobenzoimidazole include mercaptobenzimidazole, 1-phenyl-5-mercaptotetrazole, 2-mercaptobenzothiazole, 2-(p-dimethylaminostyryl)benzoxazole, 2-(p-dimethylaminostyryl)benzthiazole, 2-(p-dimethylaminostyryl)naphtho(1,2-d)thiazole, 2-(p-dimethylaminobenzoyl)styrene, diphenylacetamide, benzanilide, N-methylacetanilide, and 3',4'-dimethylacetanilide. As the sensitizer, a sensitizing dye may be used. For details about the sensitizing dye, reference can be made to paragraphs 0161 to 0163 of JP2016-027357A, the contents of which are incorporated herein by reference.

[0296] When the curable resin composition of the present invention contains a sensitizer, the content of the sensitizer is preferably 0.01 to 20 mass%, more preferably 0.1 to 15 mass%, and further preferably 0.5 to 10 mass%, based on the total solid content of the curable resin composition of the present invention. The sensitizer may be used alone or in combination of two or more kinds.

[0297] [Chain transfer agent] The curable resin composition of the present invention may contain a chain transfer agent. The chain transfer agent is defined, for example, in the Third Edition of the Polymer Dictionary (edited by the Society of Polymer Science, 2005), pages 683-684. As the chain transfer agent, for example, a group of compounds having SH, PH, SiH, and GeH in the molecule is used. These can donate hydrogen to a low activity radical to generate a radical, or can generate a radical by being oxidized and then deprotonated. In particular, a thiol compound can be preferably used.

[0298] In addition, as the chain transfer agent, the compounds described in paragraphs 0152 to 0153 of WO 2015 / 199219 can also be used.

[0299] When the curable resin composition of the present invention has a chain transfer agent, the content of the chain transfer agent is preferably 0.01 to 20 parts by mass, more preferably 1 to 10 parts by mass, and even more preferably 1 to 5 parts by mass, based on 100 parts by mass of the total solid content of the curable resin composition of the present invention. The chain transfer agent may be one type or two or more types. When two or more types of chain transfer agents are used, the total is preferably within the above range.

[0300] [Surfactant] A surfactant may be added to the curable resin composition of the present invention from the viewpoint of further improving the coating property. As the surfactant, various types of surfactants such as fluorine-based surfactants, nonionic surfactants, cationic surfactants, anionic surfactants, and silicone surfactants can be used. The following surfactants are also preferred. In the following formula, the parentheses indicating the repeating unit of the main chain indicate the content (mol%) of each repeating unit, and the parentheses indicating the repeating unit of the side chain indicate the number of repeats of each repeating unit. [ka] In addition, the compounds described in paragraphs 0159 to 0165 of WO 2015 / 199219 can also be used as the surfactant. The fluorine-containing surfactant may be a fluorine-containing polymer having an ethylenically unsaturated group in the side chain. Specific examples include the compounds described in paragraphs 0050-0090 and 0289-0295 of JP2010-164965A, such as Megafac RS-101, RS-102, and RS-718K manufactured by DIC Corporation.

[0301] The fluorine content in the fluorosurfactant is preferably 3 to 40 mass%, more preferably 5 to 30 mass%, and particularly preferably 7 to 25 mass%. A fluorosurfactant having a fluorine content within this range is effective in terms of uniformity of the coating film thickness and liquid saving properties, and also has good solubility in the composition.

[0302] Examples of silicone surfactants include Toray Silicone DC3PA, Toray Silicone SH7PA, Toray Silicone DC11PA, Toray Silicone SH21PA, Toray Silicone SH28PA, Toray Silicone SH29PA, Toray Silicone SH30PA, Toray Silicone SH8400 (all manufactured by Toray Dow Corning Co., Ltd.), TSF-4440, TSF-4300, TSF-4445, TSF-4460, TSF-4452 (all manufactured by Momentive Performance Materials, Inc.), KP341, KF6001, KF6002 (all manufactured by Shin-Etsu Silicone Co., Ltd.), BYK307, BYK323, BYK330 (all manufactured by BYK-Chemie Co., Ltd.), and the like.

[0303] Examples of hydrocarbon surfactants include Paionin A-76, Newkalgen FS-3PG, Paionin B-709, Paionin B-811-N, Paionin D-1004, Paionin D-3104, Paionin D-3605, Paionin D-6112, Paionin D-2104-D, Paionin D-212, Paionin D-931, Paionin D-941, Paionin D-951, Paionin E-5310, Paionin P-1050-B, Paionin P-1028-P, Paionin P-4050-T, and the like (all manufactured by Takemoto Oil Co., Ltd.).

[0304] Examples of nonionic surfactants include glycerol, trimethylolpropane, trimethylolethane, and their ethoxylates and propoxylates (e.g., glycerol propoxylate, glycerol ethoxylate, etc.), polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, polyoxyethylene octylphenyl ether, polyoxyethylene nonylphenyl ether, polyethylene glycol dilaurate, polyethylene glycol distearate, sorbitan fatty acid ether, and the like. Examples of such compounds include Stel, Pluronic (registered trademark) L10, L31, L61, L62, 10R5, 17R2, and 25R2 (manufactured by BASF), Tetronic 304, 701, 704, 901, 904, and 150R1 (manufactured by BASF), Solsperse 20000 (manufactured by Lubrizol Japan Co., Ltd.), NCW-101, NCW-1001, and NCW-1002 (manufactured by Wako Pure Chemical Industries, Ltd.), Paionin D-6112, D-6112-W, and D-6315 (manufactured by Takemoto Oil Co., Ltd.), Olfin E1010, and Surfynol 104, 400, and 440 (manufactured by Nissin Chemical Industry Co., Ltd.).

[0305] Specific examples of cationic surfactants include organosiloxane polymer KP341 (manufactured by Shin-Etsu Chemical Co., Ltd.), (meth)acrylic acid-based (co)polymer Polyflow No. 75, No. 77, No. 90, No. 95 (manufactured by Kyoeisha Chemical Co., Ltd.), and W001 (manufactured by Yusho Co., Ltd.).

[0306] Specific examples of the anionic surfactant include W004, W005, W017 (manufactured by Yusho Co., Ltd.), Sandet BL (manufactured by Sanyo Chemical Industries, Ltd.), and the like.

[0307] When the curable resin composition of the present invention contains a surfactant, the content of the surfactant is preferably 0.001 to 2.0 mass% and more preferably 0.005 to 1.0 mass% based on the total solid content of the curable resin composition of the present invention. The surfactant may be one type or two or more types. When the surfactant is two or more types, the total is preferably within the above range.

[0308] [Higher fatty acid derivative] In order to prevent polymerization inhibition caused by oxygen, the curable resin composition of the present invention may contain a higher fatty acid derivative such as behenic acid or behenic acid amide, and the higher fatty acid derivative may be unevenly distributed on the surface of the curable resin composition during drying after application.

[0309] In addition, the higher fatty acid derivative may be a compound described in paragraph 0155 of WO 2015 / 199219.

[0310] When the curable resin composition of the present invention contains a higher fatty acid derivative, the content of the higher fatty acid derivative is preferably 0.1 to 10 mass% based on the total solid content of the curable resin composition of the present invention. The higher fatty acid derivative may be one type or two or more types. When the higher fatty acid derivative is two or more types, the total is preferably within the above range.

[0311] [Inorganic particles] The resin composition of the present invention may contain inorganic particles, specifically, calcium carbonate, calcium phosphate, silica, kaolin, talc, titanium dioxide, alumina, barium sulfate, calcium fluoride, lithium fluoride, zeolite, molybdenum sulfide, glass, etc.

[0312] The average particle size of the inorganic particles is preferably from 0.01 to 2.0 μm, more preferably from 0.02 to 1.5 μm, further preferably from 0.03 to 1.0 μm, and particularly preferably from 0.04 to 0.5 μm. If the average particle size of the inorganic particles is too large, the mechanical properties of the cured film may deteriorate, and if the average particle size of the inorganic particles exceeds 2.0 μm, the resolution may decrease due to scattering of the exposure light.

[0313] [Ultraviolet absorber] The composition of the present invention may contain an ultraviolet absorbing agent. Examples of the ultraviolet absorbing agent that can be used include salicylate-based, benzophenone-based, benzotriazole-based, substituted acrylonitrile-based, and triazine-based ultraviolet absorbing agents. Examples of salicylate-based ultraviolet absorbers include phenyl salicylate, p-octylphenyl salicylate, and pt-butylphenyl salicylate. Examples of benzophenone-based ultraviolet absorbers include 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2,4-dihydroxybenzophenone, and 2-hydroxy-4-octoxybenzophenone. Examples of benzotriazole-based ultraviolet absorbers include 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-butyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-tert-amyl-5'-isobutylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-methylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3'-isobutyl-5'-propylphenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, and 2-[2'-hydroxy-5'-(1,1,3,3-tetramethyl)phenyl]benzotriazole.

[0314] Examples of the substituted acrylonitrile ultraviolet absorber include ethyl 2-cyano-3,3-diphenylacrylate and 2-ethylhexyl 2-cyano-3,3-diphenylacrylate. Further, examples of triazine-based ultraviolet absorbers include mono(hydroxyphenyl)triazine compounds such as 2-[4-[(2-hydroxy-3-dodecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine, 2-[4-[(2-hydroxy-3-tridecyloxypropyl)oxy]-2-hydroxyphenyl]-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine, and 2-(2,4-dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine; 2,4-bis(2-hydroxy-4-propyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-triazine; bis(hydroxyphenyl)triazine compounds such as 2,4-bis(2-hydroxy-3-methyl-4-propyloxyphenyl)-6-(4-methylphenyl)-1,3,5-triazine and 2,4-bis(2-hydroxy-3-methyl-4-hexyloxyphenyl)-6-(2,4-dimethylphenyl)-1,3,5-triazine; and tris(hydroxyphenyl)triazine compounds such as 2,4-bis(2-hydroxy-4-butoxyphenyl)-6-(2,4-dibutoxyphenyl)-1,3,5-triazine, 2,4,6-tris(2-hydroxy-4-octyloxyphenyl)-1,3,5-triazine and 2,4,6-tris[2-hydroxy-4-(3-butoxy-2-hydroxypropyloxy)phenyl]-1,3,5-triazine.

[0315] In the present invention, the above-mentioned various ultraviolet absorbents may be used alone or in combination of two or more. The composition of the present invention may or may not contain an ultraviolet absorber. When the composition of the present invention contains an ultraviolet absorber, the content of the ultraviolet absorber is preferably from 0.001% by mass to 1% by mass, and more preferably from 0.01% by mass to 0.1% by mass, relative to the total solid mass of the composition of the present invention.

[0316] [Organotitanium Compounds] The resin composition of the present embodiment may contain an organotitanium compound. By containing an organotitanium compound in the resin composition, a resin layer having excellent chemical resistance can be formed even when cured at a low temperature.

[0317] Usable organic titanium compounds include those in which an organic group is bonded to a titanium atom via a covalent bond or an ionic bond. Specific examples of the organotitanium compound are shown below in I) to VII): I) Titanium chelate compounds: Among these, titanium chelate compounds having two or more alkoxy groups are more preferred because they provide good storage stability for the negative photosensitive resin composition and provide a good cured pattern. Specific examples include titanium bis(triethanolamine) diisopropoxide, titanium di(n-butoxide) bis(2,4-pentanedionate), titanium diisopropoxide bis(2,4-pentanedionate), titanium diisopropoxide bis(tetramethylheptanedionate), titanium diisopropoxide bis(ethylacetoacetate), and the like. II) Tetraalkoxytitanium compounds: For example, titanium tetra(n-butoxide), titanium tetraethoxide, titanium tetra(2-ethylhexoxide), titanium tetraisobutoxide, titanium tetraisopropoxide, titanium tetramethoxide, titanium tetramethoxypropoxide, titanium tetramethylphenoxide, titanium tetra(n-nonyloxide), titanium tetra(n-propoxide), titanium tetrastearyloxide, titanium tetrakis[bis{2,2-(allyloxymethyl)butoxide}], and the like. III) Titanocene compounds: For example, pentamethylcyclopentadienyltitanium trimethoxide, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluorophenyl)titanium, bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl)titanium, and the like. IV) Monoalkoxytitanium compounds: For example, titanium tris(dioctylphosphate) isopropoxide, titanium tris(dodecylbenzenesulfonate) isopropoxide, etc. V) Titanium oxide compounds: For example, titanium oxide bis(pentanedionate), titanium oxide bis(tetramethylheptanedionate), phthalocyanine titanium oxide, and the like. VI) Titanium tetraacetylacetonate compounds: For example, titanium tetraacetylacetonate. VII) Titanate coupling agents: For example, isopropyl tridodecylbenzenesulfonyl titanate.

[0318] Among them, the organic titanium compound is preferably at least one compound selected from the group consisting of I) titanium chelate compounds, II) tetraalkoxytitanium compounds, and III) titanocene compounds, from the viewpoint of exhibiting better chemical resistance. In particular, titanium diisopropoxide bis(ethylacetoacetate), titanium tetra(n-butoxide), and bis(η5-2,4-cyclopentadiene-1-yl)bis(2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl)titanium are preferred.

[0319] When an organic titanium compound is blended, the blending amount is preferably 0.05 to 10 parts by mass, more preferably 0.1 to 2 parts by mass, based on 100 parts by mass of the cyclized resin precursor. When the blending amount is 0.05 parts by mass or more, the obtained cured pattern exhibits good heat resistance and chemical resistance, while when it is 10 parts by mass or less, the composition has excellent storage stability.

[0320] [Antioxidants] The composition of the present invention may contain an antioxidant. By containing an antioxidant as an additive, it is possible to improve the elongation properties of the film after curing and the adhesion to metal materials. Examples of the antioxidant include phenolic compounds, phosphite compounds, and thioether compounds. As the phenolic compound, any phenolic compound known as a phenolic antioxidant can be used. As a preferred phenolic compound, a hindered phenolic compound can be mentioned. A compound having a substituent at the site (ortho position) adjacent to the phenolic hydroxyl group is preferred. As the aforementioned substituent, a substituted or unsubstituted alkyl group having 1 to 22 carbon atoms is preferred. In addition, as the antioxidant, a compound having a phenolic group and a phosphite group in the same molecule is also preferred. In addition, as the antioxidant, a phosphorus-based antioxidant can also be suitably used. Examples of phosphorus-based antioxidants include tris[2-[[2,4,8,10-tetrakis(1,1-dimethylethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-yl]oxy]ethyl]amine, tris[2-[(4,6,9,11-tetra-tert-butyldibenzo[d,f][1,3,2]dioxaphosphepin-2-yl)oxy]ethyl]amine, and ethyl bis(2,4-di-tert-butyl-6-methylphenyl)phosphite. Examples of commercially available antioxidants include ADK STAB AO-20, ADK STAB AO-30, ADK STAB AO-40, ADK STAB AO-50, ADK STAB AO-50F, ADK STAB AO-60, ADK STAB AO-60G, ADK STAB AO-80, and ADK STAB AO-330 (all manufactured by ADEKA CORPORATION). In addition, the compounds described in paragraphs 0023 to 0048 of Japanese Patent No. 6268967 can also be used as the antioxidant. In addition, the composition of the present invention may contain a latent antioxidant as necessary. Examples of latent antioxidants include compounds in which the site functioning as an antioxidant is protected with a protecting group, and which function as an antioxidant when heated at 100 to 250° C. or heated at 80 to 200° C. in the presence of an acid / base catalyst, causing the protecting group to be eliminated.Examples of latent antioxidants include compounds described in International Publication No. 2014 / 021023, International Publication No. 2017 / 030005, and JP-A-2017-008219. Examples of commercially available latent antioxidants include Adeka Arcles GPA-5001 (manufactured by ADEKA Corporation). Examples of preferred antioxidants include 2,2-thiobis(4-methyl-6-t-butylphenol), 2,6-di-t-butylphenol, and a compound represented by the general formula (3).

[0321] [ka]

[0322] In general formula (3), R 5 represents a hydrogen atom or an alkyl group having two or more carbon atoms, and R 6 R represents an alkylene group having 2 or more carbon atoms. 7 represents a monovalent to tetravalent organic group containing at least one of an alkylene group having two or more carbon atoms, an O atom, and a N atom. k represents an integer of 1 to 4.

[0323] The compound represented by the general formula (3) suppresses the oxidative deterioration of the aliphatic groups and phenolic hydroxyl groups of the resin, and also suppresses the oxidation of metals by its rust-preventing effect on metal materials.

[0324] Since it can act simultaneously on resin and metal materials, k is more preferably an integer of 2 to 4. Examples of R7 include an alkyl group, a cycloalkyl group, an alkoxy group, an alkyl ether group, an alkyl silyl group, an alkoxy silyl group, an aryl group, an aryl ether group, a carboxyl group, a carbonyl group, an allyl group, a vinyl group, a heterocyclic group, -O-, -NH-, -NHNH-, and combinations thereof, and may further have a substituent. Among these, it is preferable to have an alkyl ether or -NH- from the viewpoint of solubility in a developer and metal adhesion, and -NH- is more preferable from the viewpoint of interaction with a resin and metal adhesion due to metal complex formation.

[0325] Examples of the compound represented by the following general formula (3) include, but are not limited to, the following structures.

[0326] [ka]

[0327] [ka]

[0328] [ka]

[0329] [ka]

[0330] The amount of the antioxidant added is preferably 0.1 to 10 parts by mass, more preferably 0.5 to 5 parts by mass, relative to the resin. If the amount added is less than 0.1 part by mass, it is difficult to obtain the effect of improving the elongation characteristics after reliability and the adhesion to metal materials, and if it is more than 10 parts by mass, there is a risk of causing a decrease in the sensitivity of the resin composition due to interaction with the photosensitizer. Only one type of antioxidant may be used, or two or more types may be used. When two or more types are used, it is preferable that the total amount thereof is within the above range.

[0331] <Restrictions on other substances> The water content of the curable resin composition of the present invention is preferably less than 5% by mass, more preferably less than 1% by mass, and even more preferably less than 0.6% by mass, from the viewpoint of the properties of the coated surface. Methods for maintaining the water content include adjusting the humidity under storage conditions and reducing the porosity of the storage container.

[0332] The metal content of the curable resin composition of the present invention is preferably less than 5 mass ppm (parts per million), more preferably less than 1 mass ppm, and even more preferably less than 0.5 mass ppm, from the viewpoint of insulation. Examples of metals include sodium, potassium, magnesium, calcium, iron, chromium, nickel, etc. When a plurality of metals are contained, the total of these metals is preferably within the above range.

[0333] Furthermore, examples of a method for reducing metal impurities unintentionally contained in the curable resin composition of the present invention include selecting raw materials having a low metal content as raw materials constituting the curable resin composition of the present invention, filtering the raw materials constituting the curable resin composition of the present invention through a filter, and lining the inside of an apparatus with polytetrafluoroethylene or the like to perform distillation under conditions that suppress contamination as much as possible.

[0334] Considering the use of the curable resin composition of the present invention as a semiconductor material, the content of halogen atoms is preferably less than 500 mass ppm, more preferably less than 300 mass ppm, and even more preferably less than 200 mass ppm from the viewpoint of wiring corrosion. Among them, those existing in the form of halogen ions are preferably less than 5 mass ppm, more preferably less than 1 mass ppm, and even more preferably less than 0.5 mass ppm. Examples of halogen atoms include chlorine atoms and bromine atoms. It is preferable that the total of chlorine atoms and bromine atoms, or chlorine ions and bromine ions, is within the above range. A preferred method for adjusting the content of halogen atoms is ion exchange treatment.

[0335] A conventionally known container can be used as the container for the curable resin composition of the present invention. In addition, it is also preferable to use a multi-layer bottle whose inner wall is made of six types of six-layer resin or a bottle with a seven-layer structure made of six types of resin, in order to prevent impurities from being mixed into the raw materials or the curable resin composition. Examples of such containers include the container described in JP-A-2015-123351.

[0336] <Uses of the curable resin composition> The curable resin composition of the present invention is preferably used for forming an interlayer insulating film for a rewiring layer. Furthermore, the present invention can also be used for forming an insulating film for a semiconductor device, a stress buffer film, or the like.

[0337] <Preparation of Curable Resin Composition> The curable resin composition of the present invention can be prepared by mixing the above-mentioned components. The mixing method is not particularly limited, and can be a conventionally known method.

[0338] In addition, it is preferable to perform filtration using a filter in order to remove foreign matter such as dust and fine particles in the curable resin composition. The filter pore size is preferably 1 μm or less, more preferably 0.5 μm or less, and even more preferably 0.1 μm or less. On the other hand, from the viewpoint of productivity, it is preferably 5 μm or less, more preferably 3 μm or less, and even more preferably 1 μm or less. The material of the filter is preferably polytetrafluoroethylene, polyethylene, or nylon. The filter may be used after being washed in advance with an organic solvent. In the filter filtration process, multiple types of filters may be connected in series or parallel. When multiple types of filters are used, filters with different pore sizes or materials may be used in combination. In addition, various materials may be filtered multiple times. When filtering multiple times, circulation filtration may be performed. In addition, filtration may be performed under pressure. When filtering under pressure, the pressure applied is preferably 0.05 MPa or more and 0.3 MPa or less. On the other hand, from the viewpoint of productivity, the pressure is preferably 0.01 MPa or more and 1.0 MPa or less, more preferably 0.03 MPa or more and 0.9 MPa or less, and even more preferably 0.05 MPa or more and 0.7 MPa or less. In addition to filtration using a filter, impurity removal treatment using an adsorbent may be performed. Filter filtration and impurity removal treatment using an adsorbent may be combined. As the adsorbent, a known adsorbent may be used. For example, inorganic adsorbents such as silica gel and zeolite, and organic adsorbents such as activated carbon may be used.

[0339] (Cured film, laminate, semiconductor device, and manufacturing method thereof) Next, the cured film, the laminate, the semiconductor device, and the methods for producing them will be described.

[0340] The cured film of the present invention is a cured film obtained by curing the resin composition of the present invention. The cured film is preferably a patterned cured film. The film thickness of the cured film of the present invention can be, for example, 0.5 μm or more, and can be 1 μm or more. The upper limit can be 100 μm or less, and can be 30 μm or less.

[0341] The cured film of the present invention may be laminated in two or more layers, or even three to seven layers, to form a laminate. The laminate of the present invention preferably includes two or more layers of the cured film, and includes a metal layer between any of the cured films. For example, a laminate including at least a layer structure in which three layers, a first cured film, a metal layer, and a second cured film, are laminated in this order, is preferred. The first cured film and the second cured film are both the cured film of the present invention, and for example, an embodiment in which both the first cured film and the second cured film are films formed by curing the resin composition of the present invention is preferred. The resin composition of the present invention used to form the first cured film and the resin composition of the present invention used to form the second cured film may be compositions having the same composition or different compositions. The metal layer in the laminate of the present invention is preferably used as metal wiring such as a rewiring layer.

[0342] The fields in which the cured film of the present invention can be applied include insulating films for semiconductor devices, interlayer insulating films for rewiring layers, stress buffer films, etc. Other examples include sealing films, substrate materials (base films and coverlays for flexible printed circuit boards, interlayer insulating films), and the formation of patterns by etching of insulating films for mounting applications such as those described above. For these applications, reference can be made to, for example, Science & Technology Co., Ltd., "High-performance and Applied Technology of Polyimides," April 2008, supervised by Masaaki Kakimoto, CMC Technical Library, "Basics and Development of Polyimide Materials," published in November 2011, and Japan Polyimide and Aromatic Polymer Research Association, "Latest Polyimides: Basics and Applications," NTS, August 2010.

[0343] The cured films according to the invention can also be used in the manufacture of printing plates, such as offset printing plates or screen printing plates, for etching molded parts, in the manufacture of protective lacquers and dielectric layers in electronics, especially microelectronics, etc.

[0344] The method for producing a cured film of the present invention (hereinafter also simply referred to as "the production method of the present invention") preferably includes a film formation step of applying the resin composition of the present invention to a substrate to form a film (resin film). The method for producing a cured film of the present invention preferably includes the film-forming step, an exposure step of exposing the film to light, and a development step of developing the film. A pattern of the cured film is obtained by the exposure step and the development step. Moreover, the method for producing a cured film of the present invention includes the above-mentioned film forming step and, if necessary, the above-mentioned developing step, and more preferably includes a heating step of heating the above-mentioned film at 50 to 450°C. Specifically, it is also preferable to include the following steps (a) to (d). (a) A film-forming step of applying a resin composition to a substrate to form a film (resin composition layer) (b) After the film formation process, an exposure process of exposing the film to light (c) a development step for developing the exposed film. (d) A heating step of heating the developed film at 50 to 450°C. By heating in the heating step, the resin layer cured by exposure can be further cured. In this heating step, for example, the thermal base generator is decomposed, and sufficient curability is obtained.

[0345] A preferred embodiment of the present invention relates to a method for producing a laminate, which includes a method for producing a cured film of the present invention. In the method for producing a laminate of the present embodiment, after forming a cured film according to the above-mentioned method for producing a cured film, the step (a), or the steps (a) to (c), or the steps (a) to (d) are performed again. In particular, it is preferable to perform each of the above steps in order multiple times, for example, 2 to 5 times (i.e., 3 to 6 times in total). By stacking the cured films in this way, a laminate can be obtained. In the present invention, it is particularly preferable to provide a metal layer on the part where the cured film is provided, between the cured films, or on both. In addition, in the production of the laminate, it is not necessary to repeat all of the steps (a) to (d), and as described above, a laminate of cured films can be obtained by performing at least (a), preferably the steps (a) to (c) or (a) to (d), multiple times.

[0346] <Film formation process (layer formation process)> A production method according to a preferred embodiment of the present invention includes a film-forming step (layer-forming step) of applying a resin composition to a substrate to form a film (layer).

[0347] The type of substrate can be appropriately determined depending on the application, but is not particularly limited to substrates for semiconductor production such as silicon, silicon nitride, polysilicon, silicon oxide, and amorphous silicon, quartz, glass, optical films, ceramic materials, vapor deposition films, magnetic films, reflective films, metal substrates such as Ni, Cu, Cr, and Fe, paper, SOG (Spin On Glass), TFT (Thin Film Transistor) array substrates, and electrode plates for plasma display panels (PDPs). In addition, these substrates may have layers such as an adhesion layer and an oxide layer on the surface. In the present invention, substrates for semiconductor production are particularly preferred, and silicon substrates, Cu substrates, and mold substrates are more preferred. Furthermore, these substrates may have a layer such as an adhesion layer made of hexamethyldisilazane (HMDS) or an oxide layer provided on the surface. As the base material, for example, a plate-shaped base material (substrate) is used. The shape of the substrate is not particularly limited and may be circular or rectangular, but is preferably rectangular. The size of the substrate is, for example, a diameter of 100 to 450 mm, preferably 200 to 450 mm, if it is circular, and, for example, a length of a short side of 100 to 1000 mm, preferably 200 to 700 mm, if it is rectangular.

[0348] When a resin composition layer is formed on the surface of a resin layer or a metal layer, the resin layer or the metal layer serves as the substrate.

[0349] The resin composition is preferably applied to a substrate by coating.

[0350] Specifically, examples of the means to be applied include a dip coating method, an air knife coating method, a curtain coating method, a wire bar coating method, a gravure coating method, an extrusion coating method, a spray coating method, a spin coating method, a slit coating method, and an inkjet method. From the viewpoint of uniformity of the thickness of the resin composition layer, more preferred are a spin coating method, a slit coating method, a spray coating method, and an inkjet method. By adjusting the solid content concentration and the coating conditions appropriately according to the method, a resin layer of a desired thickness can be obtained. In addition, the coating method can be appropriately selected depending on the shape of the substrate, and if the substrate is a circular substrate such as a wafer, a spin coating method, a spray coating method, an inkjet method, etc. are preferred, and if the substrate is a rectangular substrate, a slit coating method, a spray coating method, an inkjet method, etc. are preferred. In the case of the spin coating method, for example, it can be applied at a rotation speed of 500 to 2,000 rpm for about 10 seconds to 1 minute. Depending on the viscosity of the photosensitive resin composition and the film thickness to be set, it is also preferable to apply the film at a rotation speed of 300 to 3,500 rpm for 10 to 180 seconds. In order to obtain a uniform film thickness, a combination of multiple rotation speeds can also be used for coating. Alternatively, a coating film formed by applying the coating material to a temporary support in advance using the above-mentioned application method may be transferred onto the substrate. Regarding the transfer method, the production methods described in paragraphs 0023 and 0036 to 0051 of JP-A No. 2006-023696 and paragraphs 0096 to 0108 of JP-A No. 2006-047592 can be suitably used in the present invention. Additionally, a process may be performed to remove excess film from the edges of the substrate, such as edge bead rinse (EBR), air knife, back rinse, etc. Furthermore, a pre-wetting step may be employed in which, before applying the resin composition to the substrate, the substrate is coated with various solvents to improve the wettability of the substrate, and then the resin composition is applied.

[0351] <Drying process> The manufacturing method of the present invention may include a drying step to remove the solvent after the film forming step (layer forming step). The drying temperature is preferably 50 to 150° C., more preferably 70 to 130° C., and further preferably 90 to 110° C. The drying time is, for example, 30 seconds to 20 minutes, preferably 1 to 10 minutes, and more preferably 3 to 7 minutes.

[0352] <Exposure process> The production method of the present invention may include an exposure step of exposing the film (resin composition layer) to light. The amount of exposure is not particularly limited as long as the resin composition can be cured. For example, the amount of exposure is 100 to 10,000 mJ / cm2 in terms of exposure energy at a wavelength of 365 nm. 2 It is preferable to irradiate with 200 to 8,000 mJ / cm 2 Irradiation is more preferred.

[0353] The exposure wavelength can be appropriately determined within the range of 190 to 1,000 nm, and is preferably 240 to 550 nm. The exposure light preferably contains light having a wavelength of 365 nm or 405 nm, and more preferably contains light having a wavelength of 405 nm.

[0354] In terms of the light source, the exposure wavelength may be, in terms of the relationship with the light source, (1) semiconductor laser (wavelength 830nm, 532nm, 488nm, 405nm, etc.), (2) metal halide lamp, (3) high pressure mercury lamp, g-line (wavelength 436nm), h-line (wavelength 405nm), i-line (wavelength 365nm), broad (three wavelengths of g, h, i-line), (4) excimer laser, KrF excimer laser (wavelength 248nm), ArF excimer laser (wavelength 193nm), F2 excimer laser (wavelength 157nm), (5) extreme ultraviolet ray; EUV (wavelength 13.6nm), (6) electron beam, (7) YAG laser second harmonic 532nm, third harmonic 355nm, etc. can be mentioned. For the resin composition of the present invention, exposure by a high pressure mercury lamp is particularly preferred, and among them, exposure by i-line is preferred. This can provide particularly high exposure sensitivity. From the viewpoint of ease of handling and productivity, a broad (three wavelengths of g, h, and i lines) light source of a high-pressure mercury lamp or a semiconductor laser of 405 nm is also suitable.

[0355] The exposure method is not particularly limited as long as it is a method in which at least a portion of a film (photosensitive film) made of a curable resin composition is exposed, and examples of the exposure method include exposure using a photomask and exposure by a laser direct imaging method. In the present invention, an embodiment in which the exposure in the exposure step is performed by a laser direct imaging method is also one of the preferred embodiments.

[0356] <Developing process> The manufacturing method of the present invention may include a development step in which the exposed film (resin composition layer) is developed (the film is developed). By carrying out development, the unexposed portion (non-exposed portion) is removed. The development method is not particularly limited as long as the desired pattern can be formed, and examples thereof include discharging the developer from a nozzle, spraying, and immersing the substrate in the developer, and the like, with discharging from a nozzle being preferably used. The development step may include a step in which the developer is continuously supplied to the substrate, a step in which the developer is kept substantially stationary on the substrate, a step in which the developer is vibrated by ultrasonic waves or the like, and a combination of these steps.

[0357] The development is carried out using a developer. There are no particular limitations on the developer that can be used as long as it can remove the unexposed areas. As the developer, a developer containing an organic solvent or an alkaline aqueous solution can be used.

[0358] In the present invention, the developer preferably contains an organic solvent having a ClogP value of −1 to 5, and more preferably contains an organic solvent having a ClogP value of 0 to 3. The ClogP value can be calculated by inputting a structural formula into ChemBioDraw.

[0359] When the developer is a developer containing an organic solvent, the organic solvent may be, for example, an ester, such as ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyloxyacetates (e.g., methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate), ethyl 3-alkyloxypropionate, etc.), 3-alkyloxypropionic acid alkyl esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), 2-alkyloxypropionic acid alkyl esters (e.g., methyl 2-alkyloxypropionate, ethyl 2-alkyloxypropionate, propyl 2-alkyloxypropionate, etc. (e.g., 2-methoxypropionate, ethyl 2-alkyloxypropionate, Methyl cypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate), methyl 2-alkyloxy-2-methylpropionate and ethyl 2-alkyloxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutanoate, 2-oxobutanoic acid Ethyl and the like, and ethers, for example, diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate,Suitable examples of the organic solvent include propylene glycol monopropyl ether acetate, ketones such as methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, and N-methyl-2-pyrrolidone, cyclic hydrocarbons such as toluene, xylene, anisole, and limonene, and sulfoxides such as dimethyl sulfoxide. Mixtures of these organic solvents are also suitable.

[0360] When the developer contains an organic solvent, in the present invention, cyclopentanone and γ-butyrolactone are particularly preferred, and cyclopentanone is more preferred. When the developer contains an organic solvent, the organic solvent may be used alone or in combination of two or more kinds.

[0361] When the developer contains an organic solvent, the developer preferably contains 50% by mass or more of the organic solvent, more preferably 70% by mass or more of the organic solvent, and even more preferably 90% by mass or more of the organic solvent. The developer may also contain 100% by mass of the organic solvent.

[0362] The developer may further comprise other components. Examples of other components include known surfactants and known defoamers.

[0363] When the developer is an alkaline aqueous solution, examples of the basic compound that the alkaline aqueous solution may contain include TMAH (tetramethylammonium hydroxide), KOH (potassium hydroxide), sodium carbonate, etc., and preferably TMAH. When TMAH is used, the content of the basic compound in the developer is preferably 0.01 to 10 mass % of the total mass of the developer, more preferably 0.1 to 5 mass %, and even more preferably 0.3 to 3 mass %.

[0364] [Method of Supplying Developer] The method of supplying the developer is not particularly limited as long as the desired pattern can be formed, and includes a method of immersing the substrate in the developer, a method of supplying the developer onto the substrate using a nozzle for paddle development, and a method of continuously supplying the developer. The type of nozzle is not particularly limited, and examples thereof include a straight nozzle, a shower nozzle, and a spray nozzle. From the viewpoints of the permeability of the developer, the removability of non-image areas, and production efficiency, a method of supplying the developer through a straight nozzle or a method of continuously supplying the developer through a spray nozzle is preferred, and from the viewpoint of the permeability of the developer into the image areas, a method of supplying the developer through a spray nozzle is more preferred. Alternatively, a process may be adopted in which the developer is continuously supplied through a straight nozzle, the substrate is spun to remove the developer from the substrate, and after spin drying, the developer is continuously supplied again through a straight nozzle, and the substrate is spun to remove the developer from the substrate. This process may be repeated multiple times. As a method of supplying the developer in the development process, a process in which the developer is continuously supplied to the substrate, a process in which the developer is kept substantially stationary on the substrate, a process in which the developer is vibrated on the substrate by ultrasonic waves or the like, or a combination of these processes can be used.

[0365] The development time is preferably 5 seconds to 10 minutes, and more preferably 10 seconds to 5 minutes. The temperature of the developer during development is not particularly limited, but is usually 10 to 45°C, and preferably 20 to 40°C.

[0366] After the treatment using the developer, rinsing may be further performed. Alternatively, a method of supplying a rinsing liquid before the developer in contact with the pattern is completely dried may be adopted. Rinsing is preferably performed with a solvent different from the developer. For example, rinsing can be performed with a solvent contained in the resin composition. When the developer contains an organic solvent, the rinse liquid may be PGMEA (propylene glycol monoethyl ether acetate), IPA (isopropanol), etc., and is preferably PGMEA. In addition, the rinse liquid for development using a developer containing an alkaline aqueous solution is preferably water. The rinsing time is preferably from 10 seconds to 10 minutes, more preferably from 20 seconds to 5 minutes, and even more preferably from 5 seconds to 1 minute. The temperature of the rinse solution during rinsing is not particularly limited, but is preferably 10 to 45°C, and more preferably 18 to 30°C.

[0367] When the rinse solution contains an organic solvent, examples of the organic solvent include esters such as ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyloxyacetates (e.g., methyl alkyloxyacetate, ethyl alkyloxyacetate, butyl alkyloxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethoxyacetate), ethyl butyl methoxyacetate, ... ethyl dimethylacetate, etc.), 3-alkyloxypropionic acid alkyl esters (e.g., methyl 3-alkyloxypropionate, ethyl 3-alkyloxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.)), 2-alkyloxypropionic acid alkyl esters (e.g., methyl 2-alkyloxypropionate, ethyl 2-alkyloxypropionate, propyl 2-alkyloxypropionate, etc. (e.g., methyl 2-methoxypropionate, ethyl, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate), methyl 2-alkyloxy-2-methylpropionate and ethyl 2-alkyloxy-2-methylpropionate (e.g., methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutanoate, ethyl 2-oxobutanoate, etc., and ethyl Examples of ethers include diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate,Suitable examples of the ketones include methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, and N-methyl-2-pyrrolidone; suitable examples of the aromatic hydrocarbons include toluene, xylene, anisole, and limonene; suitable examples of the sulfoxides include dimethyl sulfoxide; suitable examples of the alcohols include methanol, ethanol, propanol, isopropanol, butanol, pentanol, octanol, diethylene glycol, propylene glycol, methyl isobutyl carbinol, and triethylene glycol; and suitable examples of the amides include N-methylpyrrolidone, N-ethylpyrrolidone, and dimethylformamide.

[0368] When the rinse solution contains an organic solvent, the organic solvent may be used alone or in combination of two or more. In the present invention, cyclopentanone, γ-butyrolactone, dimethylsulfoxide, N-methylpyrrolidone, cyclohexanone, PGMEA, and PGME are particularly preferred, cyclopentanone, γ-butyrolactone, dimethylsulfoxide, PGMEA, and PGME are more preferred, and cyclohexanone and PGMEA are even more preferred.

[0369] When the rinse liquid contains an organic solvent, the rinse liquid preferably contains 50% by mass or more of the organic solvent, more preferably 70% by mass or more of the organic solvent, and even more preferably 90% by mass or more of the organic solvent. Alternatively, the rinse liquid may contain 100% by mass of the organic solvent.

[0370] The rinse solution may further contain other ingredients. Examples of other components include known surfactants and known defoamers.

[0371] [Method of Supplying Rinse Liquid] The method of supplying the rinse liquid is not particularly limited as long as it can form a desired pattern, and examples of the method include a method of immersing the substrate in the rinse liquid, a method of supplying the rinse liquid by a paddle above the substrate, a method of supplying the rinse liquid to the substrate by a shower, and a method of continuously supplying the rinse liquid by means of a straight nozzle or the like above the substrate. From the viewpoints of the permeability of the rinse liquid, the removability of non-image areas, and production efficiency, the rinse liquid may be supplied using a shower nozzle, a straight nozzle, a spray nozzle, etc., and the method of continuously supplying the rinse liquid using a spray nozzle is preferred, while from the viewpoint of the permeability of the rinse liquid into the image areas, the method of supplying the rinse liquid using a spray nozzle is more preferred. The type of nozzle is not particularly limited, and examples thereof include a straight nozzle, a shower nozzle, a spray nozzle, etc. That is, the rinsing step is preferably a step of supplying a rinsing liquid to the exposed film through a straight nozzle or continuously supplying the rinsing liquid to the exposed film, and more preferably a step of supplying the rinsing liquid through a spray nozzle. As a method of supplying the rinsing liquid in the rinsing step, a step in which the rinsing liquid is continuously supplied to the substrate, a step in which the rinsing liquid is kept substantially stationary on the substrate, a step in which the rinsing liquid is vibrated on the substrate by ultrasonic waves or the like, or a combination of these steps can be used.

[0372] <Heating process> The production method of the present invention preferably includes a step of heating the developed film at 50 to 450° C. (heating step). The heating step is preferably included after the film forming step (layer forming step), the drying step, and the developing step. In the heating step, for example, the above-mentioned thermal base generator is decomposed to generate a base, and the cyclization reaction of the precursor of the specific resin proceeds. In addition, the resin composition of the present invention may contain a radical polymerizable compound other than the precursor of the specific resin, but the curing of the unreacted radical polymerizable compound other than the precursor of the specific resin can also proceed in this step. The heating temperature (maximum heating temperature) of the layer in the heating step is preferably 50°C or higher, more preferably 80°C or higher, even more preferably 140°C or higher, even more preferably 150°C or higher, even more preferably 160°C or higher, and even more preferably 170°C or higher. The upper limit is preferably 500°C or lower, more preferably 450°C or lower, even more preferably 350°C or lower, even more preferably 250°C or lower, and even more preferably 220°C or lower.

[0373] The heating is preferably performed at a temperature rise rate of 1 to 12°C / min from the temperature at the start of heating to the maximum heating temperature, more preferably 2 to 10°C / min, and even more preferably 3 to 10°C / min. By setting the temperature rise rate at 1°C / min or more, it is possible to prevent excessive volatilization of the amine while ensuring productivity, and by setting the temperature rise rate at 12°C / min or less, it is possible to alleviate the residual stress of the cured film. In addition, in the case of an oven capable of rapid heating, it is preferable to perform the heating from the temperature at the start of heating to the maximum heating temperature at a temperature rise rate of 1 to 8°C / sec, more preferably 2 to 7°C / sec, and even more preferably 3 to 6°C / sec.

[0374] The temperature at the start of heating is preferably 20° C. to 150° C., more preferably 20° C. to 130° C., and even more preferably 25° C. to 120° C. The temperature at the start of heating refers to the temperature at the start of the process of heating to the maximum heating temperature. For example, when a resin composition is applied onto a substrate and then dried, it is the temperature of the film (layer) after this drying, and it is preferable to gradually increase the temperature from a temperature 30 to 200° C. lower than the boiling point of the solvent contained in the resin composition.

[0375] The heating time (heating time at the maximum heating temperature) is preferably from 10 to 360 minutes, more preferably from 20 to 300 minutes, and further preferably from 30 to 240 minutes.

[0376] In particular, when forming a multi-layer laminate, from the viewpoint of interlayer adhesion of the cured film, the heating temperature is preferably 180° C. to 320° C., and more preferably 180° C. to 260° C. The reason for this is unclear, but it is thought that by setting the temperature at this level, a crosslinking reaction between ethynyl groups of the specific resin between the layers proceeds.

[0377] Heating may be performed stepwise. For example, a pretreatment step may be performed in which the temperature is raised from 25°C to 180°C at 3°C / min, held at 180°C for 60 minutes, raised from 180°C to 200°C at 2°C / min, and held at 200°C for 120 minutes. The heating temperature in the pretreatment step is preferably 100 to 200°C, more preferably 110 to 190°C, and even more preferably 120 to 185°C. In this pretreatment step, it is also preferable to treat while irradiating ultraviolet rays as described in US Pat. No. 9,159,547. Such a pretreatment step can improve the properties of the film. The pretreatment step is preferably performed for a short time of about 10 seconds to 2 hours, more preferably 15 seconds to 30 minutes. The pretreatment may be performed in two or more steps. For example, pretreatment step 1 may be performed in the range of 100 to 150°C, and then pretreatment step 2 may be performed in the range of 150 to 200°C.

[0378] Furthermore, after heating, the material may be cooled, and in this case, the cooling rate is preferably 1 to 5° C. / min.

[0379] The heating step is preferably carried out in an atmosphere with a low oxygen concentration by flowing an inert gas such as nitrogen, helium, argon, etc., in order to prevent decomposition of the specific resin. The oxygen concentration is preferably 50 ppm (volume ratio) or less, more preferably 20 ppm (volume ratio) or less. The heating means is not particularly limited, but examples thereof include a hot plate, an infrared oven, an electric heating oven, and a hot air oven.

[0380] <Metal layer formation process> The production method of the present invention preferably includes a metal layer forming step of forming a metal layer on the surface of the developed film (resin composition layer).

[0381] The metal layer is not particularly limited, and existing metal species can be used. Examples of the metal include copper, aluminum, nickel, vanadium, titanium, chromium, cobalt, gold, and tungsten. Copper, aluminum, and alloys containing these metals are more preferable, and copper is even more preferable.

[0382] The method for forming the metal layer is not particularly limited, and existing methods can be applied. For example, the methods described in JP-A-2007-157879, JP-T-2001-521288, JP-A-2004-214501, and JP-A-2004-101850 can be used. For example, photolithography, lift-off, electrolytic plating, electroless plating, etching, printing, and combinations of these methods can be considered. More specifically, a patterning method combining sputtering, photolithography, and etching, and a patterning method combining photolithography and electrolytic plating can be mentioned.

[0383] The thickness of the metal layer at its thickest portion is preferably 0.01 to 100 μm, more preferably 0.1 to 50 μm, and even more preferably 1 to 10 μm.

[0384] <Lamination process> The manufacturing method of the present invention preferably further includes a lamination step.

[0385] The lamination step is a series of steps including (a) a film forming step (layer forming step), (b) an exposure step, (c) a development step, and (d) a heating step, which are performed again on the surface of the cured film (resin layer) or metal layer in this order. However, only the film forming step (a) may be repeated. The heating step (d) may be performed collectively at the end or in the middle of the lamination. That is, the steps (a) to (c) may be repeated a predetermined number of times, and then the heating step (d) may be performed to cure the laminated resin composition layers collectively. The development step (c) may be followed by the metal layer forming step (e), and the heating step (d) may be performed each time, or the heating step (d) may be performed collectively after lamination a predetermined number of times. It goes without saying that the lamination step may further include the drying step, heating step, and the like, as appropriate.

[0386] In the case where a further lamination step is performed after the lamination step, a surface activation treatment step may be further performed after the heating step, the exposure step, or the metal layer forming step. An example of the surface activation treatment is a plasma treatment.

[0387] The lamination step is preferably carried out 2 to 20 times, more preferably 2 to 5 times, and further preferably 3 to 5 times. Moreover, the layers in the lamination step may be layers having the same composition, shape, film thickness, etc., or may be layers having different compositions.

[0388] For example, a structure having 2 to 20 resin layers, such as resin layer / metal layer / resin layer / metal layer / resin layer / metal layer, is preferred, a structure having 3 to 7 layers is more preferred, and a structure having 3 to 5 layers is even more preferred.

[0389] In the present invention, a particularly preferred embodiment is one in which, after the metal layer is provided, a cured film (resin layer) of the resin composition is further formed so as to cover the metal layer. Specifically, the steps may be repeated in the order of (a) film formation step, (b) exposure step, (c) development step, (e) metal layer formation step, and (d) heating step, or the steps may be repeated in the order of (a) film formation step, (b) exposure step, (c) development step, and (e) metal layer formation step, with (d) heating step being provided at the end or in the middle. The lamination step of laminating the resin composition layer (resin layer) and the metal layer formation step may be alternately performed, thereby allowing the resin composition layer (resin layer) and the metal layer to be laminated alternately.

[0390] (Surface activation treatment process) The method for producing a laminate of the present invention may include a surface activation treatment step of subjecting at least a part of the metal layer and the photosensitive resin composition layer to a surface activation treatment. The surface activation treatment step is usually carried out after the metal layer formation step, but after the exposure and development step, the photosensitive resin composition layer may be subjected to the surface activation treatment step before the metal layer formation step. The surface activation treatment may be performed on at least a part of the metal layer, or on at least a part of the photosensitive resin composition layer after exposure, or on at least a part of both the metal layer and the photosensitive resin composition layer after exposure. The surface activation treatment is preferably performed on at least a part of the metal layer, and it is preferable to perform the surface activation treatment on a part or all of the area of ​​the metal layer on which the photosensitive resin composition layer is formed. In this way, by performing the surface activation treatment on the surface of the metal layer, the adhesion with the resin layer provided on the surface can be improved. In addition, the surface activation treatment is preferably performed on a part or the whole of the photosensitive resin composition layer (resin layer) after exposure. By performing the surface activation treatment on the surface of the photosensitive resin composition layer in this manner, the adhesion between the metal layer or the resin layer provided on the surface that has been subjected to the surface activation treatment can be improved. Specifically, the surface activation treatment is selected from plasma treatment with various source gases (oxygen, hydrogen, argon, nitrogen, nitrogen / hydrogen mixed gas, argon / oxygen mixed gas, etc.), corona discharge treatment, etching treatment with CF4 / O2, NF3 / O2, SF6, NF3, NF3 / O2, surface treatment by ultraviolet (UV) ozone method, immersion in an aqueous hydrochloric acid solution to remove the oxide film, followed by immersion in an organic surface treatment agent containing a compound having at least one amino group and one thiol group, and mechanical roughening treatment using a brush. Plasma treatment is preferred, and oxygen plasma treatment using oxygen as the source gas is particularly preferred. In the case of corona discharge treatment, the energy is 500 to 200,000 J / m 2 is preferable, and 1000 to 100,000 J / m 2 More preferably, 10,000 to 50,000 J / m 2 is most preferred.

[0391] The present invention also discloses a semiconductor device including the cured film or laminate of the present invention. Specific examples of a semiconductor device using the resin composition of the present invention for forming an interlayer insulating film for a rewiring layer can be found in paragraphs 0213 to 0218 and FIG. 1 of JP2016-027357A, the contents of which are incorporated herein by reference. EXAMPLES

[0392] The present invention will be described in more detail below with reference to examples. The materials, amounts used, ratios, processing contents, processing procedures, etc. shown in the following examples can be changed as appropriate without departing from the spirit of the present invention. Therefore, the scope of the present invention is not limited to the specific examples shown below. "Parts" and "%" are by weight unless otherwise specified.

[0393] <Synthesis Example 1: Synthesis of Polymer A-1> 23.48g of 4,4'-oxydiphthalic dianhydride (ODPA) and 22.27g of 4,4'-biphthalic dianhydride (BPDA) were placed in a separable flask, 39.69g of 2-hydroxyethyl methacrylate (HEMA) and 136.83g of γ-butyrolactone were added, and the mixture was stirred at room temperature. 24.66g of pyridine was added while stirring to obtain a reaction mixture. After the heat generation by the reaction had ceased, the mixture was allowed to cool to room temperature and left at room temperature for 16 hours. Next, under ice cooling, a solution of 62.46 g of dicyclohexylcarbodiimide (DCC) dissolved in 61.57 g of γ-butyrolactone was added to the reaction mixture over 40 minutes while stirring, followed by a suspension of 27.42 g of 4,4'-diaminodiphenyl ether (DADPE) suspended in 119.73 g of γ-butyrolactone, which was added over 60 minutes while stirring. After further stirring at room temperature for a certain period of time, 7.17 g of ethyl alcohol was added and stirred for 1 hour, and then 136.83 g of γ-butyrolactone was added. The precipitate formed in the reaction mixture was removed by filtration to obtain a reaction liquid. By lengthening the above-mentioned certain time, the total molar content of the cyclic imide structure and the cyclic isoimide structure in the polyimide precursor can be increased, and by shortening the time, the total molar content can be decreased. For example, by setting the above-mentioned time to 30 minutes, a resin in which the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the above-mentioned polyimide precursor is 0.083 mmol / g was obtained. In the present examples and comparative examples, the above-mentioned certain time was appropriately adjusted to carry out experiments using a plurality of polyimide precursors in which the total molar content of the cyclic imide structure and the cyclic isoimide structure in the polyimide precursor was changed. In each example and comparative example, the total molar content of the cyclic imide structure and the cyclic isoimide structure is shown in the "specific structure mmol / g" column in the table. The reaction solution obtained was added to 716.21 g of ethyl alcohol to produce a precipitate consisting of a crude polymer. The produced crude polymer was filtered off and dissolved in 403.49 g of tetrahydrofuran to obtain a crude polymer solution. The obtained crude polymer solution was dropped into 8470.26 g of water to precipitate the polymer, and the resulting precipitate was filtered off and then vacuum dried to obtain a powdered polymer (polyimide precursor) A-1. The molecular weight of polymer A-1 was measured by gel permeation chromatography (standard polystyrene equivalent) to find that the weight average molecular weight (Mw) was 20,000.

[0394] <Synthesis Example 2: Synthesis of Polymer A-2> Except for changing 23.48 g of ODPA and 22.27 g of BPDA to 46.96 g of ODPA, polymer A-2 was synthesized in the same manner as in Synthesis Example 1. In the examples, the total molar content of the cyclic imide structure and the cyclic isoimide structure is shown in the column of "specific structure mmol / g" in the table.

[0395] <Synthesis Example 3: Synthesis of Polymer A-3> Except for changing 23.48 g of ODPA and 22.27 g of BPDA to 46.96 g of ODPA and changing 39.69 g of HEMA to 19.85 g of HEMA and 18.32 g of diethylene glycol monomethyl ether, polymer A-3 was synthesized in the same manner as in Synthesis Example 1. In the examples, the total molar content of the cyclic imide structure and cyclic isoimide structure is shown in the column of "specific structure mmol / g" in the table.

[0396] <Synthesis Example 4: Synthesis of Polymer A-4> 10.65g (50mmol) of 4,6-dihydroxy-1,3-phenylenediamine dihydrochloride was dissolved in 85.8g of N-methylpyrrolidone (NMP) while removing moisture in a dry reactor equipped with a stirrer, a condenser and an internal thermometer. Then, 9.74g (48mmol) of terephthalic acid chloride dissolved in 55.0g of NMP was added dropwise over 1 hour and stirred at 25°C for a certain period of time. By lengthening the above-mentioned certain time, the molar content of the benzoxazole structure in the polybenzoxazole precursor can be increased, and by shortening the time, the molar content of the benzoxazole structure in the polybenzoxazole precursor can be decreased. For example, by setting the time to 15 minutes, the molar content of the benzoxazole structure can be set to 0.373 mmol / g. After stirring, the mixture was precipitated in 2 liters of water / methanol = 75 / 25 (volume ratio) and stirred at a speed of 2,000 rpm for 30 minutes. The precipitated polybenzoxazole precursor resin was removed by filtration and washed with 1.5 liters of water. The obtained resin was dried under reduced pressure at 40 ° C for 1 day to obtain A-4.

[0397] <Synthesis Example 5: Synthesis of Polymer A-5> 29.08 g of trimellitic anhydride was placed in a separable flask, 19.85 g of 2-hydroxyethyl methacrylate (HEMA) and 136.83 g of γ-butyrolactone were added, and the mixture was stirred at room temperature. 24.66 g of pyridine was added while stirring to obtain a reaction mixture. After the heat generation by the reaction had ceased, the mixture was allowed to cool to room temperature and left at room temperature for 16 hours. Next, under ice cooling, a solution of 62.46 g of dicyclohexylcarbodiimide (DCC) dissolved in 61.57 g of γ-butyrolactone was added to the reaction mixture over 40 minutes while stirring, followed by a suspension of 27.42 g of 4,4'-diaminodiphenyl ether (DADPE) suspended in 119.73 g of γ-butyrolactone, which was added over 60 minutes while stirring. After further stirring at room temperature for a certain period of time, 7.17 g of ethyl alcohol was added and stirred for 1 hour, and then 136.83 g of γ-butyrolactone was added. The precipitate formed in the reaction mixture was removed by filtration to obtain a reaction liquid. By lengthening the above-mentioned certain time, the total molar content of the cyclic imide structure and the cyclic isoimide structure in the polyamideimide precursor can be increased, and by shortening the time, the total molar content can be decreased. For example, by setting the time to 15 minutes, the molar content of the benzoxazole structure can be set to 0.104 mmol / g. The reaction solution obtained was added to 716.21 g of ethyl alcohol to produce a precipitate consisting of a crude polymer. The crude polymer produced was filtered off and dissolved in 403.49 g of tetrahydrofuran to obtain a crude polymer solution. The crude polymer solution obtained was dropped into 8470.26 g of water to precipitate the polymer, and the precipitate obtained was filtered off and then vacuum dried to obtain a powdered polymer (polyamideimide precursor) A-5.

[0398] <Synthesis Example 6: Synthesis of Polymer A-6> Except for changing 23.48 g of ODPA and 22.27 g of BPDA to 44.54 g, polymer A-6 was synthesized in the same manner as in Synthesis Example 1. In the examples, the total molar content of the cyclic imide structure and the cyclic isoimide structure is shown in the column of "specific structure mmol / g" in the table.

[0399] <Synthesis Example 7: Synthesis of Polymer A-7> Polymer A-7 was synthesized in the same manner as in Synthesis Example 1, except that 23.48 g of ODPA and 22.27 g of BPDA were changed to 46.96 g of ODPA and 39.69 g of HEMA were changed to 52.52 g of a compound represented by the following formula (7-1). In the examples, the total molar content of the cyclic imide structure and the cyclic isoimide structure is shown in the column of "specific structure mmol / g" in the table. [ka]

[0400] <Examples and Comparative Examples> In each of the examples, the components shown in the following table were mixed to obtain a curable resin composition. In each of the comparative examples, the components shown in the following table were mixed to obtain a comparative composition. Specifically, the content of each component shown in Tables 1 to 5 is the amount (parts by mass) shown in parentheses in each column of Tables 1 to 5. The obtained curable resin composition and comparative composition were pressure filtered using a polytetrafluoroethylene filter having a pore width of 0.8 μm. In addition, in Tables 1 to 5, the notation "-" indicates that the composition does not contain the corresponding component.

[0401] [Table 1]

[0402] [Table 2]

[0403] [Table 3]

[0404] [Table 4]

[0405] [Table 5]

[0406] Details of each component shown in Tables 1 to 5 are as follows.

[0407] 〔resin〕 A-1 to A-7: Polymers A-1 to A-7 obtained by the above synthesis examples

[0408] [Photosensitizer (photoradical polymerization initiator)] B-1 to B-3: Compounds having the following structures [ka]

[0409] [Organometallic Complexes] X-1: Bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl)titanium X-2: Pentamethylcyclopentadienyl titanium trimethoxide X-3: Bis(η5-2,4-cyclopentadien-1-yl)bis(2,6-difluorophenyl)titanium X-4: Titanium tetraisopropoxide (Matsumoto Fine Chemical Co., Ltd.) X-5: Diisopropoxybis(acetylacetonato)titanium (manufactured by Matsumoto Fine Chemical Co., Ltd.) X-6~X-8: Compounds with the following structures. [ka] The above X-1 and X-3 are compounds having photoradical polymerization initiation ability.

[0410] [Crosslinking agent (radical crosslinking agent)] C-1 to C-2: Compounds with the following structures [ka]

[0411] [Polymerization inhibitors, migration suppressants] D-1 to D-7: Compounds having the following structures [ka]

[0412] [Additives] E-1 to E-6: Compounds having the following structures [ka]

[0413] [Metal adhesion improver] F-1 to F-6: Compounds with the following structures [ka] In the above structural formula, Me represents a methyl group and Et represents an ethyl group.

[0414] [Solvent (solvent)] ·NMP: N-methyl-2-pyrrolidone EL: Ethyl lactate DMSO: Dimethyl sulfoxide

[0415] <Evaluation> [Measurement of molar amount of cyclic structure] For the resins used in each Example, the total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of polyimide precursor, the molar content of benzoxazole structures contained in 1 g of polybenzoxazole precursor, and the total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of polyamideimide precursor were measured. The measurement results are shown in the column of "specific structure mmol / g" in the table. Specifically, NMR was used to measure 0.1 g of the polymer dissolved in 0.9 g of deuterated DMSO. For polyimide precursors or polyamide-imide precursors, the amount of cyclic imide structure was identified from the ratio of the peak area around 7.15 ppm to the peak area of ​​the aromatic ring. Similarly, the amount of cyclic isoimide structures in the polyimide precursor or polyamideimide precursor, and the amount of benzoxazole structures in the polybenzoxazole precursor were specified.

[0416] [Resolution evaluation] In each of the Examples and Comparative Examples, the prepared curable resin composition or comparative composition was applied onto a silicon wafer by spin coating. The silicon wafer was dried on a hot plate at 100° C. for 5 minutes to form a curable resin composition layer having a uniform thickness of 20 μm on the silicon wafer. In the examples in which the exposure condition is described as "M", the curable resin composition layer on the silicon wafer was exposed using a stepper. The exposure was performed using light having a wavelength described in "Exposure wavelength nm" in the table, using a fuse box photomask with 1 μm intervals from 5 μm to 25 μm. The exposure amount was set to the amount that minimized the minimum line width described below. In the examples with "D" in the exposure condition, exposure was performed using a direct exposure device (Adotec DE-6UH III). Exposure was performed using laser direct imaging at a wavelength of 405 nm, such that the exposed area became the line area of ​​a line and space pattern with 1 μm intervals from 5 μm to 25 μm. The exposure amount was set to the amount that minimized the minimum line width described below. The exposed curable resin composition layer was developed with cyclopentanone for 60 seconds, and then rinsed with PGMEA (propylene glycol monomethyl ether acetate). In the pattern obtained after development, the line width of the line pattern with the smallest line width among the line patterns where the silicon wafer is exposed between the line patterns was defined as the "minimum line width" and evaluated according to the following evaluation criteria. The smaller the line width, the better the resolution, which is preferable because it indicates that, for example, the width of the metal wiring formed in the subsequent plating process can be made finer. The measurement limit is 5 μm. The evaluation results are shown in the "resolution" column in the table. -Evaluation criteria- A: The minimum line width was 5 μm or more and less than 8 μm. B: The minimum line width was 8 μm or more and less than 10 μm. C: The minimum line width was 10 μm or more and less than 12 μm. D: The minimum line width was 12 μm or more.

[0417] [Exposure Sensitivity Evaluation] A curable resin composition layer having a uniform thickness of 20 μm was formed on a silicon wafer by the same method as in the above resolution evaluation. In the examples in which the exposure condition is indicated as "M", the curable resin composition layer on the silicon wafer was exposed by a stepper using a photomask having a masked portion (examples in which "negative" is indicated in the development condition column in the table) or a non-masked portion (examples in which "positive" is indicated in the current condition column in the table) with a diameter of 15.0 μm. The exposure wavelength is indicated in the "Exposure wavelength nm" in the table. The exposure dose was 50 to 500 mJ / cm. 2 in the range of 50 mJ / cm 2 It was changed in increments. In the examples where the exposure condition is marked "D", laser direct imaging exposure was performed using a direct exposure device (Adotec DE-6UH III). The exposure wavelength was 405 nm, and exposure was performed so that a non-exposed area with a diameter of 15.0 μm was formed. The exposure dose was 50 to 500 mJ / cm. 2 in the range of 50 mJ / cm 2 It was changed in increments. The sensitivity was evaluated according to the following evaluation criteria from the minimum exposure dose required to form a hole pattern with a bottom diameter of 15.0 μm. The smaller the minimum exposure dose (the higher the sensitivity), the better, and the better the exposure sensitivity. The evaluation results are shown in the "Sensitivity" column in the table. -Evaluation criteria- A: The minimum exposure dose is 100 mJ / cm 2 It was less than. B: The minimum exposure dose is 100 mJ / cm 2 More than 150mJ / cm 2 It was less than. C: The minimum exposure dose is 150 mJ / cm 2 That was all.

[0418] From the above results, it is apparent that the curable resin composition of the present invention has excellent resolution. The polyimide precursors contained in the comparative compositions according to Comparative Examples 1 to 4 have a total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of the polyimide precursor of less than 0.08 mmol / g. The polyimide precursor contained in the comparative composition according to Comparative Example 5 has a total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of the polyimide precursor exceeding 1.68 mmol / g. The polybenzoxazole precursor contained in the comparative composition according to Comparative Example 6 has a molar content of the benzoxazole structure contained in 1 g of the polybenzoxazole precursor of less than 0.22 mmol / g. The polybenzoxazole precursor contained in the comparative composition according to Comparative Example 7 has a molar content of the benzoxazole structure contained in 1 g of the polybenzoxazole precursor exceeding 3.97 mmol / g. The polyamideimide precursor contained in the comparative composition according to Comparative Example 8 has a total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of the polyimide precursor exceeding 1.186 mmol / g. The polyamideimide precursor contained in the comparative composition according to Comparative Example 9 has a total molar content of cyclic imide structures and cyclic isoimide structures contained in 1 g of the polyamideimide precursor of less than 0.062 mmol / g. It can be seen that when these comparative compositions are used, the resolution is poor.

[0419] <Example 101> The curable resin composition used in Example 1 was applied in a layer form by spin coating on the surface of the thin copper layer of the resin substrate on which the thin copper layer was formed, and dried at 100°C for 4 minutes to form a photosensitive film with a thickness of 20 μm, and then exposed using a stepper (Nikon Corporation, NSR1505 i6). Exposure was performed at a wavelength of 365 nm through a mask (a binary mask with a 1:1 line and space pattern and a line width of 10 μm). After exposure, the substrate was heated at 100°C for 4 minutes. After the heating, the substrate was developed with cyclohexanone for 2 minutes and rinsed with PGMEA for 30 seconds to obtain a layer pattern. Next, the temperature was increased at a rate of 10° C. / min in a nitrogen atmosphere, and after reaching 230° C., the temperature was maintained at 230° C. for 120 minutes to form an interlayer insulating film for a redistribution layer. This interlayer insulating film for a redistribution layer had excellent insulating properties. Furthermore, when semiconductor devices were manufactured using these interlayer insulating films for redistribution layers, it was confirmed that they operated without any problems.

Claims

1. At least one resin selected from the group consisting of a polyimide precursor having at least one of a cyclic imide structure and a cyclic isoimide structure, a polybenzoxazole precursor having a benzoxazole structure, and a polyamideimide precursor having at least one of a cyclic imide structure and a cyclic isoimide structure, and Contains organometallic complexes, the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyimide precursor is 0.285 to 1.68 mmol / g; The polyimide precursor contains a repeating unit represented by the following formula (2): the molar amount of the benzoxazole structure contained in 1 g of the polybenzoxazole precursor is 0.22 to 3.97 mmol / g; the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyamideimide precursor is 0.062 to 1.186 mmol / g; Curable resin composition. 【Chemistry 1】 In formula (2), A 1 and A 2 each independently represents an oxygen atom or NH; R 111 represents a divalent organic group; R 115 represents a tetravalent organic group; R 113 and R 114 each independently represents a monovalent organic group.

2. The curable resin composition according to claim 1 , further comprising a photopolymerization initiator.

3. The curable resin composition according to claim 2 , wherein the photopolymerization initiator is an oxime compound.

4. The curable resin composition according to any one of claims 1 to 3, further comprising a crosslinking agent.

5. The curable resin composition according to any one of claims 1 to 4, wherein the organometallic complex is a metallocene compound.

6. The curable resin composition according to any one of claims 1 to 5, wherein the metal contained in the organometallic complex is at least one metal selected from the group consisting of titanium, zirconium and hafnium.

7. The curable resin composition according to any one of claims 1 to 6, wherein the organometallic complex has a photoradical polymerization initiation ability.

8. The curable resin composition according to any one of claims 1 to 7, which is used for forming a photosensitive film to be subjected to negative development.

9. The curable resin composition according to any one of claims 1 to 8, which is used for forming an interlayer insulating film for a rewiring layer.

10. The curable resin composition according to any one of claims 1 to 9, wherein the total molar content of the cyclic imide structure and the cyclic isoimide structure contained in 1 g of the polyimide precursor is 0.285 to 0.593 mmol / g.

11. A cured film obtained by curing the curable resin composition according to any one of claims 1 to 10.

12. A laminate comprising two or more layers of the cured film according to claim 11 and a metal layer between any two adjacent layers of the cured films.

13. A method for producing a cured film, comprising a film-forming step of applying the curable resin composition according to any one of claims 1 to 10 to a substrate to form a film.

14. The method for producing a cured film according to claim 13 , comprising: an exposure step of exposing the film to light; and a development step of developing the film.

15. The method for producing a cured film according to claim 14 , wherein the exposure light used in the exposure contains light having a wavelength of 405 nm.

16. The method for producing a cured film according to claim 14 or 15, wherein the exposure is performed by a laser direct imaging method.

17. The method for producing the cured film according to any one of claims 13 to 16, comprising a heating step of heating the film at 50 to 450°C.

18. A semiconductor device comprising the cured film according to claim 11 or the laminate according to claim 12.

Citation Information

Patent Citations

  • Photosensitive polyimide precursor composition

    JP2002296767A

  • Negative photosensitive resin composition, method for manufacturing cured relief pattern, and semiconductor device

    JP2011191749A

  • Photosensitive resin composition, cured film, laminate, method for producing cured film, method for producing laminate, and semiconductor device

    WO2018025738A1